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Gold nanoparticles have drawn significant interest in recent years due to their unique 
optical, electronic, and molecular recognition properties. It is widely known that the key 
properties of gold nanoparticles are dependent on their size, morphology, and nature of 
the ligands that stabilize them against aggregation. A recent development in the field of 
gold nanoparticle chemistry is the synthesis and application of glycogold nanoparticles, 
which are water-soluble three-dimensional multivalent systems based on carbohydrate-
decorated gold nanoparticles. Glycogold nanoparticles are typically synthesized by 
attaching carbohydrates to the surface of gold nanoparticles via thiol-terminated linkers. 
They have been used to detect many toxic proteins such as concanavalin A, Ricinus 
communis agglutinin 120, cholera toxin, and viral hemagglutinin. Facile methods for the 
synthesis of gold and glycogold nanoparticles and the demonstration of the efficient use 
of glycogold nanoparticles as colorimetric sensors for toxic proteins are highly sought 
after.  
 
The work in this thesis focuses on the synthesis of gold nanoparticles of various shapes 
and sizes using the Turkevich reaction and the synthesis of glycogold nanoparticles using 
Brust-Schiffrin method, ligand exchange method, and the copper(I)-catalysed azide-
alkyne Huisgen cycloaddition. Also, the application of galactose-capped gold 
nanoparticles and full-length sialic acid terminated complex bi-antennary N-glycan-
capped gold nanoparticles as colorimetric sensors for the detection of the lectin heat-
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A note concerning terminologies related to nanoparticles 
 
Dispersity is a measure of the heterogeneity of the sizes of the nanoparticles in a sample. 
A monodisperse sample is composed of particles of same size, whereas a polydisperse 
sample contains particles of different sizes.  
 
Nanoclusters are particles smaller than 1 nm, and have a precisely defined size without 





Multivalency refers to the property of nanoparticles to be able to bind to a multiple 
number of ligands. 
 
Multifunctionality refers to the property of nanoparticles to be able to bind to different 
kind of ligands. 
 
Reference 
1. Parker, J. F.; Fields-Zinna, C. A.; Murray, R. W. Acc. Chem. Res. 2010, 43 (9), 
1289-1296. 
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Chapter 1: Introduction 
  
1.1. Background  
1.1.1. Nanoparticles 
One of the most significant developments in science in the last five decades has been the 
emergence of materials with morphology defined down to the nanometre scale. 
Nanoparticles (NPs) comprise an important sub-class of nanomaterials with all 3 
dimensions smaller than a specific threshold value (1 micron). NPs are assemblies of 
atoms that have different shapes, and typically have size in the range from 1 to 100 nm 
(Figure 1.1).
1
 Metal NPs, with their unique physicochemical properties, have drawn 
significant interest in recent years. They are expected to form the basis of many of the 




 Since the size of the most 
metal atoms falls in the range of 0.1 to 0.2 nm, metal NPs generally contain hundreds to 
several thousands of metal atoms depending on the size of the NP.
3
 There have been a 
large number of reports detailing the synthesis of metal NPs in the literature, especially 









Figure 1.1.  A schematic representation depicting the relative size of NPs in comparison 
with other biological entities. Image reproduced from Ref. 4 with permission from 
Elsevier. 
 
1.1.2. Gold nanoparticles 
Gold nanoparticles (AuNPs) are one of the most significant classes of metal NPs.
5
 AuNPs 







 To date, more than 70,000 reports focused on AuNPs 
have appeared in the literature showing the growing importance of this class of 
nanomaterial.
5
 In 1857, Michael Faraday reported the first synthesis of AuNPs (deep red 
in colour) by the reduction of an aqueous solution of tetrachloroaurate (AuCl4
ˉ 
) using 
phosphorus in CS2 (a two-phase system).
9
 Faraday`s synthesis inspired many scientists to 
invent new synthetic methods for AuNPs in the 20th century.
10-13
 Over the past decade, 
different groups have been conducting extensive studies on AuNPs mainly due to their 
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1.1.3. The Chemistry of Gold.  
Gold, a noble metal with the atomic number 79 and chemical symbol Au, is located 
below copper and silver in group 11 (IB) in the periodic table. The ground state electronic 






. Au is known to exist in several different oxidation 
states, namely (-I), (0), (I), (II), (III), (IV), and (V); however, only species containing Au 
(0), (I), and (III) are typically stable in aqueous solution.
2
 Therefore, in vivo, Au exists in 
equilibrium between its metallic ground state of (0) and its oxidized states (I) or (III).
14
 
Au is distributed in nature either in its metallic form or as a component of ores of other 
transition metals. In its metallic form, Au is soft and is one of the most ductile of the 
elements. Metallic Au is also one of the least reactive metals and it does not oxidize or 
burn in air, even when heated. It is also inert to strong acids and alkali.
15
 Even nitric acid 
is not a strong enough oxidizing agent to oxidize Au. However, aqua regia, a mixture of 
nitric and hydrochloric acid in a 1:3 molar ratio, can dissolve Au as the Au ion is 








 complex is a strong oxidizing agent, and is easily reduced by various 




1.2. Methods of AuNP synthesis 
AuNPs are prepared by both “top down” and “bottom up” procedures.
18
 In the “top 
down” approach, a bulk state metallic Au is systematically broken down to produce 
Chapter 1                                                                                                                                                                                                                              
4 
 
AuNPs of different sizes.
19
 However, the “top down” approach is limited in its use as the 
control over the shape and further functionalization of particles is difficult.
19
 
Alternatively, in the “bottom up” method AuNPs are formed from individual Au atoms 
which are themselves formed by chemical reduction.
20
 This process involves two steps: 
nucleation and successive growth; when these occur in the same reaction process, AuNP 





The LaMer theory proposed by LaMer and Dinegar in the early 1950‟s explains the 
correlation between the nucleation and the growth of the produced nuclei, and how 
monodisperse NPs are formed in a homogenous solution.
21
 This mechanism is based 
upon an extensive study of the solution-phase synthesis of sulfur colloids. In the context 
of metal NP synthesis, the concentration of metal atoms (C) increases steadily with time 
as the precursor compound is reduced (or decomposed) to give metal atoms (region (I) in 
Figure 1.2).
22
 Once C reaches a point of critical level for nucleation (Cmin or Ccrit), the 
atoms begin to aggregate to form nuclei (region (II) in Figure 1.2). In this stage, C still 
continues to increase for a while until critical limiting supersaturation is reached (Cmax).
23
 
C then decreases because of the increased consumption of metal atoms for the growth of 
nuclei, and then reaches the critical level for nucleation again. This stage corresponds to 
the end of the nucleation. Finally, the system enters and goes through the growth stage 
(region (III) in Figure 1.2) until the metal concentration is lowered so that it is close to 
the solubility level Cs. A clear separation between the nucleation and the growth stages is 
the major requirement for the formation of monodisperse particles.
24
 Hence, if the 
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nucleation rate is not high enough, i.e, the metal concentration C lingers between Cmin 
and Cmax, growth of the particles occurs along with the nucleation resulting in the 
formation of polydisperse NPs. 
 
 
Figure 1.2. A schematic representation of the LaMer model of nucleation and growth of 
NPs. The regions I, II, and III indicate the prenucleation, nucleation, and growth stages 
respectively. Image reproduced from Ref. 25 with permission from the Royal Society of 
Chemistry.   
 
1.2.1. In situ synthesis of AuNPs 
The in situ synthesis of AuNPs consists two major parts: (i) formation of NPs from 
individual Au atoms which are themselves formed by reduction of the Au precursor. 







(ii) Stabilization of particles by ligands against aggregation, and the ligands generally 













 AuNPs synthesized through the in situ 
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process can also be used as seeds for the seed-mediated growth for the synthesis of larger 




1.2.1.1. The Turkevich reaction (citrate reduction method) 
The citrate reduction method, developed by Turkevich in 1951, is the most popular in situ 
synthesis of AuNPs.
10
 Typically, an aqueous solution of trisodium citrate dihydrate 
(hereafter referred as citrate) is added to a boiling aqueous solution of HAuCl4∙3H2O with 
vigorous stirring (Scheme1.1). The yellow coloured solution turns colourless and then 
deep wine-red, indicating the formation of citrate-stabilized AuNPs (Cit-AuNPs). In 
1973, Frens reported an improved method, in which Cit-AuNPs of various sizes (from 15 
to 150 nm) were synthesized by controlling the ratio of trisodium citrate to HAuCl4.
12
 
However, any NPs formed in this way which were larger than 20 nm size were always 
found to be polydisperse.  
 
 
Scheme 1.1. Synthesis of Cit-AuNPs in the Turkevich reaction. 
 
Over the last decade, several groups have improved the Turkevich method, and have 
proposed different possible mechanisms for Cit-AuNP formation. These improved 
methods and the proposed mechanisms are discussed in detail in Chapter 2.  
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In reactions at relatively low temperatures and with strong reducing agents such as 
NaBH4, citrate only acts as a stabilizing agent due to its weak reducing nature. In 1985, 
Slot et al. reported AuNP synthesis at 60 
o
C using a mixture of tannic acid and citrate in 
which the tannic acid acted as a reducing agent and the citrate as the stabilizing agent.
32
 
Subsequently, in 1996, Brown et al. reported AuNP synthesis in which NaBH4 was used 
as the reducing agent and citrate as a stabilizing agent (Scheme 1.2).
33
 In this case AuNPs 
were obtained at room temperature simply upon the addition of a NaBH4/citrate mixture 
to the HAuCl4 solution.  
 
 
Scheme 1.2. Synthesis of 6 nm sized Cit-AuNPs using NaBH4 as the reducing agent and 
citrate as the stabilizing agent. 
 
1.2.1.2. The Brust-Schiffrin method 
In 1993, Giersig and Mulvaney demonstrated the use of alkylthiols of various chain 
lengths to stabilize AuNPs.
34
 Later, in 1994, an in situ synthesis of thiol-stabilized 
AuNPs, the two-phase Brust-Schiffrin method (BSM), was published.
26
 In the BSM, 
HAuCl4 was first transferred from an aqueous phase to toluene using 
tetraoctylammonium bromide (TOAB) as a phase transfer agent (Scheme 1.3).
26
 The two 
phases were then separated, and dodecanethiol was added to the organic phase, which 







 An aqueous solution of NaBH4 was then added to the organic phase 
Chapter 1                                                                                                                                                                                                                              
8 
 
with vigorous stirring. The colour of the toluene solution then immediately changed from 
colourless to deep-brown indicating the formation of AuNPs (Scheme 1.3).  
 
 
Scheme 1.3. A schematic representation of AuNP formation in BSM. Reprinted with 
permission from Ref. 35. Copyright (2016) American Chemical Society.  
 






+ Br (org) (Roct)4N
+AuX4(org) + HX(aq) (1.1)
 
 









 with dodecanethiol (RSH) yielded a 





_ + RSSR + (Roct)4N
+ + 4X + 3H+ (1.2)(Roct)4N
+AuX4 + 3RSH
 














+AuX4 + BH4 + RSH + RSSR
_(AuSR)n
_ + BH4 + RSH + RSSR Aux(SR)y (1.3)
Aux(SR)y (1.4)  
 
However, recent reports from Goulet and Lennox
38
 and Li et al.
39
 showed that a thiolate 
polymer −(AuSR)n− was not formed in the BSM. Instead the reduction of AuX4
ˉ 
by 
alkanethiol actually produced a new intermediate, AuX2
ˉ
, by the following reaction: 
 
(Roct)4N
+AuX4 + 2RSH (Roct)4N
+AuX2 + RSSR + 2HX (1.5)  
 










the solution before the addition of NaBH4 (Scheme 1.4).  
 
 
Scheme 1.4. Revised BSM by Goulet and Lennox.
38
 Image reprinted with permission 
from Ref. 38. Copyright (2016) American Chemical Society. 
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The BSM was a major breakthrough in AuNP synthesis for multiple reasons: (1) the easy 
synthesis of AuNPs under mild reaction conditions, (2) the AuNPs synthesized are highly 
stable, (3) the particles can be dried and re-dissolved without any decomposition or 
aggregation, (4) smaller particles (2 - 5 nm range) with a narrow size distribution can be 




In the BSM, higher S to Au molar ratios and a faster addition of NaBH4 are known to 
produce smaller AuNPs with very narrow particle size distributions.
40
 The particles 
obtained are highly stable due to the strong Au-S covalent bonds formed on the particle 
surface.
41
 The Au-S covalent bond is believed to be formed by the oxidative addition of 
the S-H bond onto two adjacent Au
0
 atoms on the surface of the AuNPs.
5
 The Au-H 
bonds formed are known to have fluxional properties (the dynamic property that allows 
the atoms to interchange between symmetry-equivalent positions), allowing the swift 
movement of H atoms on the NP surface. This movement eventually results in two Au-H 





Due to the advantages of the BSM that were explained above, it is now widely used for 
the synthesis of thiol-functionalized AuNPs.
38
 The synthesis of precise Au clusters has 




In 1995, Brust et al. published a modified BSM in which p-mercaptophenol-
functionalized AuNPs were synthesized in MeOH (Scheme 1.5) without the use of a 
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phase transfer reagent, which avoided the TAOB impurities that were observed in 
previous cases.
44
 This finding led to a large number of follow-up publications that 
focused on the synthesis of thiol-functionalized AuNPs through the BSM in a single-
phase system.
41
 It is now understood that any thiol that is soluble in the same solvent as 
HAuCl4, such as H2O, MeOH, or EtOH, can be used for the synthesis of thiol-stabilised 









NaBH4, the reducing agent used in the BSM, is much stronger than the citrate used in the 
Turkevich reaction. Thus, the rate of reduction in the BSM is much faster than that 
observed in the Turkevich reaction, which results in the formation of smaller AuNPs in 




1.2.1.3. Place exchange reactions to form mixed monolayer AuNPs 
In 1996, Hostetler et al. reported the first „place exchange reactions‟ a term which refers 
to a reaction involving the substitution of the thiol ligands on the surface of an AuNP by 
another thiol (Scheme 1.6).
40
 This reaction allowed the introduction of different 
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functionality onto the surface of AuNPs. The place exchange reaction involves the 
transfer of the hydrogen atom from the S-H bond of the incoming thiol to the S atom 
bonded to the AuNP surface (equation 1.6).
5
   
 
Au-SR + R`SH Au-S(R)...H...SR` HSR + Au-SR` (1.6) 
 
The extent of exchange on the AuNP surface is dependent on the reaction time and the 
amount of the added thiol.
45
 The major advantage of using place exchange reactions is 
that AuNPs decorated with different functional thiols can be synthesized without 





Scheme 1.6. A general scheme for place exchange reaction for alkanethiol-functionalized 




However, place exchange reactions are known to have some disadvantages, such as: (1) 
difficulty in controlling the extent of ligand substitution, (2) the possibility of irreversible 
particle aggregation, (3) the difficulty in determining the amount of ligands that have 
exchanged, and (4) incompatibilities between the incoming thiols and the solvent in 
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1.2.1.4. AuNPs stabilized with phosphorus-based ligands 
AuNPs stabilized by phosphorus-based ligands are good precursors for ligand-
substitution reactions to give functionalized AuNPs.
28
 These AuNPs also have potential 
applications in sensing, imaging, catalysis, and for therapeutic uses.
5
 The most popular 
phosphorus ligand-stabilized Au nanosystem is the Schmid‟s cluster. In 1981, Schmid et 
al. reported the synthesis of the phosphine-stabilized Au55 cluster ([Au55(PPh3)12Cl6]), 
which is now known as Schmid‟s cluster.
46
 Triphenylphosphine acts as a good stabilizing 
ligand for 1.4 nm sized Au55 clusters in Au55(PPh3)12Cl6. The cluster was synthesized by 
the reduction of Ph3PAuCl with gaseous diborane in either toluene or benzene at elevated 
temperatures. Later, in 2000, Weare et al. modified Schmid‟s method by adding NaBH4 
(instead of the diborane used in Schmid‟s method) and triphenylphosphine to HAuCl4 
and TOAB in a toluene-water mixture.
47
 The cluster [Au101(PPh3)21Cl5]  was produced, 
along with [Au(PPh3)Cl] as an impurity. In 2009, Shem et al. used the mild reducing 
agent, 9-borabicyclo-[3.3.1] nonane (9-BBN) for the synthesis of triphenylphosphine-
stabilized AuNPs.
48
 These particles had sizes in the range of 1.2 - 2.8 nm with a narrow 
size distribution. Recently, many groups have reported different methods for synthesizing 




1.2.1.5. Other capping ligands 
Although thiol compounds are the most commonly used ligands to functionalize AuNPs, 
a variety of other ligands have also been used. Apart from sulfur containing ligands, 
nitrogen- and oxygen-based ligands having functional groups such as amines, carbonyls, 
carboxylates, and phenols also have been used to stabilize AuNPs. In particular amines 
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Amongst the amine ligands used, 4-(N,N-dimethylamino) pyridine (DMAP) is 
particularly common, and DMAP-stabilized AuNPs have been extensively used for 
ligand-substitution reactions.
53
 These DMAP-stabilized AuNPs can be synthesized by 





1.2.2. The seed-mediated growth method 
The seed-mediated growth method is another common procedure used for AuNP 
synthesis. In this growth method, particles are increased in size step-by-step, and it is 
much easier to control the shapes and sizes of the AuNPs.
55
 This method has two steps: in 
the first step, small AuNP seeds are synthesized; in the second step, the seeds are added 
to a “growth” solution containing both reducing and stabilizing agents, and also a source 
of Au precursor (typically HAuCl4).
55
 The newly formed Au
0
 atoms adsorb onto the 
surface of the seeds resulting in the formation of larger AuNPs. Mild reducing agents are 




 reduction only occurs in the 
presence of Au seeds as catalysts.
56
 Hence, no new nucleation events occur under such 
conditions, and the deposition of the newly formed Au
0
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In 1998, Brown and Natan reported the first seed-mediated synthesis of AuNPs.
57
 The 12 
nm sized seeds they used in that reaction were synthesized following the Turkevich 
procedure. The growth step was based on the colloidal Au surface-catalysed reduction of 
Au
3+
 by NH2OH and spherical AuNPs with sizes between 30 and 100 nm were 
synthesized. Subsequently Murphy‟s group used 3.5 nm sized citrate-capped Au seeds for 
the seed-mediated growth reaction.
56
 The seeds were synthesized by adding an ice-cold 
aqueous solution of NaBH4 to an aqueous solution containing HAuCl4 and citrate. The 
seeds were also used for the synthesis of Au nanorods. In 2003, El-Sayed‟s group 
modified the seed synthesis by using hexadecyltrimethylammonium bromide as the 
stabilizing agent instead of citrate.
58
 Au seeds with a size smaller than 4 nm were used to 
reduce the dispersity of Au nanorods produced in the growth step. Now seed-mediated 
growth has been widely used for the synthesis of monodisperse, large, spherical or quasi-
spherical AuNPs, Au nanorods, and AuNPs of other shapes (rectangle, hexagon, cube, 




1.3. The physical properties of AuNPs 
The physical properties of NPs are significantly different to those of bulk materials and 
molecular or ionic compounds which contain the same element. Typically NPs have a 
range of interesting properties, such as size-related magnetic, electronic, and optical 
effects (a quantum size effect), and also properties related to their higher surface area to 
volume ratio.
60
 The quantum size effect of AuNPs arises due to the fact that the 
wavelength of the metallic electrons (6s
1
) is the same order of magnitude as the size of 
the NPs themselves (λ ~ 1 nm).
61
 This property results in the particles behaving 
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electronically as zero-dimensional quantum dots or quantum boxes, where they are 
subjected to quantum-mechanical rules.
61
 Apart from their size, the physical properties of 
NPs also depend strongly on the distance between the particles, their structure, and also 




In regard to the structure of thiol-functionalized AuNPs, recent X-ray crystallographic 
studies of Au25 and Au102 clusters have revealed that the thiol ligands form linear RS-Au-
SR units on the AuNP surface, in contrast to the generally accepted model for flat 
surfaces, in which thiol ligands form head-on single covalent bonds with the close-
packed Au core.
63-65
 Thus, many of the Au atoms make bonds with thiol ligands and form 
semiring structures, and these Au atoms are not part of the main particle core.
18
 However, 
since the synthesis of larger sized AuNPs always produce polydisperse particles, their 
structural studies have been limited and to what extent the structural aspects of the 
clusters match with the large particles remain to be explored. 
 
1.3.1. Surface Plasmon Resonance 
When a metal NP is exposed to light, the oscillating electromagnetic field of the light 
induces a collective coherent oscillation of the conduction band electrons of the metal. 
This electron oscillation around the NP surface results in a charge separation, which in 
turn causes a dipole oscillation along the direction of the electric field of the light (Figure 
1.3). The amplitude of the oscillation is a maximum at a specific frequency, which is 
known as surface plasmon resonance (SPR).
66
 The SPR induces a strong absorption of 
incident light, and thus can be measured using a UV-Vis absorption spectrophotometer. 
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The wavelength and intensity of the SPR band depend on the factors affecting the 
electron charge density on the NP surface, such as the particle size, structure, shape, the 




Figure 1.3. SPR of AuNPs; the collective oscillation of surface electrons with incident 




AuNPs in the size range of 5-20 nm exhibit their SPR band near 520 nm in the visible 
region. The SPR peak position is affected by the NP size (Figure 1.4) and the peak red 








Figure 1.4. UV-Vis absorption spectra of AuNPs with different sizes. 
 
In addition, the SPR frequency is very sensitive to the interparticle distance. Specifically, 
if particles aggregate the SPR band shifts to lower energies i.e. to higher wavelengths 
(typically a red-shift from ∼520 to ∼650 nm).70 This shift results in a change in the 
colour of the AuNP solution from red to blue, and this property of AuNPs has been 
exploited for the development of colorimetric sensors.  
 
1.3.2. Fluorescence 
Various studies have demonstrated that AuNPs contribute to the fluorescent activity of 
the fluorophores attached on their surface or freely present in solution.
7, 71
 AuNPs are 
known to be good fluorescent quenchers of a wide range of fluorophores.
71
 Fluorescence 
quenching is mainly observed when fluorescent ligands are attached to the surface of 
AuNPs. The fluorescent quenching occurs when the emission spectrum of the 
fluorophores matches the SPR band of the AuNPs.
72
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the size and shape of the NPs, the distance between the particle core and the 
fluorophores, and the dipole orientation with respect to NP-dye axis also affect the 




1.3.3. Ligand presentation 
Any desired ligand can be attached to the spherical or quasi-spherical scaffold of AuNPs. 
The multivalent presentation of such functionalized ligands in these AuNPs makes them 
good candidates for a variety of applications such as sensing, receptor specific 
multivalent binding, and biosystem mimicking.
73
 In addition, AuNPs carrying several 
different ligands, known as „hybrid AuNPs,‟ have also attracted considerable attention.
74
 
The extent of multifunctionalization in these particles can be controlled by regulating the 
relative molar ratios of the different ligands added during their synthesis, the way in 
which the ligands bind to the NP core, and the core size of the particles itself.
74
   
 
1.4. Synthesis and application of glycogold nanoparticles 
1.4.1. Biofunctionalized NPs 
Biofunctionalized NPs represent hybrid systems that combine inorganic nanostructures 
with biomolecules.
75
 A large variety of novel biofunctionalized NPs has been synthesized 
and used to study biologically relevant interactions.
76
 The wide range of metals that can 
be used as the metal core of these systems permits tuning of the electronic, optical, and 
magnetic properties of such NPs.
77
 The size of the biofunctionalized NPs can be varied, 
and their surface can be modified with multivalent and multifunctional ligands.
78
 
Biofunctionalized NPs can have sizes similar to those of the naturally occurring scaffolds 
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made from nucleic acids and proteins which enables these particles to be used as 





Au has been the most popular choice of metal for the core of biofunctionalized NPs.
20
 
The first studies of AuNPs decorated with peptides, antibodies, DNA, and proteins 
appeared in 1990‟s.
4
 In 2001, the Penadés group reported the synthesis of AuNPs 
attached to carbohydrates for the first time.
79
 These systems were comprised of AuNPs 
with the Au atoms covalently attached to thiols of the thiol-terminated carbohydrate 
derivatives, and these particles were termed „glycogold nanoparticles (gAuNPs).‟
79
 After 
the first report on gAuNPs by the Penadés group,
79
 the number of studies focusing on the 






Carbohydrates, also known as saccharides, are one of the most abundant biomolecules. 
Along with lipids and peptides, they constitute the essential molecules for life.
80-81
 
Carbohydrates are poly-hydroxylated aldehydes or ketones, and can exist as 
monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The 
monosaccharides and disaccharides, which are smaller carbohydrates, are generally 
referred to as sugars. Carbohydrates are synthesized by plants through photosynthesis; in 
the presence of light, CO2 reacts with water to give oxygen and carbohydrates, with the 
general formula Cm (H2O)n:
81
 






Cm(H2O)n + O2 (1.7)  
 
Carbohydrates contain a large variety of monosaccharide units with backbones of varying 
length. The monosaccharides have carbonyl groups, either as aldehydes or ketones, also 
primary and secondary alcohols. The sequence of stereogenic centres presents in the 
monosaccharide influences how it occupies in a 3-dimensional space. Each 
monosaccharide has its own enantiomer with respect to the most distant stereogenic 
centre from the carbonyl group. The prefixes D and L are assigned to distinguish between 
the two enantiomers (Figure 1.5). In the D form, the hydroxyl group (higher priority 
group) on the last chiral carbon of the open chain Fischer projection is on the right side, 
















Figure 1.5. Fischer projections of D-glucose (left) and L-glucose (right). 
 
The open chain form of monosaccharides can undergo intramolecular reaction; a 
nucleophilic attack of one of the hydroxyl groups at the intrachain aldehyde or ketone 
results in the formation of a cyclic hemiacetal or hemiketal respectively.
83
 The most 
commonly formed ring structures are furanoses (five membered rings) and pyranoses (six 
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membered rings) as shown in Scheme 1.7. The newly formed stereocenter is called the 
anomeric centre. The two possible stereochemistries formed at the anomeric centre are 
called anomers,
82
 which are diastereoisomers of one another. The configuration at the 
anomeric carbon is termed as alpha- (α-) or beta- (β-) with respect to the stereocenter that 
decides the absolute configuration (D or L form).
84
 As shown in Figure 1.6, cyclic sugars 
can be represented in different ways such as Mills, Fischer, Haworth, and chair 
representations. In a Fischer projection, if the hydroxyl group at the anomeric centre is on 
the same side as the hydroxyl group of the configurational (D- or L-) carbon, it is the α-
anomer of the sugar.
82
 If it is in the opposite side, then it is the β-anomer. In general, the 
functionalization of the anomeric hydroxyl group blocks ring opening/closing 





Scheme 1.7. Formation of furanose and pyranose from D-glucose open chain form. 
 




Figure 1.6. (a) Mills, (b) Fischer, (c) Haworth, and (d) chair representations of α-D-     
glucopyranose. 
 
With pyranoses, various ring conformations are possible. Generally, a chair conformation 
with C2, C3, C5, and the ring oxygen occupying the same plane is preferred as shown in 
Figure 1.6d.
82
 The chair form can have two conformations depending on where the C1 
and C4 are located. A conformation in which the C4 is above and the C1 is below the 
plane is known as the 
4
C1 conformation, whereas when the C1 is above and the C4 is 
below the plane, it is called a 
1
C4 conformation. One conformation is preferred over the 
other based on the stereochemical placement of substituents on the ring (Scheme 1.8). 
Typically, substituents prefer to occupy the equatorial positions, however a trade-off 
between maximizing orbital overlaps between the orbital with electron lone pair in the 





C1 (left) and 
1
C4 (right) ring conformations of D-glucose derivative. Here 
4
C1 is preferred over 
1
C4 due to the 1-3 diaxial steric hindrance (shown in red double 
headed arrows) present in 
1
C4 conformation. This preference is observed to increase with 
increasing size of substituent R. 
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C-O bond (the anomeric effect) and minimizing the 1,3-diaxial steric interactions is most 
often made. The anomeric effect is a stereoelectronic effect that explains why 
electronegative heteroatomic substituents attached to the anomeric carbon prefer the axial 
position over the less hindered equatorial position.
82
 Amongst the many explanations 
provided, a most widely accepted one is based on hyperconjugation. A stabilizing 
interaction, hyperconjugation, is seen between the lone pair of electrons in the ring 
oxygen and the ζ*C1-Y1 orbital of the axial (exocyclic) C-Y bond (Y is an electronegative 
heteroatom). Hyperconjugation occurs only when the orbital with the lone pair in the ring 
oxygen is aligned antiperiplanar (180
o
) to the ζ* orbital of the C-Y bond (Scheme 1.9, Y 
is Oxygen in this case).
85
 Thus, when C-Y bond is placed in the axial position, the overall 
energy is lowered and the molecule achieves more stability.    
 
 
Scheme 1.9. The anomeric effect is seen when the electronegative heteroatomic 
substituent at the anomeric position is in axial position. 
 
1.4.2.1. Glycosylation 
Glycosylation refers to the reactions in which a glycosyl donor, typically bearing a labile 
leaving group at the anomeric centre, is joined to a hydroxyl or other functional groups of 
another compound (glycosyl acceptor).
86
 The new bond formed through glycosylation 
between the hemiacetal or hemiketal groups of a sugar with the glycosyl acceptor is 
called a glycosidic bond, and the compound containing such a bond is called a 





 By choosing both the glycosyl donor and acceptor as monosaccharides, 
disaccharides can be made. Through further glycosylation of the disaccharide, tri-, tetra-, 
oligo-, and polysaccharides can also be synthesized. In biological systems, enzyme-
catalysed glycosylation reactions produce the necessary carbohydrate molecules, and 
conjugate them to lipids, peptides, and proteins to give glycolipids, glycopeptides, and 
glycoproteins respectively.
87
   
 
In a glycosylation reaction, the monosaccharide is attached to the acceptor via the 
anomeric carbon. Typically, the donor molecule is modified to have a suitable leaving 
group at the anomeric position. The leaving group, in general, is activated using an 
activator, such as a Lewis acid, and eliminated via the formation of an oxocarbenium ion 
intermediate (Scheme 1.10). A nucleophilic attack of a glycosyl acceptor at the reactive 
anomeric carbon of the oxocarbenium ion of the donor results in the formation of a 
glycosidic bond. The bond can be axial or equatorial (α linkage or β linkage respectively 
for glucose), or a mixture of both depending on the nature of the donor, acceptor, and the 
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Scheme 1.10. A glycosylation reaction between two monosaccharides through 
oxocarbenium intermediate formation giving α- and β- glycosides. 
 
Oligo- and polysaccharides are known to be highly flexible due to the significant freedom 
of rotation about the glycosidic bond joining the monosaccharide subunits.
88
 Due to this 
flexibility, oligosaccharides are known to possess conformational heterogeneity and often 
various conformations are attainable at ambient conditions.
88
 The alcohol groups in a 
monosaccharide can be modified by reduction, oxidation, or substitution to give deoxy-, 




A wide variety of polysaccharides can be made by choosing different monosaccharide 
units, by functionalizing the anomeric positions with different acceptors, and also 
functionalizing the hydroxyl groups with various molecules.
89
 Such a variety of 
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combinations of functionalities in a carbohydrate results in them having different 




1.4.3. The biological importance of carbohydrates 
The multitude of structural variations possible within a macromolecular carbohydrate unit 
enables them to function as an essential component in biological systems. They serve as 
the energy storage and transport units, in the form of glycogen and starch in animals and 
plants respectively, and they also act as the structural units in plants and crustaceans, for 




Apart from serving as the energy sources and structural materials, carbohydrates also 
mediate biorecognition events through their interactions with proteins and other 
biological units. For example, carbohydrates are known to be involved in immune 
response, cell communication and trafficking, fertilization, tumour genesis and 
progression, infection, and apoptosis.
91
 However, there have been many challenges which 
hamper the study and understand these processes in detail. The major hindrances in the 
development of glycoscience have been the complexity of the glycan structures involved, 
their low natural abundance, and also the weak affinities of carbohydrate-protein 
interactions.
91
 However, recent progress in the synthesis of complex carbohydrate 
structures, methods for glycan analysis, and glyconanotechnology have assisted 
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Lectins are carbohydrate-binding proteins which are known for their specificity for sugar 
molecules.
93
 One of the most significant developments in the field of glycoscience was 
the realisation that carbohydrates bind lectins in a highly cooperative way in order to 
enhance the weak affinity of individual carbohydrate-lectin interactions.
94
 The 
tremendous increase in the binding constant when multiple copies of carbohydrates 
interact with a lectin as compared to the simple sum of the total number of carbohydrate 




The understanding of the „cluster glycoside effect‟ has inspired researchers to explore the 
carbohydrate interaction processes with renewed interest.
95
 Various groups have attached 
multiple copies of carbohydrates to the scaffolds such as peptides, proteins, lipids, and 
synthetic polymers in order to study the multivalent effect.
96
 New synthetic strategies 
have been developed to control the spatial orientation and the number of ligands on the 
scaffold, and also the structure of the scaffold itself, all of which affect the binding 
affinity between the glycoconjugate and the receptor.
96
 It is expected that carbohydrate-
based therapeutics may be developed with these synthetic multivalent glycoconjugates as 





1.4.4. Glycogold nanoparticles  
The quest for a better scaffold for the synthesis of multivalent carbohydrates structures 
has led to the development of self-assembled monolayers (SAMs) of carbohydrates on 
the spherical surface of the AuNPs; a method that was termed the „glyconanotechnology 





 In 2001, the Penadés group defined glycogold nanoparticles (gAuNPs) as “a 
new, water-soluble, three-dimensional polyvalent model system based on sugar-modified 
gold nanoclusters. These so-called glyconanoparticles provided a glycocalyx-like surface 
with a globular carbohydrate display, and chemically well-defined compositions for the 




A suitably arranged saccharide layer on the surface of gAuNPs makes them soluble, 
stable, and compatible with biological media.
75
 The entity that binds the desired sugar 
moiety to the surface of AuNPs is termed a linker, and the length and nature 
(hydrophobic or hydrophilic) of the linker influence the flexibility and the accessibility of 
the sugars during any interaction with receptors.
99
 Multifunctional gAuNPs which 
contain a combination of carbohydrates, lipids, peptides, RNA, DNA, or fluorescent 
molecules on the surface of the same AuNP allow for the creation of an “artificial 
glycocalyx.”
99
 Moreover, the magnetic, electronic, and optical properties of gAuNPs can 
be altered by varying the size of the AuNP core.
99
   
 
1.4.5. The synthesis of gAuNPs 
In general, there are three methods that can be used to synthesize gAuNPs: (A) a direct 
method involving the reduction of HAuCl4 in the presence of carbohydrate derivatives 
with linkers bearing a thiol end-group (Figure 1.7A); (B) a ligand exchange reaction 
involving the replacement of the ligands on preformed AuNPs with carbohydrate 
derivatives with linkers bearing a thiol end group (Figure 1.7B); (C) a method involving a 
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chemical reaction between functional groups of the ligands attached to the surface of 





Figure 1.7. Common methods for the preparation of gAuNPs. (A) Direct synthesis, (B) 
ligand exchange, and (C) ligand modification methods. Image reprinted from Ref. 75 
with permission from Elsevier.  
 
1.4.5.1. Direct in situ formation of gAuNPs 
In 2001, Fuente et al. reported the first ever synthesis of gAuNPs, and the single-phase 
BSM was used for the synthesis.
79
 Stable gAuNPs of 2 nm average size were synthesized 
by the addition of either an aqueous or methanolic solution of thiol-derivatives of the 
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disaccharide lactose [β-Gal-(1→4)-Glc] and the Lewis X trisaccharide [β-Gal-(1→4)-[α-
Fuc-(1→3)]-β-GlcNAc, Le
X
] to an aqueous solution of HAuCl4 and the subsequent 
reduction of the Au salts with NaBH4. (Scheme 1.11) The gAuNPs formed were used to 
study the selective self-recognition of Le
X




Scheme 1.11. Structures of the thiol derivatives of the disaccharide lactose and the 
trisaccharide Lewis X synthesized by Fuente et al.
79




Subsequently many other groups have used the direct reduction method to synthesize 
gAuNPs decorated with various sugars. 
100-108
 Different thiolated linkers, such as 
hydrophilic polyethylene glycol derivatives and hydrophobic alkanes, have been used to 
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attach saccharides to the surface of AuNPs.
75
 The size of AuNP core can be varied 
approximately from 1 to 10 nm by changing the ratio of the thiol ligands to the amount of 
HAuCl4 in a direct in situ synthesis of gAuNPs.
75
 Herein larger particles are formed when 
the ratio is small, and smaller particles are formed when the ratio is high. Also, by 
manipulating the ratio of the carbohydrate ligands to non-carbohydrate ligands during the 
synthesis, gAuNPs with varied carbohydrate ligand surface densities can be synthesized. 
These gAuNPs can be used as model systems to study the influence of carbohydrate 
density on molecular-recognition processes.  
 
The most complex hybrid gAuNPs reported in the literature to date have four different 
ligands on the same AuNP (Scheme 1.12).
109
 These gAuNPs contain a peptide from 
tetanus toxoid (T-cell helper peptide), glucose, a Le
Y
 antigen, and a sialyl Tn epitope [α-
Neup5Ac-(2→6)-α-GalNAc] were synthesized in one step by single-phase BSM and 
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Scheme 1.12. Hybrid gAuNPs containing four different ligands. Image adapted from Ref. 
109 with permission from Elsevier. 
 
1.4.5.2. Two-step synthesis of gAuNPs by ligand exchange  
Cit-AuNPs synthesized by the Turkevich reaction have been used to synthesize gAuNPs 
by replacing the citrate ligands with thiolated-carbohydrate derivatives. Citrate to thiol 
ligand exchange is one of the most commonly used methods to synthesize thiol-
functionalized AuNPs in the 7 to 100 nm size range.
110
 Ligand exchange on the AuNP 
surface is driven by the higher binding affinity of Au for the thiol than for the citrate due 
to the significant energy difference between Au-S (~ 40 kcal·mol
-1
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In 2003, the Russell group synthesized gAuNPs decorated with mannose ligands by a 
ligand exchange reaction achieved by incubating Cit-AuNPs with 2-mercaptoethyl α-D-
mannopyranoside for 48 h (Scheme 1.13).
112
 Centrifugal filtering was used to remove the 
salts and the excess mannose ligands. gAuNPs bearing thiolated lactose derivatives have 










Later, in 2006, Lee et al. performed a peptide coupling between hyaluronic acid and 
cystamine to obtain a thiolated-hyaluronic acid (Figure 1.8).
113
 This thiolated ligand was  






Figure 1.8. Structure of thiolated hyaluronic acid. 
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AuNPs stabilized with ligands other than citrate have also been used to synthesize 
gAuNPs through ligand exchange. For example, gAuNPs functionalized with thiolated 
oligosaccharide moieties which were the synthetic analogues of type A Neisseria 
meningitides antigens were synthesized by exchanging the dioctylamine ligands on the 





1.4.5.3. Two-step synthesis involving chemical modifications of the AuNP surface. 
Multistep reactions involving different chemical modifications of the surface of AuNPs 
have been used for the synthesis of gAuNPs. In 2001, Otsuka et al. attached lactose and 
mannose to AuNPs functionalized with acetal-terminated mercaptopoly(ethylene glycol). 
The acetal group was first converted to an aldehyde under acidic conditions, followed by 
reductive amination with the corresponding p-aminophenyl glycosides in the presence of 
(CH3)2NHBH3 to produce gAuNPs (Scheme 1.14).
115
 This was the first example of 
monolayer-protected gAuNPs that had been synthesized by a three-step reaction. 
Subsequently, in 2009, Nagahori et al. reacted aminooxy-functionalized AuNPs with 
aldehydes derived from glycosphingolipids (GSL) to produce gAuNPs as mimics of the 
 








self-assembled microdomain model of multivalent GSLs that is seen on the cell surface 
(Scheme 1.15).
116
 The double bond in the ceramide units of different GSLs was 
selectively converted to an aldehyde by ozonolysis. These aldehydes were then reacted 
with the aminooxy groups of the previously synthesized AuNPs to attach the GSL units 
to the particle surface by oxime formation. The aminooxy functionalized AuNPs were 
synthesized in two steps; firstly AuNPs functionalized with the N-tert-butoxycarbonyl-
protected aminooxy group were made by direct synthesis, and then the N-tert-
butoxycarbonyl group was removed by treatment with an aqueous HCl at 40 
o
C. The 
GSL aldehydes were then coupled directly with the aminooxy functionalized AuNPs 
under mild conditions. Another potential method that can be used to convert AuNPs to 
gAuNPs is “Click Chemistry.” A detailed discussion of the synthesis of gAuNPs via 
“Click Chemistry” is presented in Chapter 5. 
 








1.4.6. Applications of gAuNPs 
Various aspects of gAuNPs, such as the controllable shape and size of the metallic core, 
the facile methods established to decorate the surface of the particles with various sugars 
and other functionalised ligands, and their relatively high chemical stability mean that 
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1.4.6.1. Carbohydrate-protein interactions 
Carbohydrate-protein interactions are very specific and in general multivalent 
interactions are required in order to effect strong binding between the two types of 
units.
94
 Several model systems have been prepared comprising multivalent presentations 
of carbohydrates using suitable scaffolds, to study multivalent carbohydrate-protein 
interactions.
75
 gAuNPs have also been used for this purpose, and in particular, 
colorimetric bio-assays based on the aggregation and dispersion of gAuNP solutions, 
controlled by the interactions between proteins and carbohydrate derivatives on the 




Most studies have used the aggregation of gAuNPs in the presence of a target protein as 
the strategy to study carbohydrate-protein interactions for the detection of lectins.
70, 117
 
The gAuNPs, which are well-dispersed in solution, undergo aggregation in the presence 
of a suitable protein due to the specific binding of the sugars on the surface of gAuNPs 
with multiple binding sites present on the protein. This mechanism of gAuNP 
aggregation is explained in detail in Chapter 3.  
 
While the optical properties of AuNPs are determined by its SPR, there is significant 
change in these properties when NPs come close and form aggregates due to the coupling 
of the plasmon oscillations of the interacting particles.
118
 The plasmon oscillation 
produces an electric field localized on the AuNP surface which decays with distance 
away from the NP. The near-field of particles present in close proximity can interact with 
each other strongly. Thus the electric field felt by each particle is the sum of the incident 
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light field and the perturbation due to the presence of the electric dipole present on the 
neighbouring particle.
118
 The coupling of the plasmon oscillations causes a change in the 
position of the SPR peak and that can be observed using UV-Vis spectrophotometry. The 
aggregation process can also be observed with the naked eye as the colour of the AuNP 
solution typically turns from red to purple.  
 
In 2001, the Kataoka group used gAuNPs to study carbohydrate-protein interactions for 
the first time.
115
 gAuNPs functionalized with lactosyl-poly(ethylene glycol) were 
synthesized and used to detect the bivalent lectin, Ricinus communis agglutinin 
(RCA120).
115
 The lactose units on the surface of the gAuNPs selectively interacted with 
the lectin, causing reversible aggregation (upon the addition of galactose the aggregates 
were redispersed) of the gAuNPs. UV-Vis studies showed that the extent of the 
aggregation was proportional to the concentration of RCA120. In addition, investigation 
with gAuNPs of varying lactoside ligand density (0-65%) demonstrated that particle 
aggregation also depended on that parameter; a critical lactoside density (>20%) was 
essential for aggregation to occur.  
 
Later, in 2003, Russell and co-workers synthesized mannose-functionalized gAuNPs for 
the selective detection of the lectin concanavalin A (ConA).
112
 Rapid detection of sub-
micromolar concentrations of ConA was achieved with the gAuNPs as monitored by UV-
Vis spectrophotometry. The Russell group also synthesized gAuNPs functionalized with 
thiolated galactose, mannose, and lactose derivatives for the colorimetric detection of 
RCA120, ConA, and cholera toxin respectively.
70
 In general these studies showed that the 
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gAuNP size, the length of the linker, and the sugar density on the particle surface all 





Subsequently, in 2003, Lin et al. reported the first quantitative study into the multivalent 
interactions between gAuNPs and lectins.
101
 SPR binding assay studies with mannose-
functionalized gAuNPs showed that ConA had an affinity that was one to two orders of 
magnitude higher for multivalent presentation as compared to monovalent presentation of 
the mannose ligands. These results confirmed that the multivalent presentation of sugars 
on a NP surface significantly increases their binding affinity without altering their 
specificity for lectins.  
 
1.4.6.2. Carbohydrate-carbohydrate interactions 
Carbohydrate-carbohydrate interactions are known for their specificity, their weak 
affinities, and their dependency on bivalent cations.
75
 Weak individual binding affinities 
are overcome by multivalent interactions.
75





 independently introduced the concept of carbohydrate-carbohydrate 
interaction in cell adhesion processes. This finding inspired the development of various 
model systems to undertake studies into the quantification of carbohydrate-carbohydrate 
interactions.
98, 121-122
 However the precise details of these interactions are still not clear 
and so further research is on-going. One difficulty lies in the design and preparation of 
well-defined carbohydrate conjugates which can be used to analyse carbohydrate-
carbohydrate interactions. Several groups have studied these interactions with the help of 
model systems, such as micelles, giant vesicles, and artificial glycoviruses.
75
  




In 2004, the Penadés group demonstrated that gAuNPs can be used as multivalent model 
systems to quantify carbohydrate-carbohydrate interactions at the molecular level.
98
 
gAuNPs decorated with the trisaccharide Le
X
 were used to study the Ca
2+
 dependency of 
the Le
X
 self-aggregation process. Two different 2 nm sized gAuNP systems, one 
decorated with thiolated-lactose derivatives and the other with thiolated-Le
X 
derivatives 
were synthesized. TEM was used to follow the aggregation of these gAuNPs in the 
presence and absence of Ca
2+
 ions. The lactose-functionalized gAuNPs showed no 
aggregation in the presence of Ca
2+
 ions. In contrast, the Le
X
-functionalized gAuNPs 
aggregated reversibly in the presence of Ca
2+
 ions (the aggregates could be redispersed 
by the addition of ethylenediaminetetraacetic acid (EDTA)) at all the Ca
2+ 
concentrations 
tested (0.1-0.9 mg/mL).  
 
Subsequently, in 2006, the Russell group synthesized a series of gAuNPs (16 nm) 
decorated with lactosyl derivatives bearing thiolated oligoethylene glycol linkers of 
varying lengths.
110
 TEM and UV-Vis studies showed that the length and the nature of the 
oligoethylene glycol linkers used had a significant effect on the Ca
2+
-induced aggregation 
of these particles. UV-Vis studies also revealed that the aggregation of particles was 
rapid; the absorbance intensity changed 30 only seconds after the addition of the Ca
2+
 
ions. In contrast, previous studies using smaller gAuNPs (~2 nm) functionalized with 
lactose and other carbohydrates, showed either no aggregation or that it only occurred 
after several hours. 
79, 98, 123
 These results indicate that the size of the NPs used in gAuNP 
model systems has a significant effect on the self-aggregation of the carbohydrates. 
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1.4.6.3. gAuNPs as anti-adhesion agents 
Carbohydrate interactions are directly involved in a variety of cell-cell adhesion 
processes which, unfortunately, also include undesired pathogenic ones.
75
 In general, 
adhesion of pathogens to host tissues is a necessary condition for the initiation of the 
infection. The adhesion of pathogens to host receptor cells can be mediated by 
carbohydrate-carbohydrate and/or carbohydrate-protein interactions.
75
 The crucial role of 
carbohydrates in these types of recognition events has led to the development of new 
antimicrobial agents that are carbohydrate-based mimics of host glycoconjugates. These 





For instance, in 2004, Rojo et al. demonstrated that gAuNPs can be used as anti-adhesion 
agents against the advancement of lung metastasis in mice.
125
 A murine melanoma cell 
line (B16) that causes metastasis in lungs was used as a model system to study the 
inhibitory effect of gAuNPs in metastasis and tumour progression. Previously Hakomori 
et al. have shown that a carbohydrate-carbohydrate interaction between lactosylceramide 
of endothelium cells and the ganglioside GM3 (α-Neu5Ac(2→3)-β-Gal(1→4)-β-
Glc(1→1)-Cer) of B16 cells is the first and the crucial step of the adhesion of tumour 
cells to the endothelium.
126
 This step can therefore be considered as a possible target for 
the inhibition of the progression of metastasis. Thus, Rojo et al. synthesized gAuNPs (1.8 
nm size) each bearing 70 lactose units as potential inhibitors of the binding of melanoma 
cells to endothelial cells.
125
 Glucose-functionalized gAuNPs, which are not involved in 
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the adhesion process, were also synthesized and used as a control. The structures of the 
thiolated lactose and glucose derivatives used as ligands are shown in Figure 1.9.   
 
 
Figure 1.9. Structures of the thiolated (a) lactose and (b) glucose derivatives used by 
Rojo et al.
125
 for the synthesis of gAuNPs.  
 
Mice were inoculated with melanoma cells (B16F10), which were pre-incubated with the 
lactose- and glucose-functionalized gAuNPs (Figure 1.10a). They were sacrificed after 
three weeks and the tumour foci in the lungs were observed under a microscope. Ex vivo 
pre-incubation of the tumour cells with the lactose-functionalized gAuNPs at 90 μM 
concentration was seen to inhibit cancer metastasis by up to 70%. Comparison studies in 
which mice were injected either only with the melanoma cells, or with the melanoma 
cells incubated with glucose-functionalized gAuNPs were also conducted. Analysis of the 
images (Figure 1.10b) at two different magnifications (x 8 and x 80) revealed that at the 
same particle concentration (90 μM), many large (>1 mm; blue arrows) and small 
tumoural foci (<1 mm; black arrows in Figure 1.10b) were seen when glucose-
functionalized gAuNPs were used, whereas tumoural foci were only very scarcely seen 








Figure 1.10. (a) Schematic representation of ex vivo studies evaluating cell viability and 
the anti-metastatic effect of gAuNPs functionalized with glucose derivatives (Glucose-
gAuNPs) and lactose derivatives (Lactose-gAuNPs). (b) Images of the lungs taken at two 
different magnifications (x 8, x 80) corresponding to mice subjected to B16F10 cells and 
Glucose-gAuNP (left) and Lactose-gAuNP (right). Blue triangles indicate the presence of 
large foci (>1 mm) and black arrows shows the small foci (<1 mm). Image reprinted from 
Ref. 
125
. Copyright (2016) WILEY-VCH Verlag GmbH & Co. KGaA.  
 
1.4.6.4. gAuNPs in cellular and molecular imaging 
Cellular and molecular imaging probes that are highly stable under biological conditions, 
which are very specific to the desired target, and also non-toxic to the biological system, 
are highly sought after. The use of gAuNPs as non-invasive bio-imaging tools has been 
explored. In 2008, Lee et al. synthesized gAuNPs functionalized with hyaluronic acid 
derivatives which were labelled with the near-infrared fluorescence (NIRF) dye Hilyte-
647 (Figure 1.11).
127
 The gAuNPs were denoted as HHAuNPs. The fluorescence of the 
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dye was quenched (Figure 1.11, left) due to the NP surface energy transfer (NSET) 
between the dye-labelled hyaluronic acid and the AuNP core. Highly metastatic tumour 
and rheumatoid arthritis are known to express excess amount of hyaluronidase (HAdase) 
and reactive oxygen species (ROS), respectively, and cause the degradation of local 
hyaluronic acid in the extracellular matrix.
128-129
 In the study by Lee et al., in vivo 
imaging of mice with tumour and arthritic inflammation after injection of HHAuNPs 
showed the sensitive detection capability of these particles.
127
 When the HHAuNPs 
reached the target zone (tumours and arthritic joints) the excess amount HAdase and ROS 
present there cleaved and released the dye-labelled oligo-hyaluronic acid conjugates. The 
release of the dye from the gAuNP surface deactivated the NSET and resulted in the 
recovery of fluorescence (Figure 1.11, right) and thus allowed the ultra-sensitive 








Figure 1.11. A schematic representation of NSET interaction between a AuNP and a 
Hilyte-647 dye labelled oligo-hyaluronic acid. Left: fluorescence quenching by NSET 
between the AuNP core and the dye-labelled oligo-hyaluronic acid and; Right: 
fluorescence recovery in the presence of HAdase/ROS, which cleaved and released the 
surface immobilized dye-labelled oligo-hyaluronic acid conjugates. Image reprinted from 
Ref.
127
 with permission from Elsevier  
 
1.5. Characterization of AuNPs and gAuNPs. 
Several analytical techniques are commonly employed for the characterization of AuNPs 
and gAuNPs. Some techniques are used for the analysis of the organic ligands on the 
surface of the particles, whilst other methods focus on the metallic core.
41
 In the 
following section, only the techniques that were used in this project will be discussed. 
 
1.5.1. UV-Vis spectrophotometry 
UV-Vis spectrophotometry has been used to analyse the optical properties of AuNP 
solutions. AuNPs with sizes larger than ca. 2 nm exhibit an SPR band in the visible 
region in the UV-Vis absorption spectrum. 
61
 The SPR of an AuNP solution is not only 
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dependent on the size of the NPs, but also on the solvent, the temperature, and the ligand 
shell.
130
 When the temperature, solvent, and the ligand shell are the same for two 
samples, the absorption maximum depends solely on the particle size and shape. The 
width of the SPR band is a measure of the polydispersity of the particles in solution.
130
 
Moreover, using UV-Vis spectrophotometry, the aggregation of AuNPs can be studied. 
When AuNPs are in close proximity, the surface electrons of the neighbouring particles 
are delocalized causing a shift in the SPR band to longer wavelengths which can be 




1.5.2. Electron microscopy 
Electron Microscopy (EM) is used to determine the mean metallic core size of NPs. An 
electron microscope uses a beam of electrons as an illumination source. Since electron 
wavelengths can be up to 10
5
 times smaller than that of visible light photons, an electron 
microscope has a much larger resolution (smallest distance between two points in the 
sample that can be seen as two separate entities) than a light microscope.
131
 Thus, an 
electron microscope can be effectively used to analyse the size of NPs.  
 
Transmission electron microscope (TEM), one of several electron microscopes, uses a 
high voltage electron beam to image the sample. The electron beam is generated by an 
electron gun, which is generally fitted with a tungsten filament or lanthanum hexaboride 
as the source of electron. The electron beam is then accelerated by an electric potential 
and focused on the sample by a number of electromagnetic and electrostatic lenses.  
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For the imaging, samples are prepared by drying NPs on a Cu grid that is coated with a 
thin layer of carbon. Successful imaging of NPs using TEM depends on the contrast of 
the sample compared to the background in the grid. Materials that have significantly large 
number of electrons as compared to carbon are easily imaged because of the enhanced 




The electron beam is transmitted through the NP sample prepared on the grid, which is 
placed in the sample holder of the microscope. The beam that emerges from sample is 
magnified by the objective lens (Figure 1.12). The image is viewed by projecting the 
magnified beam onto a fluorescent screen. Alternatively, the image can be recorded 
photographically by projecting the beam onto a charge-coupled device (CCD) camera or 
a complementary metal-oxide semiconductor (CMOS) camera.  
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Although TEM is effective for imaging and measuring the size of NPs due to its high 
resolution, it has several drawbacks. Firstly in TEM, the field of view is relatively small, 
thus there is a chance that the region viewed may not be a true representation of the 
whole sample. Secondly the sample structure may be altered during the sample 
preparation, and in some cases there is a chance that the sample can be damaged by the 
electron beam.  
 
1.5.3. Dynamic light scattering  
Dynamic light scattering (DLS, also known as photon correlation spectroscopy) is a non-
invasive technique used to measure the size distribution of proteins, polymers, and 
nanoparticles.
134-135
 DLS gives the size of the particles by measuring the speed at which 
the particles diffuse in the solvent due to the Brownian motion. Brownian motion is 
defined as the random movement of particles due to their bombardment by solvent 
molecules that surround them, and is inversely proportional to the size of the particles. 
The DLS measurement is performed by passing a monochromatic light beam through a 
solution containing particles and measuring fluctuation of the scattered light intensity. 
The solution temperature must be stable in order to obtain accurate DLS measurements; 
otherwise any convection current in the solution may cause non-random movements that 
would give an incorrect interpretation of the particle size. The diameter of the particles 
obtained by DLS is referred to as the hydrodynamic diameter since its measurement 
relies on particle diffusion in the solvent. The hydrodynamic diameter does not just 
depend on the core size of the particles, but also on the surface structures, and the type, 
and concentration of ions in the system.
136
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The light absorption and scattering properties of AuNPs are strongly enhanced due to the 
SPR oscillation of the surface electrons. For example, a AuNP with a diameter of 60 nm 
has a light-scattering cross-section 200-300 times larger than that of a polystyrene bead 
of the same size, and is 4-5 orders of magnitude larger than that of a fluorescent dye, such 
as fluorescein.
137
 Therefore, AuNP-based DLS assays have been extensively used for the 
detection of various analytes.
73, 138
 Moreover, the scattered light intensity from AuNPs is 
much stronger than that from biological samples, and thus there is no background 
interference from the sample matrix. AuNP size measurements with DLS have been 




Unlike TEM, DLS is very easy to use and it provides a quick method of analysis. Also, a 
large number of particles are measured in one measurement, giving a dataset that is 
statistically significant. However, there is a major drawback to DLS; since the intensity 
of scattered light changes with the sixth power of the particle diameter, relatively small 
amounts of impurities can severely interfere with the measurements. 
 
1.5.4. Thermogravimetric and Elemental Analysis 
Thermogravimetric analysis (TGA) is a technique in which the sample mass is measured 
as a function of time or temperature as the sample is heated in a controlled atmosphere.
139
 
It is generally used to determine the properties of materials that show either mass gain or 
loss because of oxidation, decomposition, or the loss of volatile components upon 
heating.
139
 In the case of AuNPs, TGA is used to determine the relative mass of the 
organic ligands on the particle surface.
139
 As the temperature is increased, the organic 
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ligands that comprise the AuNPs decompose forming solid carbon and the weight change 
that accompanies this process can be measured. As the metallic core of the particle 
simply produces elemental bulk Au which does not react at temperatures below 1000 
o
C, 
any changes in the mass that are measured below 1000 
o
C correspond to the 
decomposition or reaction of the organic shell of the AuNPs.
36
 Thus, in effect, the use of 
TGA can be used to measure the metal-to-ligand ratio of a NP sample. Also, if the 
decomposition temperature of different ligands attached to the particle is known, the 




Elemental analysis (EA) is used for the determination of the elemental composition of a 
compound. Generally, the relative mass percentage of carbon, hydrogen, and nitrogen 
(CHN) are determined by the combustion of a sample and detection of the resulting 
combustion products. In the case of AuNPs, EA is used to quantify the ligand shell 
composition and to confirm the metal-to-ligand ratio.
100
 In addition, if the theoretical 
elemental composition of AuNPs is known, EA can be used to confirm the purity of the 
sample.  
 
1.5.5. Nuclear Magnetic Resonance Spectroscopy 
Nuclear Magnetic Resonance (NMR) has been extensively used to characterize thiolate-




C NMR signals of the solutions of thiolate-





C NMR spectra of alkanethiolate-functionalized AuNPs show that 
that linewidths change systematically with the position of carbon relative to the particle 









C NMR peaks of the methyl group of the 
octanethiolate ligand in octanethiolate-functionalized AuNPs were broader than those of 
the methyl group of the dodecanethiolate ligand in the dodecanethiolate-functionalized 
AuNPs.
142
 Also, the 
13
C methylene linewidths were seen to increase as the position of the 
methylene groups get closer to the particle surface.  
 
Spectral broadening of particular signals of AuNPs can arise from a number of factors:  
(1) Spin-lattice relaxation (T1, also known as longitudinal relaxation, or relaxation in the 
z-direction) is the process by which energy absorbed by the excited spins is released back 
into the surrounding lattice to regain thermal equilibrium. T1 relaxation corresponds to 
the process of re-establishing the normal Gaussian population distribution of the spin 
states in the magnetic field. In AuNPs, the methylene groups closest to the particle 
surface are the most densely packed, and they behave like a solid, i.e. they undergo fast 
T1 relaxation from dipolar interactions; short relaxation time implies faster signal decay 
and low signal information and thus broad signals.
143
 In contrast, the methylene groups 
furthest away from the particle surface experience freedom of motion, and their spin-




(2) It has been proposed that difference in the nature of the binding site (vertices, edges, 
and terraces) of the ligands at the particle surface may cause α- and β-methylene groups 
to have a distribution of chemical shifts, and thus resulting in the broadening of the 
13
C 
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(3) Spin-spin relaxation (T2, also known as transverse relaxation, or relaxation in the x-y 
plane) is the random and temporary interaction between two excited spins that results in a 
cumulative loss in phase causing an overall loss of signal. T2 broadening is dependent on 
the rate of tumbling of the particles in solution, and for the methyl resonance T2 changes 
as r
 -3





1.5.6. Infrared Spectroscopy 
In infrared (IR) spectroscopy, the vibrational modes of atoms in molecules are excited 
and the corresponding absorption is detected. The absorption spectrum covers the range 
from 400-4000 cm
-1
 of the electromagnetic spectrum, and is generally given in units of 
wavenumbers. In the case of AuNPs, IR spectroscopy can also be used to analyse the 
ligand shell.
141
 The specific IR bands of functional groups can be identified to confirm 
the nature of species present in the ligand shell. Sometimes, additional insights about the 
particles can be obtained; for instance, Brust et al. have reported that the S-H vibrational 
mode disappeared when the thiol ligand was attached to the NPs, and they used that result 




1.6. Project Objectives 
The goal of this research project was to explore new methods for the production and 
application of AuNPs and gAuNPs. This thesis describes the use of the Turkevich method 
to synthesize Cit-AuNPs of various shapes and sizes, and the use these NPs in ligand 
exchange reactions with different saccharide derivatives to make gAuNPs. Studies of 
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applications of gAuNPs that were synthesised were focused on the colorimetric sensing 
of heat-labile enterotoxin and influenza virus particles and hemagglutinin.  
 
Chapter 2 describes the synthesis of AuNPs with different sizes and shapes by tuning the 
conditions of the Turkevich reaction. 
 
Chapter 3 describes the synthesis of galactose-functionalized gAuNPs, and their 
application for the colorimetric sensing of the lectin, heat-labile enterotoxin.  
 
Chapter 4 describes the extraction of sialylglycopeptide from egg yolks, the synthesis of 
gAuNPs decorated with sialylglycans, and application of these gAuNPs for the 
colorimetric detection of influenza hemagglutinin and influenza virus particles. 
 
Chapter 5 describes attempts to synthesize gAuNPs in a one-pot reaction by use of the 
copper(I)-catalysed azide-alkyne Huisgen cycloaddition.  
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The aim of this chapter was to perform a detailed and systematic study to elucidate the 
effect of the reagent molar ratios and the reaction temperature on the shape and size of 
the AuNPs produced in the Turkevich reaction. The Turkevich reaction has been widely 
used throughout my work to obtain citrate-stabilized AuNPs used as a precursor 
compound to synthesize glycogold nanoparticles.  
 
2.2. Introduction 
2.2.1. AuNPs with various shapes  
AuNPs have drawn significant interest in recent years due to their unique 









 It is widely known that the magnetic, electronic, and 
optical properties of AuNPs are often dependent upon their size and morphology. Recent 
developments in the synthesis of shape-specific AuNPs have opened further exciting 
opportunities for applications in the fields of plasmonics (the study of the interaction 
between electromagnetic field and electrons in a metal)
8
 and cancer hyperthermia (a 
medical treatment in which tissue is exposed to higher temperatures either to kill cancer 
cells or to increase the effect of radiation and anti-cancer drugs on cancer cells).
9
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Therefore, there is now a considerable impetus to develop methods that allow the 
synthesis of size- and shape-specific AuNPs. 
 













 In addition to the synthesis 
of AuNPs with a desired morphology, it is also important to be able to control their 
assembly into various secondary structures, such as nanochains, nanowires, and 







 Nanochains can be defined as elongated one-dimensional 
assemblies of NPs arranged one after another, like the beads in a chain, in which it is 
possible to easily distinguish the individual particles. Nanowires can be defined as 
elongated one-dimensional assemblies of fused NPs in which the adjacent particles 
strongly overlap, making it impossible to distinguish them individually. Methods used for 







 and manipulation using 




2.2.2. The Turkevich reaction 
Although a number of different methods have been employed for the synthesis of AuNPs, 
the citrate reduction method, also known as the Turkevich reaction originally developed 
by Turkevich
39
 and further modified by Frens,
40
 is still very popular due to its simplicity 
and efficiency. In the Turkevich reaction, trisodium citrate reduces Au
3+
 ions to Au atoms 
and also stabilizes the AuNPs that are formed from clustered Au atoms. Citrate-stabilized 
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AuNPs (Cit-AuNPs) are commonly used as the starting material for a range of AuNP-
based studies and applications such as ligand exchange reactions,
41
 controlled NP self-
assembly formation,
42
 surface charge studies,
43





 NP growth mechanism studies,
46
 and studies of the effect of NPs on 
biological systems.
47
 Investigations into the Turkevich reaction by various groups over 
the last 50 years have shown that when the citrate to Au ratio was increased by a factor of 
5, i.e. from 0.4 to 2, the AuNP size was decreased by a factor of 7 (Figure 2.1).
39-40, 48-49
 
However when the ratio was further increased from 2 to 7 very little changes were 
observed in the size of the NPs formed.  
 
 
Figure 2.1. Change in AuNP size with ratio of concentrations of citrate to gold. Adapted 
from Kumar et al.
50
 Reprinted with permission from Ref. 50. Copyright (2016) American 
Chemical Society. 
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2.2.3. Mechanism of AuNP formation in the Turkevich reaction 
In 2007, Kumar et al. developed a model that explains the various steps in the Turkevich 
reaction in detail.
50
 The oxidation of trisodium citrate to dicarboxyacetone is the first step 

























 the disproportionation step is driven by dicarboxy 
acetone, which forms a complex with AuCl molecules as shown in Figure 2.2. In the 
complex, three AuCl molecules interact with a minimum of two dicarboxy acetone 
molecules. According to Gammons et al.
51
 once AuNPs are formed the 










O + CO2 + H
+ + 2e (2.1)
AuCl3 + 2e AuCl + 2Cl (2.2)
3AuCl 2Au0 + AuCl3 (2.3)




Figure 2.2. Dicarboxy acetone-AuCl complex. 
 
Thus the overall stoichiometry of the reaction can be written as:  
 
 
According to the equation 2.4, three citrate ions are required to reduce two AuCl3 
molecules. But Frens has reported the complete reduction of AuCl3 with a citrate to Au 
ratio as low as 0.43.
40
  Kumar et al. hypothesised that the products formed from the 
degradation of dicarboxy acetone can also reduce the AuCl3 molecules.
50
 Dicarboxy 






 and Turkevich et al.
39
 have demonstrated that AuCl3 can be reduced to 
AuNPs by reaction with acetone. Therefore Kumar et al. assumed that in the Turkevich 
reaction the acetone formed from dicarboxy acetone reduces AuCl3 to AuCl  as shown in 
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equation (2.6), and that accounts for the complete reduction of AuCl3.
50
 According to this 




Thus the overall mechanism of AuNP formation proposed by Kumar et al. can be 
summarized as follows. Firstly citrate reduces the Au
3+




and then the 
dicarboxy acetone formed from the oxidation of citrate forms a multimolecular complex 
with the Au
+
. The disproportionation of the complex results in the formation of Au
0
 
atoms, and these atoms then adsorb Au
+
 species. Further complexation of the Au
+
 with 
dicarboxy acetone and disproportionation of the complex results in the formation of 
larger Au aggregates. The disproportionation and aggregation of Au atoms continues 
until a critical size is reached at which point a nucleus of Au atoms is formed. The Au 
atoms produced by ongoing disproportionation become adsorbed onto this nucleus, 




2.2.4. Nucleation and particle growth in the Turkevich Reaction 
Different groups have proposed various theories to account for the nucleation and growth 
of Cit-AuNPs in the Turkevich reaction. Turkevich and co-workers, through their 
extensive work on the Turkevich reaction came to the conclusion that Cit-AuNPs are 
formed following the classical LaMer growth model (discussed in Chapter 1, Section 
1.5),
53







 also studied the formation of Cit-AuNPs and came to the same conclusion that 
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uniform Cit-AuNPs are formed as a result of a burst of nucleation followed by particle 
growth. However, later studies showed that the classical LaMer growth model failed to 





In 1994, Chow and Zukoski reported that the size of the Cit-AuNPs decreased as a 
function of time during the Turkevich reaction.
60
 It was observed that large NPs were 
formed in the beginning of the reaction, which then shrank to produce smaller particles as 
the reaction proceeded. The large NPs appeared to be made of smaller NPs. Chow and 
Zukoski proposed a model for Cit-AuNP formation that explained these observations as 
follows: citrate reduces AuCl4
ˉ 
ions to produce Au
0 
atoms which adsorb to other AuCl4
ˉ 
and citrate ions. The reduction continues along with the growth of the particles. The 
preferential binding of the particles to AuCl4
ˉ 
as opposed to citrate results in the growing 
particles to have a low surface potential and causes the particles to aggregate.
61
 The steric 
barrier created by the adsorbed ions prevents irreversible particle aggregation. The on-
going reduction process completely consumes the AuCl4
ˉ 
ions resulting in an increase in 
the surface potential of the particles. The electrostatic repulsive forces generated by the 
increase in surface potential causes the particles to break away from the aggregate and to 
form a stable colloidal system.  
 
In 2006, Kimling et al. proposed a different multistep mechanism. Herein the entire 
amount of Au
3+






 atoms form clusters, and in turn 
they assemble into larger polycrystalline NPs, which is followed by further aggregation. 
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In contrast, the mechanism proposed by Pong et al. involves the formation of nanochains 
and networks followed by their fragmentation to produce NPs.
63
 Here it is proposed that 
Au
3+
 undergoes fast reduction to give Au
0
 atoms, which is followed by the formation of 
clusters with an average radius of 2.5 nm (Figure 2.3a). These clusters then assemble 
themselves into chains and networks (Figure 2.3b and c). A TEM study revealed that the 
chains and networks were comprised of crystalline particles with an approximate size of 
4 nm, and that these particles were interconnected by amorphous Au. As the reaction 
proceeded, the chains and networks were observed to grow in diameter and then to 
fragment into smaller particles (Figure 2.3d). The fragmentation proceeded along the 
segments until these segments were cleaved into small spherical-like particles (Figure 
2.3e and f). These particles undergo Ostwald ripening to give the final large spherical 
particles. Ostwald ripening, a process first described by Wilhelm Ostwald in 1896, is a 
phenomenon observed in colloidal suspensions or in solid solutions, and is the process 
through which smaller colloidal particles or crystals dissolve and then are redeposited 
onto bigger colloidal particles or crystals over time.
64
 Ostwald ripening is a 
thermodynamically-driven process, and it occurs because larger particles are more 
energetically stable than smaller particles. The higher stability of the larger particles 
arises from the fact that molecules on the surface of a particle are energetically less stable 
than the interior ones which are packed and well ordered. As a system tends to reduce its 
overall energy, the energetically unstable molecules on the surface of a small particle 
detach and defuse in the solution and then attach to the surface of bigger particles. Thus, 
the number of smaller particles continues to decrease, whilst the larger particles continue 
to grow in size.
65
  




Figure 2.3. A schematic representation of the growth mechanism for the spherical Cit-
AuNP formation according to Pong et al.
63
 Reprinted with permission from Ref. 63. 
Copyright (2016) American Chemical Society.  
 
In 2010, Polte et al. proposed a sequential process for AuNP formation consisting of a 
four-step nucleation and growth model.
46
 The first step is fast formation of nuclei, which 
is then followed by aggregation of these nuclei into bigger particles. The third step 
consists of slow diffusion controlled growth of the bigger particles that is maintained by 
the continued reduction of Au
3+ 
ions and also further aggregation. In the fourth and final 
step, the particles grow quickly to their final size (Figure 2.4).  
 
 




Figure 2.4. A schematic representation of the mechanism of AuNP formation according 
to Polte et al.
46
 Reprinted with permission from Ref. 46. Copyright (2016) American 
Chemical Society.  
 
2.2.5. The Structure of citrate layers of Cit-AuNPs 
Biggs et al.
66
 and Chow et al.
60
 have reported that in Cit-AuNPs, the citrate anions are 
coordinated to the Au surface through inner sphere complexation of the carboxylate 





ˉ are also present on the Au surface. In 
2014, Park et al. demonstrated by infrared (IR) and X-ray photoelectron spectroscopy 
(XPS) analysis that a specific coordination of adsorbed citrate is prevalent on Cit-
AuNPs;
67




coordination of the central carboxylate group (Figure 2.5). These IR studies also showed 
that dangling citrate ions not in direct contact with the Au surface are also present along 
with the coordinated citrate ions.
67
 The citrate ions that are directly coordinated to the Au 
surface interact with adjacent adsorbed citrate ions and dangling citrate ions by hydrogen 
bonding between the terminal carboxylic acid moieties. The hydrogen bonded 
dihydrogen citrate ions form one-dimensional chains, in which the ions interact with each 
other through van der Waals interactions between nearby CH2 groups, resulting in the 
formation of a self-assembled layer of citrate ions on the AuNP surface (Figure 2.5).
67
 It 
is well-known that electrostatic repulsion between particles due to the negatively charged 
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surface bound citrate anions confers stability to the Cit-AuNPs.
68
 Various studies also 
indicate that steric repulsion between citrate layers of various particles also has a role in 
stabilizing Cit-AuNPs.
66, 69
 Prior to the study of Park et al., only the free carboxylate 
groups of the adsorbed citrate ions were thought to be the source of the negatively 
charged surfaces of Cit-AuNPs.
68
 However,  the investigation by Park et al. suggested 
that the negative charge of the outer layer comprised of the dangling citrate anions may 





Figure 2.5. A diagrammatic representation of the surface structure of Cit-AuNPs. 
Reprinted with permission from Ref. 67. Copyright (2016) American Chemical Society.  
 
2.2.6. Turkevich reaction and non-spherical nanostructures 
In general, the Turkevich method typically yields spherical AuNPs. However, several 
groups have recently attempted to fine-tune this method in order to synthesise anisotropic 
AuNPs, nanochains, wires, and networks. For example, Shankar et al. reported the 
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synthesis of mixtures containing spherical and triangular AuNPs at low temperature.
70
 
Reaction temperature is an important parameter that influences the shape of the AuNPs 
formed. By reducing the temperature, the rate of the reduction of the Au ions can be 
slowed down, resulting in the growth of Au nanotriangles. The TEM and UV-Vis-NIR 
studies reported by Shankar et al. indicated that the formation of Au nanotriangles was a 
kinetically controlled process.
70
 They also observed that halide ions influenced the shape 
of the particles formed in the Turkevich reaction. Cl
ˉ









 and Liu et al.
72
 reported the synthesis of Au nanowires and chains at low 
molar ratios of citrate to HAuCl4. According to Pei et al. the crucial factor in the 
formation of Au nanowires is the adsorption of AuCl4
ˉ
 instead of citrate ions onto the 
surface of the AuNPs.
71
  In 2009, Qiu et al. selectively fabricated nanochains and 
nanowires by seed-mediated shape evolution of Cit-AuNPs
73
 using 13 nm Cit-AuNPs as 
the seeds. It was observed that both the presence of the seeds and the use of a low citrate 
to HAuCl4 molar ratio (< 0.3) yielded nanochains and nanowires. Patungwasa et al. 
reported the synthesis of AuNPs with predominantly polyhedral shapes by performing the 
reaction at lower pH.
74
 The pH of the solution was regulated by the citrate and citric acid 
equilibrium that acted as a buffer in the 3.5-7.5 pH range. When the reaction was 
performed below pH 5 AuNPs of predominantly polyhedral shapes were obtained. The 
shape-selective AuNP synthesis was achieved at a lower pH by altering the charge on the 
citrate ions, which in turn affected their stabilizing effects during AuNP growth. At a 
lower pH the selective detachment of citrate ions from certain faces of the AuNPs might 
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have been promoted due to the protonation of the carboxyl groups resulting in different 
growth rates at the different faces of the crystals.  
 
Although the Turkevich reaction has been examined in detail by various groups, a 
systematic study focused on the effect of the reagent molar ratios at low temperature has 
not been reported. To the best of our knowledge, the selective synthesis of nanostructured 
Au systems comprising only polygonal particles and only chains without the presence of 
any spherical NPs simply by tuning the temperature and reagent ratios of the Turkevich 
reaction has not been previously reported. The remaining sections of this chapter will 
detail the synthesis of Cit-AuNPs of various shapes (spheres, polyhedrons, chains, wires, 
and networks) and sizes as well as providing possible explanations for the formation of 
these anisotropic structures. 
 
2.3. Results and discussion 
2.3.1. The Turkevich reaction under various reaction conditions and TEM analysis 
The reactions carried out in this study, namely the reduction of HAuCl4 by trisodium 
citrate in water at various temperatures and reactant ratios, are summarized in Table 2.1. 
The molar ratio of trisodium citrate to HAuCl4 is referred to as R. In a typical reaction, 
150 mL of 0.25 mM aqueous solution of HAuCl4∙3H2O was refluxed (2.1a) or heated to 
the desired temperature (70 
o
C for 2.1b, 2.2a, 2.3a, and 2.4b, and 95 
o
C for 2.4a) in a 
temperature-controlled oil bath with continuous magnetic stirring (500 rpm). The 
required amount of trisodium citrate was rapidly added as an aqueous solution (38.8 mM) 
and the reaction was continued for 15 min, after which the reaction mixture was cooled to 
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room temperature. In the case of 2.4a, the reaction was additionally carried out for 60 
minutes. 
 
In the entire range of the R values employed in this study, i.e. from 8.7 to 0.7, refluxing 
the reaction mixture (2.1a) resulted in the formation of only spherical and quasi spherical 
AuNPs (Figure 2.6), with the AuNP size ranging from 12 to 86 nm (Table 2.1). These 
results are in accordance with previous reports in the literature.
39-40, 75-76
 For example, 
Frens et al. synthesized AuNPs with sizes ranging from 16 to 97 nm by varying the R 
values from 3.1 to 0.6 respectively.
40
 Histograms of the particle size distributions of the 
spherical and quasi-spherical particles synthesized in this study are provided in Figure 
2.7. Analysis of the TEM images of the Cit-AuNPs (in each case at least 200 particles 
were measured) were performed using ImageJ software. 
 











Mean particle size  
(nm) 
2.1a 8.7 reflux spherical NPs 12 ± 1 
2.1a 0.7 reflux spherical & quasi 
spherical NPs 
92 ± 5 
2.1b 8.7 70 spherical NPs 12 ±1 
2.1b 1.7 70 spherical& quasi 
spherical NPs 
40 ± 4 
2.2a   1.6-1.1 70 spherical &   
polygonal NPs  
             57 ± 11 
2.3a   1.0-0.8  70 polygonal NPs 
53 ± 13 
2.4a 0.7 
95 
Wires & networks 
 
11 ± 2 (diameter) 
2.4b 0.7 70 
Chains made of 
spherical &   
polygonal NPs 
86 ± 15 (size of NPs 
within chains) 
Table 2.1. Summary of the reagent molar ratios (R) and reaction temperatures used, 
which resulted in formation of AuNPs with the listed shapes and sizes (averaged along all 
axes for non-spherical particles). 
 
 
Figure 2.6. TEM images of spherical and quasi spherical Au NPs obtained in 
experiments (2.1a) and (2.1b):(a) R value of 8.7 (reflux or 70 
o
C), (b) R value of 1.7 
(reflux or 70 
o
C), (c) R value of 0.8 (reflux), and (d) R value of 0.7 (reflux). 
 




Figure 2.7. Size distribution histograms of spherical and quasi spherical Au NPs obtained 
in experiments (2.1a) and (2.1b): a) R value of 8.7 (reflux or 70 
o
C), (b) R value of 1.7 
(reflux or 70 
o
C), (c) R value of 0.8 (reflux), and (d) R value of 0.7 (reflux). 
 
Reduction of the reaction temperature to 70 
o
C did not result in any change in the shapes 
of the AuNPs formed, within the range of R values from 8.7 to 1.7 (2.1b). However, 
reduction of the R value below 1.7 while carrying out reaction at 70 
o
C resulted in the 
formation of nanostructures with different morphologies. When the R value was 
maintained within the range of 1.6 to 1.1 (2.2a), a mixture of spherical and polygonal 
AuNPs was obtained (Figure 2.8a). The AuNPs formed in (2.2a) were quite polydisperse 
with a mean particle size of 57 ± 11 nm (Figure 2.9a). However, when the R value was 
maintained in the range of 1.0 to 0.8 (2.3a) at the same temperature, only polygonal 
AuNPs were obtained (Figure 2.8b). Though the particles obtained in this case were quite  




Figure 2.8. TEM images of the nanosystems obtained under different reaction 
conditions: (a) 2.2a, (b) 2.3a, (c) 2.4a (time:15 min), (d) 2.4a (time: 15 min) at higher 
magnification, (e) 2.4b, and (f) 2.4a (time: 60 min). Table 1 summarizes the reaction 
conditions employed for the preparation of the different Au nanosystems. 
 
polydisperse with mean particle size of 53 ± 13nm (Figure 2.9b), the selective formation 
of only the polygonal AuNPs by simple control of both the temperature and reagent ratio 
in the Turkevich reaction is a very interesting result. From Figure 2.8a and Figure 2.8b it 
is clear that in (2.2a) and (2.3a) the polygonal particles were comprised of triangular, 
tetragonal, pentagonal, and hexagonal AuNPs. In (2.2a) approximately 60% of the    




Figure 2.9. Size distribution histograms of Au NPs obtained in (2.2a) and (2.3a). 
 
particles were spheres, whilst the remaining particles were triangular (ca. 9%), tetragonal 
(ca. 11%), pentagonal (ca. 8%), and hexagonal (ca. 12%). In (2.3a) no spherical particles 
were formed and the ratio of the populations of the triangular (ca. 23%), tetragonal (ca. 
26%), pentagonal (ca. 23%), and hexagonal (ca. 28%) particles were approximately the 
same as in (2.2a). The edge lengths of the polygonal AuNPs formed in (2.2a) and (2.3a) 
were not equal in size, and so the sizes of the AuNPs quoted here are the averages of their 
lengths along all axes. Since mixtures of particles with several different shapes were 
formed under these conditions the particle size distributions were somewhat wider than at 
the higher temperatures due to different growth rates of specific shapes. 
 
A further, but relatively small reduction in the value of R from 0.8 to 0.7 led to a 
significant change in the growth regime. When the reaction temperature was maintained 
at 95 
o
C, and the R value was reduced to 0.7 (2.4a), Au nanowires were obtained as 
shown in Figure 2.8c. Figure 2.8d shows a TEM image of the nanowire (2.4a) under high 
magnification from which the average diameter of the nanowire was found to be 11 ± 2 
nm (Figure 2.10a). A further reduction of the reaction temperature to 70 
o
C with the same 
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R value of 0.7 (2.4b) resulted in the formation of nanochains comprised of spherical as 
well as polygonal AuNPs (Figure 2.8e). The AuNPs in the chain showed the greatest 
polydispersity, with a mean particle size of 86 ± 15 nm (Figure 2.10b). From Figure 2.8e 
it is clear that in (2.4b) there were no spherical or polygonal AuNPs that were not part of 
the chain. This demonstrates an added advantage of this method over to that reported by 
Liu et al.
72
 in which spherical AuNPs were present along with the chain. Both the Au 
nanowires and chains prepared in (2.4a) and (2.4b) ranged from several hundred 
nanometres to more than 4 microns in length. 
 
 
Figure 2.10. Size distribution histograms: (a) the diameter of the nanowires obtained in 
experiment (4a) and (b) individual particles discernable in the chains obtained in 
experiment (4b). 
 
All of the reactions discussed so far were carried out for 15 minutes. As the duration of 
Turkevich reaction can affect its outcome, an investigation into the effect of reaction time 
was also performed.
71,61 
Pei et al have reported that the Au nanowires formed in the 
Turkevich reaction after 30 minutes were transformed into a network structure when the 
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In our study it was found that reactions carried out for a longer duration (60 minutes) 
gave the same outcome, except for the case of (2.4a). Here (2.4a) when the reaction time 
was increased to 60 minutes or longer, Au nanonetworks uniformly covering the 2D 
space were obtained (Figure 2.8f) in accordance with the observations of Pei et al.
71
 The 
AuNPs in (2.1a)-(2.3b) were found to be stable for more than a month and the wires, 
networks and chains in (2.4a) and (2.4b) were stable for at least two weeks in solution at 
room temperature. 
 
2.3.2. UV-Vis analysis 
Au nanosystems exhibit strong surface plasmon resonance (SPR) absorption that is 
dependent on their size and shape.
77-78
 Spherical AuNPs in general show a single size-
dependent narrow absorption band between 520 and 560 nm.
79
 The UV-Vis spectra of the 
spherical particles made in experiments (2.1a) and (2.1b) are shown in Figure 2.11 and, 
as expected, the position of the SPR peak maximum shifted from 527 to 558 nm as the 
AuNPs increased in size from 12 nm to 90 nm. 
 




Figure 2.11. UV-Vis spectra of all different sized spherical AuNPs. The inset shows the 
corresponding photographs of the AuNP solutions. 
 
From Figure 2.12, it is clear that two distinct SPR bands were observed for (2.2a) 
confirming that this sample was a mixture of polygonal and spherical AuNPs. The band 
centred at 535 nm in (2.2a) corresponds to spherical nanoparticles, whilst the band 
centred at 700 nm was attributed to polygonal AuNPs. In the case of (2.3a), Figure 2.12 
clearly shows a broad SPR absorption band centred at 580 nm along with a smaller peak 
at around 700 nm. These observations match well with previous reports in the literature 
that showed that the polygonal AuNPs possess an additional broad band in the near-IR 
region, which is attributed to quadrupole plasmon resonance of the NPs.
80-82
 The 
morphology of nanomaterials decides how they are polarized and the number of  
plasmonic peaks they possess.
83
 For instance, absorption spectra of small NPs with the 
most symmetrical shape i.e. a sphere have just one plasmonic peak because a small 
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both in dipole and quadrupole modes.
84






Figure 2.12. UV-Vis spectra of the solutions containing mixture of spherical and 
polygonal AuNPs, and polygonal AuNPs alone. The inset shows the corresponding 
photographs of the AuNPs solutions. 
 
In general, non-spherical nanosystems exhibit two SPR peaks corresponding to their long 
and short axes.
10, 86
 In samples (2.4a) and (2.4b), which contain the nanochains, wires, 
and network structures, both transverse and longitudinal bands were expected due to their 
anisotropy. However, it can be seen in Figure 2.13 that nearly flat absorption peaks were 
observed from 500 to 800 nm. This result can be explained by an earlier observation that 
when one axis of the one dimensional nanomaterial exceeds 60 nm in length the 
corresponding longitudinal absorption peak appears above 1000 nm.
86
 Since the 
nanochains, wires, and network present in samples (2.4a) and (2.4b) have lengths greater 
than 60 nm, it is possible that the longitudinal peak appears beyond 1000 nm; this was 
not visible as the technical limitations of our UV-Vis instrument allow measurements 
only up to 800 nm. Nevertheless, the UV-Vis spectra for chains and wires observed here 
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match well with the ones reported by Pei et al.
71
 and Qiu et al.
73
 The transverse 
absorption peak corresponding to the short axis of the nanochains and wires appears 
between 400 to 900 nm as expected. Because of particle aggregation, both in the chains 
and the wires, the transverse absorption peaks were shifted to the higher wavelengths; 
560 nm for the wires and 600 nm for the chains respectively.
87-88
 It can also be seen that 
the SPR peak in the UV-Vis spectrum of the chains (2.4b) is not as flat as that of the 
wires made using the same reagent ratio but at a different temperature (2.4a). According 
to Liu et al. this is indicative of the relatively ordered one-dimensional NP formation 





Figure 2.13. UV-Vis spectra of Au nanochains, wires, and networks. 
 
2.3.3. Explanation for the chain and wire formation 
When the R value is low the rate of reduction of Au
3+
 is relatively slow and only a small 
number of Au nuclei are formed.
71





















2.4a (time: 15 min)
2.4a (time: 60 min)
2.4b
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and a large number of nuclei are formed. After the initial nucleation, the continuous 
reduction of the remaining AuCl4
ˉ
 in the solution creates more Au
0
 atoms and the 
attachment of these newly formed atoms onto the nuclei results in the formation of 
AuNPs.
54
 As the number of nuclei formed initially determines the size of the particles, 
under high R conditions very small particles are formed and under low R conditions, 
relatively large-sized particles are formed. As the reaction continues, AuNPs collide 
because of the attraction force due to the adsorption of AuCl4
ˉ
 and they become stuck 
together.
63
 Atomic Force Microscopy (AFM) measurements have demonstrated that 
repulsive interactions were dominant between Au surfaces in citrate solution due to the 
adsorption of citrate anions at the Au/water interface.
66, 89
 However, only attractive forces 
were observed in AuCl4
ˉ
 solution, that is, both in AuCl4
ˉ
 without any citrate ions and also 




 Also, the addition 
of AuCl4
ˉ
 ions to the AFM cell pre-adsorbed with citrate ions caused the intermolecular 
forces to change from repulsion to attraction.
61
 As the citrate anions were displaced by 
AuCl4
ˉ
, the diffuse layer potential of the Au surface was seen to decrease.
66
 It was 
therefore concluded that AuCl4
ˉ
 is adsorbed as AuCl3 with one of the Cl
ˉ 
ligand displaced 
and not as a charged ion.
66
  Also, AuCl4
ˉ
 adsorption onto the Au surface can reduce the 





According to Pei et al. the Au atoms get preferentially adsorbed on the concave surface 
formed at the joint of two NPs as shown in Figure 2.14.
71
 This preferential adsorption 
eventually results in the formation Au nanowires, and they grow in diameter and length 
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and with time form a 2D network structure. Under high R value conditions eventually all 
the Au
3+
 ions are completely reduced, resulting in the breakdown of Au nanowires to 
form AuNPs.
63
 However when the R value is low, AuCl4
ˉ 
remains on the Au surface and 
the Au nanowires survive.
63
 Pei et al have confirmed through TEM and UV-Vis studies 
that irrespective of the difference between the experimental conditions Au nanowires 
were formed when a large amount of AuCl4
ˉ
 was present in solution and these wires 
collapsed to spherical particles when the AuCl4
ˉ
 ions had been completely consumed.
71
 
Thus it is clear that the low R value and the consequent presence of excess AuCl4
ˉ
 in 
solution result in the formation of the wires.  
 
 
Figure 2.14. A Schematic representation of (a) the formation process of Au nanowires in 
the Turkevich reaction and (b) preferential deposition of Au
0
 atoms on the concave 
surface when two particles are adhered together. Reprinted with permission from Ref. 71. 
Copyright (2016) American Chemical Society.  
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2.3.4. Explanation for the polygonal particle formation 
The most widely used model for morphology control of crystals is given by the Gibbs-
Curie-Wulff theorem.
90
 This theorem suggests that the morphology of a crystal is 
determined by the surface energy of individual crystallographic faces of the crystal. The 
crystal attains its final morphology in such a way that the total surface energy of the 
crystal is minimized.
91
 This theorem has been successful in explaining most of the shape 
control of crystals. However, since it is based on a thermodynamic model, it does not 




Thus the formation of polygonal AuNPs at lower temperatures in this study, as in the 
cases of (2.2a) and (2.3a), could be a result of the difference in change of the rates of 
nucleation and particle growth with temperature. It has been proposed that the final shape 
of NPs formed can be controlled by the kinetics of the crystal growth.
92
 Under a 
thermodynamically controlled growth regime, isotropic growth of the nuclei into a 
thermodynamically favoured equilibrium shapes such as spherical or near-spherical 
polyhedral structures is preferred.
93
 Previously, it has been shown that at high 
temperature the rate of nucleation is high, resulting in efficient consumption of Au atoms 
to form nuclei, and the subsequent Ostwald ripening process allows the isotropic growth 
of the nuclei to form thermodynamically favoured spherical AuNPs.
54, 94
 Also, the higher 
reaction temperature favours higher rates of surface diffusion, and that also results in the 
formation of thermodynamically favoured spherical NPs.
54
 In a kinetically controlled 
regime, the anisotropic growth of the nuclei into particles with different morphology is 
often observed due to different growth rates for specific crystal facets.
93-94
 Kinetic control 
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Here, in the cases of (2.2a) and (2.3a) the low reaction temperature and the low molar 
ratios of citrate to HAuCl4 result in a slowing down of the rate of the reduction of AuCl4
-
 
ions, allowing kinetic control of the particle shape. Also, at a lower temperature, the rate 
of nucleation is expected to be reduced, which could favour the deposition of reduced 
atoms on existing nuclei along specific crystallographic directions, resulting in the 




A previous study of the Turkevich reaction by Shankar et al.,
70 
demonstrated that the 
formation of a mixture of triangular and spherical AuNPs could be ensured by choice of 
appropriate reaction temperature. In this study we have unravelled the effects of both the 
temperature and the reagent ratios with the aim of achieving better control over product 
morphology. The selective formation of polygonal-only AuNPs at the intermediate R 
ratio of 1.0 to 0.8, and the selective formation of only chains (without any individual 
spherical NPs) at the R ratio of 0.7 proves that the reagent ratio plays a significant role in 




This chapter has described the significant role of the molar reagent ratios of citrate and 
HAuCl4 in controlling the morphology of the Au nanosystems obtained by the Turkevich 
reaction when performed at various temperatures. High temperatures and molar ratios 
resulted in the formation of spherical and quasi-spherical particles, whilst reactions 
 Chapter 2                                                                                                                                                                          
90 
 
involving intermediate molar ratios yielded polygonal-only AuNPs at low temperatures, 
and the use of the lowest molar ratios resulted in the formation of complex structures 
(chains, wires, and networks) at low temperatures. It would appear that combined control 
of the molar ratio of reagents and temperature in the Turkevich reaction opens new 
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Chapter 3: Galactose-capped gold nanoparticles for the 
colorimetric detection of heat-labile enterotoxin 
 
3.1. Objective 
The aim of this chapter was to develop a simple and rapid colorimetric sensing system for 
the B-subunits of heat-labile enterotoxin (LTB) using thiol-modified galactose capped 
glycogold nanoparticles (Gal-gAuNPs). The Gal-gAuNP-based colorimetric sensor 
described in this chapter is a step towards the development of a size-optimised, easy to 
use, cheap, selective, highly sensitive, and fast sensing platform for the detection of LTB. 
 
3.2. Introduction 
3.2.1. AuNP-based colorimetric assays 
AuNP-based colorimetric assays have attracted significant interest over the past 
decade. The major advantages of AuNP-based colorimetric assays are: 
1. Facile methods established for binding AuNPs to a wide variety of ligands.
1
  
It has been shown that a wide variety of molecules: sugars, ranging from       
monosaccharides to oligosaccharides, peptides and proteins, antibodies, dendrimers, 
drug molecules, DNA, and lipids can be bound to the surface of AuNPs.
1
  
2. High extinction coefficients of AuNPs.
2
 







which is around 1000 times higher than that of traditional organic dyes.
2
 Thus, 
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AuNP solutions exhibit colour at nanomolar concentrations, allowing the detection 
of even small amounts of analytes with the naked eye.  
3. The distinctive colour change of AuNP solutions. 
If the presence of the target analyte results in the aggregation of the NPs, the solution 
colour changes from red to purple/blue, and vice versa in the case of the 
redispersion of the aggregates (purple/blue to red).
3
  
4. Simplicity and wide applicability.
3
  
The detection of target analytes using AuNP-based colorimetric assays is possible 
with the naked eye or with a UV-Vis spectrophotometer, which is commonly 
found in every Chemistry laboratory. 
 
All these benefits make AuNPs an ideal choice to form the basis of a colorimetric 
sensor for a plethora of analytes.
4
 To date, AuNP-based colorimetric sensors have 
been used to detect alkali and alkaline earth metal ions,
5-6















3.2.2. gAuNP-based colorimetric detection of toxic lectins 
Lectins are carbohydrate-binding proteins that are highly specific for sugar 
moieties.
13
 Generally a lectin contains two or more carbohydrate binding sites, whilst 
some lectins also form oligomeric structures, which therefore possess with multiple 
binding sites. A series of carbohydrates units present on the surface of one cell 
interact with the binding sites of lectins on the surface of another cell. In this way a 
number of relatively weak but specific interactions join the lectins and carbohydrates. 
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These interactions between the lectins and the carbohydrates resemble the action of 
Velcro; the interaction between each unit is relatively weak but the overall binding is 
strong.
13
 Though lectins are essential for various biological functions in animals, 
there are certain plant lectins that are amongst the most poisonous compounds 
known. For example, extracts from the seeds of Ricinus communis (castor beans) and 
Abrus precatorious contain the lectins ricin and abrin respectively; consumption of 
these toxins even in small quantities can be lethal and can cause irreversible inhibition of 




Colorimetric sensors based on gAuNPs have been used to detect various toxic 
lectins. Otsuka et al. have shown that the AuNPs modified with α-lactosyl-ω-
mercapto-poly(ethylene glycol) can be used to detect the lectin Ricinus communis 
agglutinin (RCA120) - a ricin surrogate.
16
 Hone et al. have developed a thiolated 
mannose-stabilized AuNP sensor, which was used to detect the lectin concanavalin A 
(Con A).
17
  Con A, a toxic lectin isolated from the jack bean Canavalia ensiformis, 
causes agglutination of red blood cells, followed by hemolysis, and eventual cell 
death.
18
 Schofield et al. have  developed thiolated galactose-stabilized and thiolated 
lactose-stabilized AuNP sensors for the detection of RCA120 and cholera toxin 
respectively.
19,20
 Cholera toxin, a lectin secreted by the bacterium Vibrio cholerae, is 
the pathogenic agent responsible for cholera, an acute infection affecting the 
intestine.
21
 Recently, Wei et al. have shown that the AuNPs modified with structural 








3.2.3. Effect of ligand density snd length, and size of AuNPs on their 
colorimetric detection 
gAuNPs are typically synthesised by attaching saccharides or glycoconjugates to the 
surface of AuNPs via thiol-terminated linkers. Previous studies have shown that both 
the length of the linker and the density of the ligands on the gAuNP surface can 
affect the efficacy of subsequent colorimetric sensing assays.
16, 19,23-28 
The chain 
length of the thiolated linker that binds the sugar to the AuNP surface has an 
influence on both the stability and the sensitivity of the gAuNPs.
4
 The general trend 
observed is that ligands with a longer chain give a more stable monolayer, whilst a 
shorter chain length results in better detection limits for colorimetric aggregation 
assays.
4
 The sugar density on the gAuNP surface is an important parameter that has a 
direct effect on the multivalent interaction between gAuNPs and lectins, and hence in 
the colorimetric aggregation assays. Previous studies have shown that the ligand 
density on the gAuNPs required for the optimal aggregation of the NPs depends on 




It has been shown that size of AuNPs also has an influence on their performance in 
colorimetric sensing.
29-32
 Krpetić et al. have shown the effect of AuNP size in the 





AuNPs with 45 nm diameter were found to be the optimal sensor for the detection of Ni
2+ 
ions. Niikura et al. have studied the effect of the particle size in the efficiency of 
colorimetric bioassays.
31
  AuNPs of 5, 10, and 15 nm diameter were capped with a 
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thiolated sialic acid derivative and used for the colorimetric detection of John 
Cunningham (JC) virus.
31
 Optical detection of virus was only achieved with the 15 nm 
sized gAuNPs. Although the majority of the reported gAuNP-based colorimetric assays 
have used 8-20 nm diameter gAuNPs, there has been no specific study into the effect of 
gAuNP size on the colorimetric sensing of toxic lectins. 
 
3.2.4. Heat-labile enterotoxin 
Heat-labile enterotoxin (LT), a lectin secreted by enterotoxigenic Escherichia coli, is 
one of the pathogenic agents responsible for a form of intestinal disease, commonly 
called „traveller‟s diarrhoea.‟
33
 Although in the case of a healthy adult this disease is 
either self-limiting or curable with antibiotics, it leads to the deaths of thousands of 
children per year in underdeveloped countries.
34
  LT is a member of the AB5 
bacterial toxin family, which also includes cholera toxin, shiga toxin, shiga-like 
toxin, and pertussis toxin.
35
 LT is very similar to cholera toxin (CT) in terms of 
structure, sequence, and function.
34
 All the AB5 toxins contain a disease causing A 
subunit, which is symmetrically surrounded by five carbohydrate binding B-subunits 
(Figure 3.1).
33
 The B-subunits of heat-labile enterotoxin (LTB) bind to the 
ganglioside GM1, which is present on the surface of mammalian intestinal cells. In 
the GM1 ganglioside, ceramide is linked to the branched pentasaccharide β-Gal-
(1→3)-β-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-Gal-(1→4)-β-Glc-ceramide.
33 
Binding of this pentasaccharide to the carbohydrate recognition domains of LTB is 
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Crystallographic studies have shown that interaction between GM1 and LTB occurs 
mainly through the terminal galactose residues of GM1; only minimal interactions have 
been observed between the N-acetylneuraminic acid of GM1 and LTB.
36
 The significant 
contact between LTB and galactose, 79% of which is buried in the binding pocket, 
explains the high selectivity of LTB for GM1, compared to other gangliosides.
37
 X-Ray 
crystallographic studies of the interaction of LTB with lactose revealed that that the high  
 
 
Figure 3.1. (A) LT holotoxin crystal structure and (B) a schematic representation of 




specificity for galactose arises from the fact that every hydrogen-bond acceptor and donor 
of the galactose unit, other than the ring and anomeric oxygens, is involved in hydrogen 
bonding.
34, 38
  Like others in their work on other AB5 toxins,
20,39-40  
we therefore chose 
galactose as the LTB binding motif for the development of a colorimetric sensing system.  
 
Several methods have already been developed for the detection of LT. These include 
phenotypic assays based on recognition of monoclonal antibodies (MAbs),
41-47
 genotypic 
methods based on DNA/DNA hybridization,
48
 and the use of the polymerase chain 
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reaction (PCR), or real-time PCR techniques.
49-51
 Ito et al. have reported that the 
automatic latex agglutination test is capable of measuring LT at a concentration of 1 
ng/mL.
52
 Ristaino et al. have shown that the least amount of toxin detected by GM1-
ELISA was 7 ng/mL.
53
 Menezes et al have reported that 25 µg/mL of anti-rabbit heat-
labile toxin IgG enriched fraction and 10 µg/mL of IgG2B monoclonal antibody allowed 
the capture of less than 10 ng of the toxin.
54
 Spangler et al. have used the Spreeta
®
 
surface plasmon resonance sensor and a quartz crystal microbalance and have shown that 
the least amount of toxin detected was 3 to 6 µg/mL,
55
 which is similar to the detection 
level in our study. Although these methods have a high level of sensitivity and 
specificity, the majority of them require complex instrumentation and involve protracted 
operating procedures. More recently, colorimetric sensing of the heat-labile enterotoxin 
gene was reported by Jyoti et al.
56
 using thiol-modified oligonucleotide capped AuNPs, 
indicating the desirability of an operationally straightforward colorimetric assay. 
Interestingly, so far there have been no reports that discuss the use of AuNPs stabilized 
with simple sugar moieties for the colorimetric detection of heat-labile enterotoxin.  
 
The remaining sections of this chapter will detail the synthesis of Gal-gAuNPs of various 
sizes, containing AuNP metal cores of 2, 7, 12, and 20 nm, and investigations into their 
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3.3. Results and discussion 
3.3.1. Synthesis of the thiol-terminated galactose ligand 
 
 
Scheme 3.1. Synthesis of the thiol-terminated galactose ligand. 
 
The known disulfide 3.4 (Scheme 3.1) was accessed by following the procedure of 
Schofield et al. with slight modifications.
19
 D-Galactose was acetylated by reaction with 
acetic anhydride and sodium acetate to give penta-O-acetyl--D-galactopyranose 3.1 
(Scheme 3.1).
57-58
 Reaction of 3.1 with triethyleneglycol in the presence of the Lewis 
acid, BF3∙Et2O, afforded the -triethylene glycol glycoside 3.2.
19 
Initially, for the 
introduction of a thioacetate at the terminus of the linker, alcohol 3.2 was reacted with 
tosylchloride (TsCl) in pyridine, to form an intermediate tosylate, which could be used to 
obtain the thioacetate 3.3. However,  this reaction proved to be problematic, presumably 
due to the presence of water in the pyridine used. As an alternative approach, alcohol 3.2 
was reacted with mesylchloride (MsCl) and triethylamine in DCM, to form an 
intermediate mesylate, which was then reacted with potassium thioacetate in DMF to 
 Chapter 3                                                                                                                                                                          
104 
 
afford the thioacetate 3.3. Global deactylation of 3.3 by reaction with sodium methoxide, 
followed by air oxidation afforded the disulfide 3.4.
19  
 
3.3.2. Synthesis and characterization of different sized Gal-gAuNPs 
Density of the thiol-terminated sugar ligands on the surface of gAuNPs can be 
manipulated by introducing additional „spectator‟ or „filler‟ ligands. By varying the ratio 
of the sugar ligands and the „filler‟ ligands in the synthesis of gAuNPs, the desired sugar 
density on the surface of gAuNPs can be obtained. In this study, only the thiol-terminated 
galactose was used as a ligand to synthesize Gal-gAuNPs, so that the effect of the gAuNP 
size alone on the performance of these systems in colorimetric sensing could be 
specifically and systematically studied. The 2 nm sized Gal-gAuNPs (Gal-gAuNP-2) 
were synthesized following the procedure of Barrientos et al., a modified version of 
Brust-Schiffrin method (BSM).
59-60
 Disulfide 3.4, dissolved in MeOH, was added to an 
aqueous solution of HAuCl4. Sodium borohydride, dissolved in water, was then added to 
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Scheme 3.2. Synthesis of Gal-gAuNP-2 following a modified version of BSM. 
 
The 7 nm (Gal-gAuNP-7), 12 nm (Gal-gAuNP-12), and 20 nm (Gal-gAuNP-20) sized 
Gal-gAuNPs were obtained by ligand exchange reactions of Cit-AuNPs of 7, 12, and 20 
nm respectively with the disulfide 3.4 (Scheme 3.3).
17
 The disappearance of the 
characteristic IR bands for citrate (at 1400 and 1600 cm
-1 
for the carboxylate and 
carbonyl groups, see Appendix, Figure A3.1-A3.5)
62
 after the reaction of the Cit-AuNPs 
with the thiol confirmed that the citrate ligands had been were successfully replaced.
   
 
Scheme 3.3. Synthesis of Gal-gAuNP-7/Gal-gAuNP-12/Gal-gAuNP-20 by ligand 
exchange method.  
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The 12 and 20 nm sized Cit-AuNPs used in these reactions were themselves synthesized 
using the standard Turkevich reaction.
63
 The 7 nm sized Cit-AuNPs were synthesized by 
following a recently developed procedure by Sivaraman et al.
64
 In this modified 
Turkevich process, the addition of a solution of HAuCl4 to a solution of citrate, which is 
the reverse order compared to the standard Turkevich reaction, produced AuNPs of 7 nm 
size. Through their kinetic studies, Sivaraman et al. have shown that the pH of the 
reaction mixture and the initial molar ratio of citrate to HAuCl4 both play a crucial role in 




Particle size and size distributions (as demonstrated by TEM) and the UV-Vis absorption 
spectra of all of the AuNPs were essentially the same both before and after ligand 
exchange, indicating that the AuNP cores had not been affected. Analysis of the TEM 
images of the Gal-gAuNPs (in each case at least 200 particles were measured) using 
ImageJ software revealed the particle sizes to be 2.3 ± 0.5, 7.3 ± 0.9, 12.0 ± 1.7, and 20.3 
± 1.8 nm (histograms for the size distribution of the AuNPs are shown in the Appendix 
Figure A3.6) for Gal-gAuNP-2, Gal-gAuNP-7, Gal-gAuNP-12, and Gal-gAuNP-20 
respectively (Figure 3.2).   
 




Figure 3.2. Representative TEM images of Gal-gAuNPs: a) Gal-gAuNP-2, b) Gal-
gAuNP-7, c) Gal-gAuNP-12, and d) Gal-gAuNP-20. The scale bar is 20 nm. 
 
It is known that as AuNPs increase in size, the corresponding SPR peaks in the UV-Vis 
absorption spectra shift toward longer wavelengths.
65
 Here, the absorption maxima for 
Gal-gAuNP-7, Gal-gAuNP-12, and Gal-gAuNP-20 were found to be 518, 523, and 527 
nm respectively (Figure 3.3) whilst Gal-gAuNP-2 had an absorption shoulder at 506 nm. 
ESI-MS and FT-IR analysis (see Appendix) also confirmed that the galactose ligands had 
been successfully incorporated. The average molecular formula of the Gal-gAuNPs was 
determined through TGA (see Appendix Figure A3.7-A3.10), and was also confirmed by 
elemental analysis.  The average molecular formulae were found to be 
Au377(C12H24O8S)162, Au12060(C12H24O8S)2181,  Au53568(C12H24O8S)3074, and 
Au259328(C12H24O8S)9761 for Gal-gAuNP-2, Gal-gAuNP-7, Gal-gAuNP-12 and Gal-
gAuNP-20 respectively.  
 




Figure 3.3. UV-Vis absorbance spectra of the Gal-gAuNPs. 
 
The number of Au atoms (NAu) and the number of thiolate ligands (NL) per NP was 
calculated according to the following equation:
66-67
 
    
         
   
 
  
   
 
           
     
   
 
(
   
 )
             
      
    
       
mAu= NAu x 196.97 
mL= mAu x (wt% of L/ wt% of Au) 
NL= mL/ ML 
where VNP is the volume of a spherical AuNP, VAu is the volume of a Au atom, APF is 
atomic packing factor, rNP and dNP are the radius and the diameter of a AuNP, and rAu is 
the radius of a Au atom. mAu, mL, and ML are the mass of the Au atoms in the NP, mass 
of the ligands in the NP, and the molecular mass of the ligand respectively. The wt% of 
the ligand (L) and wt% of Au are obtained from TGA. 
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3.3.3. The effect of Gal-gAuNP size on the efficacy of colorimetric detection of LTB 
To investigate the effect of the size of the Gal-gAuNPs on the colorimetric detection of 
LTB, purified Gal-gAuNPs with particle sizes 2, 7, 12, and 20 nm were freeze-dried, and 
then re-suspended in phosphate buffer (10 mM, pH 7.2) to give a NP concentration of 10 
nM. A series of solutions with a range of LTB concentrations (300, 600, 900 and 1200 
nM) were prepared separately in Milli-Q water. Then, an aliquot of each of the LTB 
solutions (150 μl) was added (with mixing) to an aliquot of the Gal-gAuNP solution (150 
µl), and the progress of the reaction was monitored by UV-Vis spectroscopy, recording 
the absorption at 620 nm prior to recording of the whole UV-Vis absorbance spectrum.   
 
Interestingly, it was found from both TEM and UV-Vis studies that Gal-gAuNP-2 did 
not undergo any aggregation upon the addition of LTB; hence Gal-gAuNP-2 was not 
suitable for the colorimetric sensing of LTB. However in the cases of the 7, 12, and 20 
nm diameter Gal-gAuNPs a correlation was observed between the concentration of the 
LTB that was added, and the degree of Gal-gAuNP aggregation. In these cases both the 
red-shift and the intensity of the SPR peak increased with increasing amounts of LTB due 




TEM analysis (Figure 3.4b-d) clearly showed that, following the addition of LTB, the 
Gal-gAuNPs were no longer present as individual particles, but had assembled into 
networks of aggregated NPs, except in the case of Gal-gAuNP-2 (Figure 3.4a). LTB 
detection was possible with the naked eye as the colour of the colloidal solution changed 
from ruby red to purple upon Gal-gAuNP aggregation (Figure 3.5). 




Figure 3.4. Representative TEM images of Gal-gAuNPs after the addition of LTB: non-
aggregated a) Gal-gAuNP-2 (with 10 µM LTB) and aggregated b) Gal-gAuNP-7, c) 




Figure 3.5. Gal-gAuNPs of various sizes before (top row) and after (bottom row) the 
addition of LTB (600 nM). 
 
As shown in Figure 3.6a, the original SPR peak of Gal-gAuNP-7, centred at 518 nm, did 
not undergo a significant shift when LTB was added to give final LTB concentrations of 
either 150 or 300 nM. However, when the final LTB concentration was increased to 450 
nM, the SPR peak shifted to 536 nm and the solution turned purple, indicating that  




Figure 3.6. UV-Vis absorption spectra of Gal-gAuNP-7: (a) with varying nM 
concentrations of LTB (each spectrum was recorded 10 min after mixing with LTB) and 
(b) time dependence of absorbance at 620 nm. 
 
significant aggregation of the Gal-gAuNPs had occurred. When the LTB concentration 
was increased further to 600 nM, an even more pronounced red-shift was observed, and 
the SPR maximum moved to 542 nm. Kinetic studies of these reactions were also carried 
out by monitoring the time dependence of changes in the absorption at 620 nm (Figure 
3.6b).
19,20 
At final LTB concentrations of 450 and 600 nM, 95% of the total increase in 
absorbance (I95) occurred within two minutes, whilst 99% of the total increase (I99) 
occurred within 5 minutes, indicating that aggregation of the Gal-gAuNPs was relatively 
fast, and that rapid detection of LTB is possible by this method.  
 
With Gal-gAuNP-12 (Figure 3.7a), aggregation was even observed after the addition of 
only 150 nM LTB. Therefore even lower LTB concentrations were used in order to 
determine the minimum detection limit of LTB by Gal-gAuNP-12. Although no SPR 
peak shift was observed using 50 nM LTB, at 100 nM a shift in the SPR peak was 
observed from 523 to 528 nm. These results indicated that Gal-gAuNP-12 was more 
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effective than the Gal-gAuNP-7 for the colorimetric detection of LTB. With Gal-
gAuNP-12, when the LTB concentration was increased from 150 to 600 nm, the SPR 
maxima shifted gradually from 533 to 557 nm, indicating increased aggregation. Kinetic 
studies of Gal-gAuNP-12 aggregation (Figure 3.7b), again involving monitoring the 
absorbance at 620 nm, revealed that I95 occurred within 2 minutes and that I99 occurred 
within 4.5 minutes at all LTB concentrations investigated (100-600 nM). 
 
 
Figure 3.7. UV-Vis absorption spectra of Gal-gAuNP-12: (a) with varying nM 
concentrations of LTB (each spectrum was recorded 10 min after mixing with LTB) and 
(b) time dependence of absorbance at 620 nm.   
 
When the size of the Gal-gAuNPs was further increased to 20 nm, the minimum 
concentration of LTB required to produce a red-shift of the SPR maximum was found to 
be 300 nM, i.e. a higher LTB concentration than was required for Gal-gAuNP-12, but 
lower than for Gal-gAuNP-7 (Figure 3.8a). Kinetic data obtained for Gal-gAuNP-20 are 
shown in Figure 3.8b; similarly to the cases of both Gal-gAuNP-7 and Gal-gAuNP-12, 
I95 occurred within two minutes, and I99 occurred within 5 minutes.  




Figure 3.8. UV-Vis absorption spectra of Gal-gAuNP-20: (a) with varying nM 
concentrations of LTB (each spectrum was recorded 10 min after mixing with LTB) and 
(b) time dependence of absorbance at 620 nm. 
 
To further understand the size-dependence of LTB detection by the Gal-gAuNPs, the 





was plotted against the LTB concentration for all of the Gal-gAuNPs (Figure 3.9). These 
data show that Gal-gAuNP-12 was not only capable of detecting LTB at much lower 
concentrations, but also that the increase in absorbance intensity that was observed as the 
LTB concentration was increased was much higher for Gal-gAuNP-12 as compared to 
the other Gal-gAuNPs.  
 




Figure 3.9. Plot of the ratio of the absorbance intensity at 620 nm both with and without 
LTB vs LTB concentration for Gal-gAuNPs of different sizes. Each point is the average 
of three measurements with the error bars representing the standard error. 
 
In the cases of the 7, 12, and 20 nm Gal-gAuNPs the NP concentration used for the 
colorimetric study was 10 nM. In the case of Gal-gAuNP-2 a much higher NP 
concentration (1 µM) was required because at a AuNP concentration of 10 nM absorption 
by the colloid was too low to be detected by the UV-Vis spectrometer; this was due to a 
combination of the significantly lower total amount of Au present, and a low extinction 
coefficient, which decreases as particle size decreases.
68-69
 At the much higher 
concentration of 1 µM, it was anticipated that a higher concentration of LTB would be 
required to aggregate Gal-gAuNP-2. However even with a correspondingly higher 
concentration of LTB (10 µM, i.e. the same overall molar ratio which caused the onset of 
the SPR shift for Gal-gAuNP-12), no shift in the SPR peak was observed, and TEM 
(Figure 3.4a) confirmed that the Gal-gAuNP-2 had not aggregated in the presence of 
LTB. Moreover the 2 nm sized Gal-gAuNP-2 are not ideally suited to colorimetric 
sensing since they fall at the borderline of non-metallic/metallic NPs; as a result they 
















 The precise reason why Gal-gAuNP-12 was more effective at detecting LTB 
than either Gal-gAuNP-7 or Gal-gAuNP-20 is not yet clear, and further investigations 
are required in order to adequately explain this finding. Furthermore, whether this size-
related phenomenon is specific to this particular toxin, or is dependent on the spatial 
arrangement of the different carbohydrate-binding sub-units of the toxin, also remains to 
be demonstrated. 
 
3.3.4. Gal-gAuNP aggregation in the presence of LTB 
A pictorial representation of the LTB-induced aggregation of Gal-gAuNPs, based on 
previous reports on related analyte-induced aggregation-effected sensors,
4, 20 
is shown in 
Figure 3.10. The performance of a AuNP-based colorimetric sensing system depends on 
how efficiently the AuNP dispersion is converted to AuNP aggregates, or vice versa, in 
the presence the analyte of interest.  
 
 
Figure 3.10. Schematic representation of the mechanism of aggregation Gal-gAuNPs in 
the presence of LTB. 
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In general, gAuNPs are stabilized against attractive van der Waals forces by steric 
repulsion of the surface capping ligands; in this study the thiol-terminated galactose 
ligands.
3 
Aggregation of gAuNPs can be achieved in two ways - either via non-
crosslinking or via interparticle crosslinking.
3
 In non-crosslinking approach, particle 
aggregation is achieved by the controlled loss of electrostatic (Figure 3.11A), 
electrosteric (Figure 3.11B), or steric stabilizations (Figure 3.11C) without any 










Figure 3.11. AuNP aggregation through non-crosslinking approach. A) In pathway A, 
AuNPs are aggregated when they lose their electrostatic stabilization provided by small 
charged molecules on their surface. Representative examples include the use of AuNPs to 
monitor a biological reaction in which the reactant and product have different effects on 
the surface charge properties of AuNPs; B) In pathway B, the loss of (electro)steric 
stabilization for (charged) polymer-stabilized AuNPs, such as the removal of DNA 
molecules from AuNPs by endonuclease cleavage causes the particle aggregation; C) In 
Pathway C, (charged) polymer conformational transitions, such as DNA aptamer folding 
upon binding to its target causes the AuNP aggregation. Image reprinted from Ref. 3. 
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The alternative interparticle crosslinking aggregation mechanism can works in either of 
two ways (Figure 3.12). In the first case, particles are made to aggregate by using target 
analytes (crosslinkers) that possess multiple binding sites for the ligands attached on the 
surface of AuNPs. In the second case, two sets of AuNPs are used to achieve the 
aggregation; one set is capped with receptor molecules and the other set with 
complementary molecules (anti-receptor). The direct interaction between these two set of 








Figure 3.12. AuNP aggregation through interparticle crosslinking approach. A) In 
pathway A, AuNPs are aggregated by crosslinkers that posess multiple binding sites for 
the ligands on AuNP surface. In pathway B, the processes that remove crosslinkers 
deaggregates the AuNPs. Processes that modifies the crosslinkers (pathway C) or the 
ligands on AuNP surface (pathway D) controls the particle aggregation and dispersion. 
B) AuNP aggregation is achieved by direct interaction (without any crosslinker 
molecules) of receptor- and anti-receptor-capped AuNPs. Processes that remove these 
direct interactions result in deaggregation (pathway E). The aggregation can also be 
controlled by processes that alter the surface-bound receptors (pathway F). Image 
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Interparticle crosslinking aggregation can be postulated as the basis of the sensing 
response reported here; controlled aggregation of the Gal-gAuNPs occurs because of 
binding of the multiple galactose recognition domains present in LTB to the galactose 




3.3.5. Stability and selectivity of the Gal-gAuNPs  
In order to demonstrate the selectivity of toxin detection aliquots of a Gal-gAuNP-12 
solution were mixed with Bovine Serum Albumin (BSA, aqueous solutions of 300-1200 
nM), the lectins ConA and Hemagglutinin (aqueous solutions of 600 nM), and a variety 




















all at a 
concentration of 100 µM). It was found that none of these species had any effect on either 
the UV-Vis absorption spectrum or the colour of the Gal-gAuNP-12 solution, confirming 
that the Gal-gAuNPs did not undergo non-specific aggregation, and that amongst the 
species investigated the detection was selective for LTB. Furthermore the Gal-gAuNPs 
were found to be stable in an electrolyte solution (a solution containing Cl
ˉ
 at 100 mM, 
Na
+
 at 135 mM, K
+
 at 15 mM, and HCO3
ˉ
 at 45 mM) that was selected to mimic the 
typical „watery stool‟ of diarrhoea patients.
72,73-74
 Gal-gAuNP-12 was then used to detect 
LTB in this electrolyte solution. A plot of the absorbance intensity at 620 nm vs LTB 
concentration (Figure 3.13) shows that in the electrolyte solution the minimum 
concentration required for the change in the absorbance at 620 nm was also found to be 
100 nM; a similar result to that shown in Figure 3.9. Thus the AuNP sensor was also 
effective in an ionic environment that was deemed „typical‟ of a clinical sample. Gal-
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gAuNPs were found to be stable at least for three months at 4 
o
C; re-testing them after 
this time period gave similar results for the detection of LTB. 
 
 
Figure 3.13. Plot of the absorbance intensity at 620 nm vs LTB concentration for Gal-




This chapter has described the synthesis and use of Gal-gAuNPs for the simple and rapid 
colorimetric detection of LTB at nanomolar concentrations. A series of Gal-gAuNPs of 
different sizes (2, 7, 12, and 20 nm) were synthesized and assayed for their ability to 
detect LTB.  The presence of multiple binding sites on LTB, together with the specific 
binding of these receptors to galactose units attached to the Gal-gAuNPs, caused NP 
aggregation as the basis for LTB detection. The 2 nm Gal-gAuNPs did not aggregate in 
the presence of LTB, and did not show any shift in the surface plasmon band. However, 
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detection level of LTB at first improved from 450 nM down to 100 nM and then declined 
to 300 nM, indicating that the optimal size for Gal-gAuNPs for the colorimetric detection 
of LTB was 12 nm. These results indicate that the size of gAuNPs is also an important 
parameter that should be considered, alongside those of linker-length and the percentage 
of ligand coverage, in order to construct efficient and optimised colorimetric sensors for 
toxic lectin detection. Kinetic studies revealed that the response developed within 2 
minutes after the addition of LTB. Furthermore the Gal-gAuNPs did not undergo any 
non-specific aggregation in the presence of BSA, the lectins ConA and hemagglutinin, or 
various ions.  
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Chapter 4: Influenza virus detection by gold nanoparticles 




The aim of this chapter was to develop a simple and rapid colorimetric and DLS-based 
sensing system for the influenza virus by detection of viral hemagglutinin using thiol-
modified sialylglycan capped glycogold nanoparticles (SG-gAuNPs). The SG-gAuNP-
based sensor reported in this chapter is a step towards the development of an easy to use, 
cheap, selective, and highly sensitive sensing platform for the detection of the influenza 
virus. 
 
4.2. Introduction  
4.2.1. AuNP-based colorimetric assay 
Constructs comprised of metal NPs attached to a variety of chemical entities with specific 







 AuNPs are particularly suited to such applications for a 
number of reasons; there are well-established methods for the synthesis of AuNPs with 
defined sizes and shapes, it is easy to modify their surfaces, and they have excellent 
stability and biocompatibility.
5-9
 In particular, interest in the application of modified 
AuNPs as colorimetric sensors has increased exponentially over the past decade. A 
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detailed discussion on the major advantages of AuNP-based colorimetric assays is 
provided in Chapter 3, Section 3.1.1.   
 
4.2.2. Influenza virus 
The influenza virus is a respiratory pathogen which causes an acute febrile respiratory 
infection in humans and other mammals. Influenza causes regular seasonal epidemics and 
occasional pandemics in the human population.
10
 Recent reports show that seasonal 
influenza epidemics result in ~300,000 human deaths annually.
11
 The influenza virus 
particle contains two types of surface glycoprotein, neuraminidase (NA) and 
hemagglutinin (HA), and influenza A viruses are subtyped according to the variations of 
these two glycoproteins, for example as H1N1.
12
 Viral HA is an integral membrane 





HA from the influenza virus is made up of ~556 amino acids, and accounts for more than 
80% of the envelope proteins of the virus.
10,14
 One of the essential steps in influenza viral 
infection is binding of the viral particles to host cells, a process which is mediated by 
specific interaction between the HA of the virus and sialic acid residues present on the 
host cell.
15
 It has been found that human-adapted influenza viruses preferentially bind to 
sialylglycans with terminal α(2→6) linkages, whereas avian influenza viruses 
preferentially bind to α(2→3) linked sialylglycans (Figure 4.1).
16
 Whilst the binding 




), the binding 
constant between the multiple HAs of a viral particle with the multiple sialic acids 
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 Thus a multivalent effect 





Figure 4.1. a) A schematic representation of the trimeric influenza viral hemagglutinin, 
with the monomers shown in purple, orange, and grey. Hemagglutinin (HA) is a 
transmembrane protein that is made of the stalk-like HA2 part and globular HA1 part. 
Each HA1 domain binds to sialic acid, and the binding site in one monomer is shown 
with a red circle; b) schematics of an example of an avian influenza virus receptor 
α(2→3)-sialyllactose and a human influenza virus receptor α(2→6)-sialyllactose; c) 
trimeric hemagglutinin surface representation (monomers are shown in grey, orange and 
purple) in complex with N-acetylneuraminic acid (Neu5Ac) (as a stick representation in 
yellow) (Protein Data Bank (PDB) accession 1HGG). Red circles show the glycan-
binding site; d) close-up image of the sugar-binding site of hemagglutinin. Selected 
important contacts between the Neu5Ac (yellow) and hemagglutinin residues Ser136, 
Asn137, and Glu190 (purple) are highlighted (grey dashes). The sugar moieties are 
depicted in stick representation, with nitrogen atoms in blue and oxygen atoms in red; e) 
superposition of an avian influenza virus hemagglutinin in complex with α2,3-
sialyllactosamine (yellow) (PDB accession 2WR2) and the human receptor α2,6-
sialyllactosamine (cyan) (PDB accession 2WR7). Image reprinted with permission from 
Ref. 20. 
 




Sialylglycopeptide (SGP) 4.1, a sialic acid terminated bi-antennary complex-type N-
glycan attached to a short peptide (H-Thr-Lys-Asn-Ala-Val-Lys-OH, and the peptide is 
attached to the sugar through the Asn, Figure 4.2), is one of the components present in 
hens‟ egg yolk. SGP has drawn significant interest in recent years due to its antiviral and 
antimicrobial properties.
21
 It has also been shown that SGP and its derivatives have the 
potential to be 
 
 
Figure 4.2. The structure of SGP. 
 
developed into prophylactic drugs (i.e. drugs that are designed and used to prevent a 
disease from occurring) against bacterial and viral infections.
21-22
 In 1997, Seko et al. 
demonstrated for the first time that SGP is naturally found in hens‟ unfertilized egg 
yolks.
23
 The yield of SGP from egg yolks was compared with the other major yolk 
proteins such as phosvitin, α- and β-lipovitellins, and low density lipoprotein (LDL); the 
yield of SGP per gram of yolk was found to be lower than that of other yolk proteins. 
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However, due to the low molecular weight of SGP as compared to other proteins the 




Three egg yolk glycoproteins; riboflavin-binding protein (RBP), immunoglobulin Y 
(IgY), and phosvitin have N-linked silalylglycans.
24-26
 The glycan of SGP is similar to 
those of phosvitin and RBP, as none possess either bisecting-N-acetylglucosamine 
residues or high mannose-type structures.
26
 The difference in the structure of the glycans 
of the various yolk glycopeptides and glycoproteins is probably due to the different 
tissues in which they are formed.
23
 The origin of SGP in egg yolks still remains unclear.  
 
Due to the homogeneity seen in the amino acid sequence in SGP, it might be possible that 
enzymatic proteolysis of certain glycoproteins results in its formation.
23
 Seko et al. have 
suggested that vitellogenin, one of the major storage protein precursors in yolk, could be 
the source of SGP; Vtg II, a major chicken vitellogenin, has the same amino acid 
sequence in the peptide of SGP.
23
 However this hypothesis has yet to be verified. 
 
4.2.4. gAuNPs and influenza virus and viral HA detection 
gAuNPs have been used as sensors for various biomolecules and toxins,
27-32
 including the 
detection of pathogenic agents such as bacteria and viruses.
33-35
 Indeed the detection of 
both the influenza virus itself and viral HA using gAuNPs have been reported very 
recently,
36-38
 and gAuNPs have also been tested for their efficiency in inhibiting influenza 
virus infection.
19
 In 2010, Papp et al. used a synthetic sialic acid-terminated glycerol-
based dendron (Scheme 4.1) to functionalize 2 and 14 nm sized AuNPs.
19
 These gAuNPs 
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were tested for their inhibition of influenza virus infection. TEM results showed that the 
14 nm sized gAuNPs were effective in influenza virus inhibition, whilst 2 nm sized 
gAuNPs did not have any significant effect. The procedure used for the synthesis of the 
sialic acid-terminated glycerol dendrimer is shown in the Scheme 4.1. The Brust- 
Schiffrin method (BSM) was used to synthesize 2 nm gAuNPs, and the Turkevich 
reaction followed by 
 
Scheme 4.1. Synthetic procedures for the sialic acid-terminated glycerol dendron and the 
spacer ligand. Reagents and conditions:  a) 2,2‟-Dimethoxypropane (DMP), p-
toluenesulfonic acid (PTSA); b) NaOH, tetrabutylammonium iodide (TBAI), C11H21Br; 
c) Dowex-H
+
, MeOH, reflux; d) propargyl bromide, NaH; e) azido-sialic acid, click 
reaction, sodium ascorbate, CuSO4⋅5H2O; f) AcSH, azobisisobutyronitrile (AIBN), 
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ligand exchange was used to prepare the 14 nm gAuNPs. In a related work, Lee et al. 
synthesized sialic acid-functionalized gAuNPs (20 nm size) in one-pot without 
chemically modifying the sialic acid.
36
 In this case sialic acid acted as both the reducing 
agent and the stabilizing ligand for Au during the gAuNP synthesis. These gAuNPs were 
then used for the colorimetric detection of the influenza virus (Scheme 4.2).  
 
Scheme 4.2. Synthesis of sialic acid reduced and stabilized gAuNPs (SA-AuNP), and 
their application as colorimetric sensor for the influenza virus. Image reproduced from 
Ref. 36 with permission from Elsevier.  
 
In a similar fashion Marín et al. synthesized gAuNPs (16 nm size) that were 
functionalized with both a thiolated trivalent α(2→6)-thio-linked sialic acid derivatives 
(Scheme 4.3) and a thiolated polyethylene glycol (PEG) derivative.
37
 Use of the 
Turkevich reaction followed by ligand exchange allowed them to prepare 16 nm sized 
gAuNPs that were functionalized with different ratios of the sialic acid and the PEG 
ligands. A optimum colorimetric detection of the human influenza virus X31 (H3N2) was 
achieved when the ratio of thiolated trivalent α(2→6)-thio-linked sialic acid derivatives 
and a thiolated polyethylene glycol (PEG) derivative was 25:75. Moreover, the gAuNPs 
selectively detected human-adapted influenza viral particles which have binding 
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Scheme 4.3. Synthesis of thiolated trivalent α(2→6)-thio-linked sialic acid derivative 
(B). Reagents and conditions: (a) 10% Pd-C, EtOAc; (b) azidohexanoic acid NHS ester, 
Et3N, CH2Cl2; (c) NaOMe-MeOH; (d) 
t
butyldimethylsilyl chloride/DMF; (e) 
Ac2O/Pyridine; (f ) 10% TFA in 80% aq. AcOH; (g) triflic anhydride/Pyridine; (h) 
Et2NH/DMF; (i) NaOMe/MeOH; ( j) CuSO4-sodium ascorbate, 
t
BuOH/H2O 1 : 1; (k) 1 
M aq. NaOH; (l) 80% aq. TFA; and (m) γ-thiobutyrolactone/DTT/0.5 M aq. 
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Most recently in 2014, Wei et al. synthesised a series of gAuNPs (13 nm size) 
functionalized with sialic acid derivatives, with either α(2→6) or α(2→3) linkages, as 
shown in Scheme 4.4.
38
 The Turkevich reaction followed by ligand exchange was used to 
prepare the 13 nm sized gAuNPs functionalized with the sialic acid derivatives. The sialic 
acids were modified by sulfation, fucosylation, and N-acetylation. Thus these compounds 
represented the termini of naturally occurring glycans seen in cell surface glycolipids and 
glycoproteins. It was demonstrated that these gAuNPs could be effectively used for the 




Scheme 4.4. Chemoenzymatic synthesis of gAuNPs functionalized with sialic acid 
derivatives, with either α(2→6) or α(2→3) linkages (12a-12g). Reagents and conditions: 
(a) CuI, DMF/MeOH, rt, 50-80%; (b) α(2→3)-SiaT or α(2→6)-SiaT, CMP-Neu5Ac, 
Tris-HCl buffer (pH 8.0), 37 
o
C, 2 h, 17-87%; (c) deionized water, rt, 24 h. 
Abbreviations: SiaT, sialyltransferase; CMP, cytidine 50-monophosphate; GNP, Cit-
AuNPs. Reprinted with permission from Ref. 38. Copyright (2016) American Chemical 
Society.  
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Thus, the majority of previous studies have involved gAuNPs decorated with synthetic 
oligosaccharides of various lengths that were terminated in sialic acid. Although none of 
these materials corresponded to the full-length N-glycans that are typically found on the 
mammalian cell surface, their syntheses were nonetheless time-consuming, expensive, 
and logistically demanding.
19, 37-38
 Additionally in the case where sialic acid itself was 
used as the ligand for gAuNPs,
36
 the selective detection of human-adapted influenza 
viruses that prefer  α(2→6)-linked sialylglycans was not possible.  
 
The remaining sections of this chapter will detail the extraction of SGP from egg yolks, 
the synthesis of SG-gAuNPs, and investigations into their performance for the detection 
of the influenza virus and viral hemagglutinin. 
 
4.3. Results and Discussion 
4.3.1. Extraction of SGP and conversion to a thiol 
The original procedure developed by Seko et al. for the extraction of SGP from egg yolks 
was quite tedious; it involved a phenol extraction, centrifugation, an EtOAc wash, and 
then repeated size exclusion and ion exchange chromatographies.
23
 Also, the 9% phenol 
aqueous solution used to precipitate the unrelated proteins and to extract the SGP from 
yolks caused significant emulsification due to the blending of soluble proteins, lipids, 
phenol, and water. Emulsification meant that separation of supernatant and precipitates 
was always incomplete, even under high-speed centrifugation. Zou et al. simplified the 
final stage of the purification by employing porous graphite carbon extraction instead of 
the multiple gel-filtration procedure.
39
 In 2012, Sugawara et al. reported the use of water 
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to extract defatted egg yolks, and that the supernatant could be consequently treated with 
organic solvents to precipitate SGP.
40
 However, all these procedures had the drawbacks 
of emulsification, the need of high-speed centrifugation for long duration, and protracted 
purification procedures which limited the large-scale extraction of SGP. Therefore we 
followed the most recent extraction procedure recently developed by Sun et al. in which 





Egg yolks were separated from 300 chicken eggs purchased from super market, and the 
yolks were lyophilized. The yolk powder obtained was successively washed with diethyl 
ether and 70% aqueous acetone solution to remove the lipids present. The removal of 
lipids in this step significantly reduced the amount of emulsification during the later 
steps. The SGP in the yolk powder was then extracted into 40% aqueous acetone 
solution, and the residual yolk powder was removed by simple filtration of the extract 
through Celite
®
. Sun et al.
41
 reported that 40% aqueous acetone solution was the a better 
solvent system to use for this extraction as compared to all other possible combination of 
water and acetone, and also the 9% aqueous phenol solution used by Seko et al.
23
 SGP 
was purified from the extract using an active carbon/Celite
®
 (1:1) chromatography 
purification. The active carbon/Celite
®
 column was sequentially washed with 5% and 
10% aqueous MeCN followed by elution with 30% aqueous MeCN afforded 1.2 g of 
SGP 4.1 (Scheme 4.5). In active carbon/Celite
®
 column the activated carbon acts as a 
„reverse phase‟ column by inducing hydrophobic interaction with eluent. As activated 
carbon is a very compact material, the Celite
®
 was used to increase the porosity of the  




                           Scheme 4.5. Isolation and synthesis of the sialyloligosaccharide disulfide ligand 4.7. 




column to allow faster elution; it is thought that the Celite
®
 did not interact significantly 
with the eluted species.   
 
Incubation of the SGP 4.1 with pronase (from Streptomyces griseus) in Tris-HCl buffer 
(pH 7.5) at 37 
o
C then afforded the asparagine-linked complex bi-antennary N-glycan 
4.2.
42
 The term pronase actually refers to a group of proteolytic enzymes that are 
generated in the culture supernatant of Streptomyces griseus (a species of bacteria in the 
genus Streptomyces generally found in soil).
43
 Pronase contains at least ten proteolytic 
components, and thus has a very broad specificity and is used when extensive 
degradation of proteins is required.
43
 Reaction of thioglycolic acid 4.3 with acetyl 
chloride and triethylamine in 1,4-dioxane afforded S-acetylmercaptoacetic acid 4.4.
44
 
Reaction of 4.4 with N-hydroxysuccinimide and dicyclohexylcarbodiimide (DCC) in 
THF gave the activated ester 4.5,
45
 which was then reacted with the Asn-linked glycan  
4.2 in sodium phosphate buffer (pH 7.4) containing 20% acetonitrile to give the 
thioacetate 4.6. Deacetylation of 4.6 by treatment with hydroxylamine hydrochloride, 
followed by air oxidation afforded the disulfide 4.7. The procedure followed here meant 
that the disulfide 4.7 could typically be made on a multi-hundred milligram scale. 
 
4.3.2. Synthesis and characterization of SG-gAuNPs 
The 12 nm sized SG-gAuNPs were synthesised using a ligand exchange reaction on Cit-
AuNPs (12 nm) with the disulfide 4.7 (Scheme 4.6). Reaction of trisodium citrate with 
HAuCl4 in water under reflux afforded 12 nm sized Cit-AuNPs. Reaction of disulfide 4.7 
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with Cit-AuNPs in water for 48 h yielded SG-gAuNPs.  Excess unbound disulfide 4.7 
and other impurities were removed by centrifugal filtration with water as the solvent. 
Membrane filters with a molecular weight cut off  of 10 kDa was used for the centrifugal 
filtration as the SG-gAuNPs has an average molecular weight of more than 10 kDa and 
all the impurities from the exchange reaction has a molecular weight of less than 10 kDa. 
The FT-IR spectrum of the sialylglycan-capped SG-gAuNPs was similar to that of the 
free disulfide 4.7 (Figure 4.3), indicating both the removal of citrate and the successful 
incorporation of sialylglycans on the surface of the NPs.
46
 
Scheme 4.6. Synthesis of 12 nm sized SG-gAuNPs by ligand exchange method. 
 
ESI-MS results also confirmed that the sialylglycan had been successfully incorporated 
into the SG-gAuNPs. The particle sizes and size distributions (as demonstrated by TEM) 
and the UV-Vis absorption spectra (Figure 4.4) of the AuNPs were essentially the same 









Figure 4.3. FT-IR spectra of SG-gAuNPs. 
 
 
Figure 4.4. UV-Vis absorption spectra of AuNPs before and after SG ligand exchange. 
 
Analysis of the TEM images (Figure 4.5a) of the SG-gAuNPs (at least 200 particles were 
measured using ImageJ software), revealed the particle sizes to be 12.1 ± 1.6 nm (Figure 
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4.6). The average molecular formula of the SG-gAuNPs was determined by TGA (Figure 
4.7) to be Au54464(C90H14N8O65S)12404, which was confirmed by elemental analysis.
47-48
 
The average molecular formula calculations were carried out in the similar manner as 
described in Chapter 3, Section 3.2.2. Interestingly, this is the first report of the synthesis 




Figure 4.5. Representative TEM images of the SG-gAuNPs: a) before and b) after the 
addition of HA. 
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Figure 4.7. TGA plot of SG-gAuNPs 
 
4.3.3. Colorimetric detection of influenza HA using SG-gAuNPs 
In order to perform the colorimetric detection of influenza HA, a solution of SG-gAuNPs 
(3 nM) in phosphate buffer saline (PBS) of pH 7.4 was prepared.  The NP concentration 
(3 nM) in the solution was confirmed by atomic absorption spectroscopy (AAS). A 
solution of HA (0.25 mg/mL) in PBS (pH 7.4) was prepared. Then, aliquots of the HA 
solution of various sizes (5, 10, 20, 30 and 40 µl) were added (with mixing) to an aliquot 
of the SG-gAuNP solution (200 µl), and in each case solution was made up to a total 
volume of 300 µl by adding PBS. The progress of the reaction in each case was 
monitored by UV-Vis spectroscopy at different time intervals. 
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When HA was added to the SG-gAuNPs (3 nM) to give a final HA concentration of 71 
nM, the SPR band peak maximum of SG-gAuNPs centred at 523 nm did not undergo any 
significant shift, either immediately or upon standing (Figure A4.1 in the Appendix). 
However, when the final concentration of HA was increased to 141 nM, the SPR peak 
began to shift gradually in a time dependent fashion, indicating that aggregation of the 
SG-gAuNPs was occurring (Figure 4.8a). After 60 minutes no further change in the 
absorbance spectrum was observed, and the SPR peak maximum had shifted to 531 nm.  
 
 
Figure 4.8. UV-Vis absorption spectra SG-gAuNP with a) 141, b) 283, c) 424, and d) 
564 nM of HA. 
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When the HA concentration was further increased to 283, 424, and 564 nM, the SPR 
peak maximum underwent even more pronounced shifts to 534, 539, and 544 nm 
respectively over the same time period (60 minutes), indicating the formation of 
progressively larger SG-gAuNP aggregates as the HA concentration was increased 
(Figure 4.8b-d). TEM analysis also clearly showed that, following the addition of HA, the 
SG-gAuNPs were no longer present as individual well-separated particles (Figure 4.5a), 
but had assembled into networks of aggregated NPs (Figure 4.5b). HA detection was also 
possible with the naked eye, as the colour of the colloidal solution changed from red to 
purple upon SG-gAuNP aggregation (Figure 4.9). 
 
 
Figure 4.9. SG-gAuNP solutions: a) before and b) after the addition of HA. 
 
A further demonstration of the effect of the HA concentration on the SPR band of the 
SG-gAuNPs is shown in Figure 4.10, which is a plot of the ratio of the absorbance 




]650) against the HA 
concentration between 71 and 564 nM. These data show a linear relationship between the 
concentration of HA added and the degree of SG-gAuNP aggregation. This change in 
absorbance can therefore be used to estimate the concentration of HA in an unknown 
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sample. Wei et al. reported
38
 that at HA concentrations higher than 4.2 µg/mL 
(equivalent to 71 nM) AuNPs stabilized with synthetic mimics of sialylglycans were red-
shifted. Figure 4.10 demonstrates that the SG-gAuNPs reported here are similar in terms 
of detection efficiency, and that the sensitivity is comparable to the results obtained from 
traditional methods such as ELISAs and glycan microarrays.
49-51
 However considering 
the logistically demanding and time  
 
 
Figure 4.10. Plot of the ratio of absorbance intensity at 650 nm both with and without 
HA vs HA concentration for Sg-gAuNP. Each point is the average of three measurements 
with error bars representing the standard error. 
 
consuming chemo-enzymatic synthetic procedure required to make the sialylglycan 
mimics in the report of Wei et al.,
38
 the use of naturally occurring full length N-glycans 
that we have developed offers a simpler and more attractive method for the development 
of an AuNP-based sensor for HA detection. 
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4.3.4. Colorimetric detection of the influenza virus 
It is known that in general avian-adapted influenza A viruses prefer sialylglycans with 
α(2→3) linkages that are present in the intestinal epithelial cells of birds, whilst human-
adapted influenza A viruses prefer α(2→6) linkages which are commonly expressed in 
the upper respiratory tract of humans.
16
 In order to investigate any selectivity of the SG-
gAuNPs produced here UV-Vis studies were performed with two influenza virus strains,  
A/Puerto Rico/8/34 (H1N1) and A/New Caledonia/20/1999 (H1N1). This part of the 
work was done in collaboration with Dr. Matloob Husain`s virology group in Otago 
University.
52
 The A/Puerto Rico/8/34 strain (hereafter referred as the Puerto Rico strain) 
specifically binds α(2→3)-linked sialylglycans,
53
 whilst the influenza A/New 





The New Caledonia (6 x 10
5 
PFU/mL) and Puerto Rico strains (2 x 10
7
 PFU/mL) were 
prepared in PBS (pH 7.4). In virology, PFU or Plaque Forming Unit is a measure of the 
viral particles capable of forming plaques (a plaque is a visible structure formed within a 
cell culture and counting the number of plaques is used as a method of virus 
quantification) per unit volume. PFU is a functional measurement and not a measurement 
of the exact number of viral particles. For example, viral particles that fail to infect the 
target cell will not generate a plaque and therefore they will not be counted.  
 
In order to perform the colorimetric detection of influenza virus particles, aliquots of the 
New Caledonia solution (1.6, 8, 16.7, 33.4, and 50.1 µl) were added (with mixing) to an 
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aliquot of the SG-gAuNP solution (30 µl of 20 nM solution) and formalin (15 µL of 10% 
stock solution). Formalin was used to inactivate the live virus. In each case solution was 
made up to a total volume of 300 µl by adding PBS. The progress of the reaction was 
monitored by UV-Vis spectroscopy at different time intervals. In the case of the A/Puerto 
Rico/8/34 (H1N1) virus 1.5 µl of the stock solution was added to the SG-gAuNP 
solution.  
 
Upon the addition of 10,000 PFU of the New Caledonia strain to the SG-gAuNPs (3 nM), 
there was a significant increase in the absorbance intensity at 650 nm (Figure 4.11). 
However the addition of the same number of PFU of the Puerto Rico strain (and 
additionally with 30,000 PFU, data not shown) did not cause any increase in the 
absorbance intensity at 650 nm, confirming that the SG-gAuNPs selectively detected 
viral particles which have an α(2→6) specificity (Figure 4.11). 
 
 




Figure 4.11. Plot of the absorbance intensity at 650 nm vs time for SG-gAuNPs with two 
different influenza viral strains, and a negative control. 
 
A further demonstration of the effect of the influenza virus concentration on the SPR 
peak of the SG-gAuNPs, is shown in Figure 4.12, which plots the ratio of the absorbance 





]650) against the New Caledonia strain concentration between 1,000 and 30,000 
PFU. These data show a linear relationship between the concentration of virus added and 
the degree of SG-gAuNP aggregation, which is similar to the case of HA shown in Figure 
4.10. Additionally, the binding of the SG-gAuNPs to the virus was found to be faster than 
to HA. The virus-SG-gAuNP interaction was complete within 30 minutes, in line with the 
report of Wei et al.
38
 It is clear from Figure 4.12 that the SG-gAuNPs used here can 
readily detect the New Caledonia strain in amounts as low as 10,000 PFU. 
 




Figure 4.12. Plot of the ratio of the absorbance intensity at 650 nm with and without the 
New Caledonia strain vs the New Caledonia viral concentration. Each point is the average 
of three measurements with error bars representing the standard error. 
 
4.3.5. SG-gAuNP aggregation in the presence of HA  
A pictorial representation of the HA-induced aggregation of SG-gAuNPs, based on 
previous reports on similar analyte-induced aggregation-effected sensors, is depicted in 
Figure 4.13.
38, 55
 The performance of an AuNP-based colorimetric sensing system 
depends on how effectively the AuNP dispersion is converted to AuNP aggregates by the 
analyte of interest. Typically, gAuNPs are stabilized against attractive van der Waals 
forces by the steric effects of the surface capping ligands; in this study the sialic acid 
terminated complex bi-antennary N-glycans.
56 
Aggregation of gAuNPs can be achieved 
in two ways - either via interparticle crosslinking or via non-crosslinking.
56 
Interparticle 
crosslinking aggregation is presumed to be the basis of the sensing response reported 
here; controlled aggregation of the SG-gAuNPs occurs because of binding of the multiple 
sialic acid binding sites of HA to the sialic acid-  
 




Figure 4.13. Schematic representation of the mechanism of aggregation of SG-gAuNPs 
in the presence of HA. 
 
terminated ligands present on the SG-gAuNPs.
16 
A detailed discussion of the theory of 
aggregation of gAuNPs is provided in Chapter 3, Section 3.2.4. Indeed it was found that 
the addition of excess sialic acid (10 mM) to a solution of SG-gAuNP aggregates formed 
in the presence of HA (564 nM) resulted in aggregate re-dispersion, as demonstrated by a 
colour change (from blue to red) and by a blue-shift in the SPR peak maximum to 523 
nm. The dissociation of these aggregates to individual particles in the presence of sialic 
acid showed that binding of the SG-gAuNPs to HA was reversible, and also provides 
strong supporting evidence for the mechanism of aggregation depicted in Figure 4.13. 
 
4.3.6. Dynamic light scattering detection of HA using SG-gAuNPs 
The aggregation of SG-gAuNPs by the addition of varying concentrations of viral HA 
was also investigated using Dynamic Light Scattering (DLS), a technique which can 
provide a quantitative estimate of the average diameter of the AuNP aggregates 
produced.
57
 As the ability of AuNPs to scatter light is significantly higher than that of 
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biomolecules, DLS is selective for the AuNPs present in these solutions.
58
 In the DLS 
assays carried out here, the HA-induced SG-gAuNP aggregates were not physically 
separated from any remaining non-aggregated NPs that may have been present. However, 
the inherent bias of DLS towards larger particles/aggregates means that estimated 




In order to perform the DLS assay of influenza HA, a solution of the SG-gAuNPs (3 nM) 
was prepared in phosphate buffer saline (PBS) of pH 7.4. A solution of HA (0.25 mg/mL) 
was also prepared in PBS (pH 7.4). Then, aliquots of the HA solution (5, 10, 20, 30 and 
40 µl) were added (with mixing) to an aliquot of the SG-gAuNP solution (200 µl), and in 
each case solution was made up to a total volume of 300 µl by adding PBS. The sample 
was equilibrated at 25 
o
C for 120 seconds before DLS analysis. Each DLS measurement 
consisted of 12 scans, each of 30 seconds duration.  
 
DLS results can be reported in terms of intensity, volume, or number-based distributions. 
The fundamental size distribution produced by DLS is intensity-based distribution and 
therefore this measurement is less prone to error. Intensity distribution can be converted 
to a volume distribution using Mie theory. The volume-based distribution can further be 
transformed to a number-based distribution. Since the volume and number-based 
distributions are derived using various equations using several assumptions the 
probability of obtaining biased results in these measurements are large.  
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Number-based distribution is preferred for studying particles with smaller sizes as this 
generally reports the smallest size measured. However, for noisy data the number-based 
size distribution could be misleading; for example, when transforming from intensity to 
number, small noise in the intensity distribution could be over-amplified and lead to 
wrong conclusions. The best choice to detect and report even small amounts of 
aggregation of particles is the intensity-based size distribution as aggregated particles will 
be highlighted and the smaller individual particles will be suppressed in this 
measurement. Thus, in this study we have used intensity-based size distribution data to 
analyse the aggregation of SG-gAuNPs in the presence of HA. 
 
From the DLS measurements the size of the “as made” SG-gAuNPs was found to be 21 ± 
1 nm (Figure 4.14a). The diameter of the AuNPs in solution measured by DLS is always 
larger than the AuNP core diameters as measured by TEM
60
 because organic ligands on 
the Au surface are transparent to electrons and so do not contribute to the size of the 
AuNPs when measured by TEM,
61
  whereas DLS measures the hydrodynamic radius of 









Figure 4.14. DLS measurements of the average diameters of a) SG-gAuNP and b) SG-
gAuNP in the presence of 71 nM of HA 
 
When HA was added to SG-gAuNPs (3 nM) to obtain a final HA concentration of 71 
nM,  DLS assay gave a particle size of 21 ± 1 nm, indicating that no aggregation had 
occurred at that HA concentration (Figure 4.14b). All DLS measurements were carried 
out 60 minutes after the addition of HA to the SG-gAuNP solution, as after that point the 
SPR band of the solutions remained constant. When the final HA concentration was 
increased to 141 nM, DLS indicated that the mean diameter of the SG-gAuNPs had 
increased to 97 ± 4 nm, clearly indicating aggregate formation in the presence of the HA 
at this concentration (Figure 4.15a). When the final HA concentration was further 
increased to 283, 424, and 564 nM, the mean diameter of the SG-gAuNP aggregates 
formed correspondingly increased to 183 ± 5, 389 ± 11, and 596 ± 21 nm respectively 
(Figure 4.15b-d). The larger standard deviation observed for the larger aggregates 
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indicates that that the polydispersity of the aggregates also increased as the concentration 
of HA increased.  
 
 
Figure 4.15. DLS measurements of the average diameters of the SG-gAuNP aggregates 
formed in the presence of a) 141, b) 283, c) 424, and d) 564 nM HA. 
 
A plot of the size of SG-gAuNP aggregates measured by DLS vs the HA concentration 
(Figure 4.16) was found to be linear, with an R
2
 value of 0.9748. This linear relationship 
can therefore be used to estimate an unknown concentration of HA, in a similar fashion to 
the change in absorbance intensity at 650 nm using UV-Vis spectroscopy (as shown in 
Figure 4.10). The proportionality constants of the two corresponding linear equations, 
0.007 and 1.143 for the colorimetric and DLS assays respectively, indicate that the DLS 









Figure 4.16. A plot of the SG-gAuNP aggregate size vs concentration of the HA added. 
Each point is the average of three measurements with error bars representing the standard 
error. 
 
4.3.7. Selectivity of the SG-gAuNPs for HA 
In order to demonstrate the selectivity of HA/influenza virus detection by the SG-
gAuNPs aliquots of a SG-gAuNP solution were mixed with BSA, and the lectins Con A 
and LTB (each at 600 nM). It was found that none of these species had any effect on 
either the UV-Vis absorption band or the DLS measurements, confirming that the SG-
gAuNPs did not undergo non-specific aggregation and that amongst the species 
investigated detection was selective for HA and virus.  
 
4.4. Conclusions 
This chapter has described the use of AuNPs capped with naturally occurring sialic acid 
terminated complex bi-antennary N-glycans for the simple and highly selective detection 
of viral HA and the influenza virus, by the use of both DLS and UV-Vis spectroscopy. A 
homogeneous SGP, isolated from egg yolks by a simple procedure, was converted to a 
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thiol and then used in a ligand exchange reaction with Cit-AuNPs to obtain SG-gAuNPs. 
The presence of sialic acid binding sites on viral HA, and their specific and multivalent 
binding to sialic acid residues at the termini of the ligands on the SG-gAuNPs, caused 
AuNP aggregation as the basis for HA/virus detection. Both UV-Vis and DLS 
measurements revealed a linear relationship between SG-gAuNP aggregation and the 
concentration of HA that was added. Additionally the SG-gAuNPs selectively detected 
viral particles which had binding specificity for α(2→6)-linked sialylglycans. The SG-
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Chapter 5: An attempt towards the development of a one-pot 
synthesis of glycogold nanoparticles by use of Click Chemistry. 
 
5.1. Objective 
The aim of this chapter was to develop a facile one-pot synthesis of gAuNPs decorated 
with unprotected sugars using the Cu(I)-catalysed azide-alkyne Huisgen cycloaddition 
(CuAAC). The scarcity of reports on the use of the CuAAC reaction for gAuNP 
synthesis, and the discovery of a facile protecting-group free one-pot synthesis of 
glycoconjugates using CuAAC
1
 in our group motivated us to investigate the use of Click 
Chemistry to synthesize gAuNPs. From the work detailed in the preceding chapters it is 
evident that the development of a facile one-pot synthesis of glycogold nanoparticles 
would enable us to synthesize a wide variety of sugar-decorated gold nanoparticle-based 
sensors by following one simple synthetic procedure. 
 
5.2. Introduction  
The three most common methods used to synthesize gAuNPs stabilized with thiolated-
sugar derivatives are: (1) direct reduction of HAuCl4 in the presence of carbohydrate 
derivatives with linkers bearing a thiol end-group, (2) ligand exchange on previously 
synthesized AuNPs with carbohydrate derivatives attached to linkers bearing a thiol end 
group, and (3) modification of functional groups present on the surface of AuNPs with 
suitably functionalized carbohydrates.
2
 A detailed discussion of these three methods is 
provided in Chapter 1, Section 1.4.5. One of the potential approaches that can be used to 
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modify the ligands on the surface of AuNPs with sugars to produce gAuNPs is by using 
Click chemistry, which is the focus of this Chapter.  
 
5.2.1. 1,3-Dipolar cycloaddition 
The 1,3-dipolar cycloaddition is a chemical reaction between a 1,3-dipole and a 
dipolarophile to give a five-membered ring product.
3
 A 1,3-dipole is a molecule 
containing four electrons in three parallel atomic p-orbitals, in which the centre atom has 
a formal positive charge that compensates the negative charge spread over the two 
terminal atoms.
4
 The most widely used dipolarophiles are alkynes and alkenes. The first 
reports on 1,3-dipolar cycloaddition reactions appeared in the literature during the late 
19
th
 century, after the discovery of 1,3-dipoles.
4
 At present, the 1,3-dipolar cycloaddition 
reaction is widely used to perform the regio- and stereoselective synthesis of five-
membered heterocycles.
5
   
 
The generally accepted mechanism of 1,3-dipolar cycloaddition, as proposed by Rolf 
Huisgen, consists a concerted pericyclic cycloaddition as shown in Scheme 5.1.
3
 A 1,3-
dipole reacts with a dipolarophile in a concerted and symmetry-allowed [4πs + 2πs] 
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Scheme 5.1. Mechanism of 1,3-dipolar cycloaddition. 
 
5.2.2. The Cu-catalysed Azide-alkyne Huisgen Cycloaddition (CuAAC) 
The azide-alkyne Huisgen cycloaddition (AAC) is a 1,3-dipolar cycloaddition between an  
organic azide and an alkyne to give triazole ring products, as shown in Scheme 5.2 (a 
mixture of the 1,4-triazole and the 1,5-triazole is typically formed).
7
 In the 1960s, Rolf 
Huisgen established the mechanism and explored the synthetic application of this 
reaction. The AAC reaction has been referred to as "the cream of the crop"
8
 of click 




Scheme 5.2. AAC reaction between an organic azide (1,3-dipole) and an alkyne   
(dipolarophile) resulting in the formation of triazole products. 
 
In 2001, Barry Sharpless defined click chemistry to be a group of reactions that “…must 
be modular, wide in scope, give very high yields, generate only inoffensive by-products 
that can be removed by non-chromatographic methods, and be stereospecific (but not 
necessarily enantioselective). The required process characteristics include simpler 
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reaction conditions (ideally, the process should be insensitive to oxygen and water), 
readily available starting materials and reagents, the use of no solvent or a solvent that is 
benign (such as water) or easily removed, and simple product isolation. Purification, if 
required, must be by non-chromatographic methods, such as crystallization or distillation, 
and the product must be stable under physiological conditions.”
8 
 
The AAC has gained significant interest over the past decade, especially since the 
introduction of Cu(I) catalysis, which led to major improvements in both the 
regioselectivity and rates of the reaction.
10-12
 Without the Cu(I) catalyst, the Huisgen 
cycloaddition is very slow and gives a mixture of 1,4- and 1,5-traizoles.
7
  The versatility 
of the Cu(I)-catalysed azide-alkyne Huisgen cycloaddition (CuAAC) has been 
demonstrated by its robustness, insensitivity to water and oxygen, and capability to use a 
wide range of substrates, and has been exemplified with several applications in the 
biological and chemical sciences.
13
 CuAAC works under water- and oxygen-tolerant 
conditions, and gives products in good yields with minimal side product formation. 
Indeed, triazole chemistry has been effectively used to enhance antibacterial, antitumor, 
antiviral, and antifungal properties of various compounds.
14-16
 Thus, a number of catalytic 
conversions of azides and acetylenes in a wide range of syntheses has been performed in 
the last decade.
17-20
 Also, CuAAC has been used in the synthesis of peptidomimetics and 
in bioconjugations
21-23




The triazole ring moiety has been shown to be chemically inert under a wide range of 
reaction conditions, such as hydrolysis, oxidation, and reduction. Moreover, its synthesis 
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can be carried out either in aqueous or in organic media.
23, 25
 The CuAAC mechanism has 
been extensively studied and debated.
26-27
 The major difference between the CuAAC and 
its non-catalysed counterpart (AAC) is the alteration in the activation energy barrier. 
Quantum mechanical calculations have shown that the transition state of the non-
catalysed reaction is largely non-polarized.
28
 Some 18.1 of the total 29.9 kcal/mol ΔG
‡  
required is associated with the energy needed for the distortion of the azide prior to the 
reaction with acetylene. A stepwise catalytic process decreases the transition state energy 
by 11 kcal/mol and thus achieves significant rate enhancement.
29
 In the CuAAC reaction, 
first, the Cu(I) coordinates with the π-electrons of acetylene lowering the pKa of the 
acetylenic proton by up to 9.8 pKa units, allowing de-protonation to occur in an aqueous 
solvent without the addition of any base (Scheme 5.3). This coordination step is then 
followed by an exothermic formation of a Cu(I)-acetylide complex 5.2. The complex 5.2 
then coordinates to the azide 5.3, which rearranges into a metallocycle 5.4, and then 
further into the Cu-metallated triazole 5.5. The Cu-triazole complex then releases the free 
triazole 5.6 and 2Cu(I)L. 




Scheme 5.3. Proposed catalytic cycle for the CuAAC reaction. 
 
Although there have been some minor revisions to this mechanism,
26-27
 the contribution 
of the Cu(I) catalyst in the reduction of the transition state energy remains unchallenged. 
The CuAAC reaction can be performed with almost any source of solvated Cu(I).
26
 
However, the Cu(I) can be easily oxidized to Cu(II), resulting in the inactivation of the 
catalyst. There are a number of methods used to produce the active catalyst for this 
reaction. One of the most common methods is to reduce Cu(II) salts, such as 
CuSO4·5H2O, in situ to form Cu(I) salts. Sodium ascorbate is typically used as the 
reducing agent,
26





 have also been used successfully. 
 Chapter 5                                                                                                                                                                          
168 
 
Alternatively, it is possible to directly add Cu(I) salts, such as CuBr, CuI, 
[Cu(NCCH3)4][PF6], or CuOTf·C6H6,.
32
 These Cu(I) sources do not need a reducing 
agent, but the reaction has to be performed in a deoxygenated environment and in an 
organic (or mixed) solvent system meaning that protecting groups may be required. 
Another disadvantage with these methods is that they also tend to lead to side products.
32-
33
 Thus, it can be concluded that the usage of Cu(I) salts is not as reliable as the in situ 
reduction of Cu(II) salts.  
 
5.2.3. Biological Applications of 1,2,3-triazoles  
Cu(I)-catalysed triazole formation has been widely used for the modification of 
pharmaceuticals and natural products. CuAAC allows the attachment of various chemical 
entities to a drug in order to enhance important properties, such as solubility and/or 
bioavailability.
34-35
 A number of reviews are available which describe the benefits of 
using click chemistry for pharmaceutical applications.
36
 The biological interest in 
triazoles arises from the fact that they are easy to make and are very stable under 
biological conditions.
9, 37
 The ability of triazoles to tolerate oxygen, water, biological 
molecules, a wide range of solvents, and the in vivo conditions of living systems 
(hydrolysis, reductive environment etc.) makes them suitable candidates as isosteres of 




The CuAAC reaction has also been used to click carbohydrates to a wide variety of 
entities. In fact, a prominent method for attaching saccharides to other organic molecules 
has been to introduce an azide in the 1-, 2-, or 6-positions of the saccharide and then to 
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react it with a variety of organic alkynes using CuAAC.
1, 38-40
 The CuAAC reaction has 





5.2.4. AuNP surface modification using AAC  
In 2006, Fleming et al. used the AAC reaction to attach a series of different molecules to 
AuNPs.
43
 For the AAC reaction, small AuNPs (1.8 nm) were used because of their easy 
synthesis, high solubility, and good ligand exchange properties. A two-phase Brust-
Schiffrin method (BSM) was firstly used to synthesize decanethiol-stabilized AuNPs. 
These particles were then reacted with BrC11H22SH to replace some of the decanethiol 
ligands with Br-terminated undecanethiol ligands (Scheme 5.4). Nucleophilic substitution 
of the Br termini with NaN3 then resulted in AuNPs decorated with azide functionalities 
on their outermost periphery (Scheme 5.4). Alkyne derivatives of nitrobenzene (NB), 
ferrocene (Fc), anthracene (An), pyrene (Pyr), aniline (Ani), and poly(ethylene glycol) 
(PEG) were synthesized for the click reaction with the AuNP surface (Figure 5.1). All 
these compounds contained a carbonyl group next to the terminal alkyne to provide a 
more electron withdrawing environment that would increase the rate of the AAC 
reaction. It was observed that a small amount of AuNPs underwent irreversible 
aggregation during the reaction. However, a majority of the AuNPs (> 90%) remained 
soluble and could be separated from the aggregates after the reaction. Although Fleming 
et al. successfully performed the AAC reaction on AuNPs, the yields (i.e. the extent of 
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Scheme 5.4. The functionalization and the AAC reaction on AuNP surface. Reagents and 
conditions: (i) Br(CH2)11SH in DCM, 60 h, rt; (ii) NaN3 in DCM/DMSO solution, 48 h; 
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Following the work of Fleming et al. various groups have used different conditions to try 
and increase the efficiency of the AAC reaction on AuNP surfaces. Limapichat et al. used 
electron deficient alkyne derivatives to perform the AAC reaction and observed that 75% 
of the azide on AuNP surface underwent cycloaddition in 16 h (Scheme 5.5).
45
  Ismaili et 
al. carried out the AAC reaction with a number of terminal-acyl alkynes under hyperbaric 





Scheme 5.5. Azide functionalization and AAC reaction on AuNP surface using electron 












Scheme 5.6. AAC reaction performed under hyperbaric conditions. Reagents and 
conditions: (i) Br(CH2)11SH in C6H6, 48 h, rt; (ii) NaN3 in C6H6/DMSO solution, 48 h; 






In 2014, Gobbo et al. used interfacial strain promoted azide-alkyne cycloaddition (I-
SPAAC) to modify AuNP surfaces.
47
  2.8 nm Sized AuNPs functionalized with strained 
dibenzocyclooctyne derivative (DBCO-AuNP) were synthesized as shown in Scheme 
5.7. These AuNPs were treated with azide-decorated polymersomes (a class of artificial 
vesicles) which were successfully functionalized with AuNPs in 1 h (Scheme 5.8). 
 




Scheme 5.7. Synthetic scheme of AuNPs functionalized with strained alkyne derivatives. 
HBTU = O-Benzotriazole, N,N,N',N'-tetramethyl-uroniumhexafluoro-phosphate 










Scheme 5.8. A schematic representation of the I-SPAAC reaction between azide-
functionalized polymersomes and strained alkyne functionalized AuNPs (DBCO-AuNPs) 
in water. Image reproduced from Ref. 47 with permission from the Royal Society of 
Chemistry.   
  
5.2.5. AuNP surface modification by CuAAC  
In 2006, Brennan et al. demonstrated that enzyme-AuNP conjugates could be synthesized 
by click chemistry.
48
 Azide-functionalized AuNPs were synthesized by treating standard 
Cit-AuNPs (14 nm size) with an aqueous solution of thiolated azide ligand, as shown in 
Scheme 5.9. An acetylene-functionalized Thermomyces lanuginosus lipase was attached 
to these azide-functionalized water-soluble AuNPs by CuAAC (Scheme 5.9). The 
enzymes retained their activity after the click reaction. However, the excess of Cu 
(million-fold excess in comparison to the azide) and lipase used, the long reaction 
duration (3 days), the extensive purification procedure required, and the poor conversion 
of azide to triazole (less than 1%) limited further use of this procedure. 
 




Scheme 5.9. Functionalization of AuNPs with thiolated-azide ligand, and attaching of 
lipase to these AuNPs using Click Chemistry. Reagents and conditions: (I) H2O, rt, 18 h; 
(II) H2O, CuSO4, ascorbic acid, rt, 3 d. Reprinted with permission from Ref. 48. 
Copyright (2016) American Chemical Society.  
 
Later, in 2007, Sommer et al. developed a simpler method to perform CuAAC on AuNP 
surface.
49
 Microwave-assisted CuAAC was used to attach a variety of alkyne derivatives 
to azide functionalized AuNPs (Scheme 5.10). The use of the microwave heating for the 
CuAAC reaction reduced the reaction time to 5-10 min and also gave nearly quantitative 
conversion of the azides to triazoles. However, significant particle decomposition or 
aggregation was observed when AuNPs were treated for more than 15 min in the 
microwave reactor.  
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Scheme 5.10. The CuAAC reactions performed under microwave heating. Reagents and 
conditions: (I) HS(CH2)11N3, C6H6, rt, 7 h; (II) dioxane/
t
BuOH/H2O or THF, CuSO4, 
sodium ascorbate, microwave heating (1000 W), 5-10 min.
49
   
 
Boisselier et al. reported several modifications to try and overcome the common 
problems faced in the CuAAC reaction of the AuNPs.
50
 They reasoned that one important 
constraint that needed to be addressed to perform an efficient click reaction was the 
solubility of the reagents; alkanethiol-functionalized AuNPs are soluble in organic 
solvents, whereas water is required to dissolve the catalyst CuSO4. In order to circumvent 
the solubility problem, a homogenous water-THF solvent system was used where AuNPs 
in THF were added to either an aqueous solution containing water-soluble alkyne 
derivatives or a THF-water solution of organic soluble alkyne derivatives. The amount of 
ascorbic acid and Cu(I) catalyst was also increased to stoichiometric amounts with 
respect to alkyne and azide. Also, the click reaction was performed under an inert 
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atmosphere. It was observed that if any of the above mentioned conditions were not met, 
the reaction gave a very poor yield, but when all the conditions were fulfilled, the azide to 
triazole conversion was virtually quantitative at rt. The reaction was performed with a 
variety of alkynes and good results were obtained despite the different sizes of the 
alkynes and their hydrophilicity. The overall reaction scheme is shown in Scheme 5.11 
and the variety of alkynes used is shown in Figure 5.2.  
 
 
Scheme 5.11. The overall synthetic scheme of AuNP functionalization and the click 
reaction by Boisselier et al.
50
 Reagents and conditions: (I) HS(CH2)11Br, DCM, rt, 5 d; 
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Following these reports, several other groups have used the CuAAC reaction on AuNPs 




 and protein quantification (for 
proteins capable of reducing Cu (II) to Cu (I)).
55
 In general, two systems of AuNP, one 
functionalized with azide ligands and other with alkyne ligands, were synthesized and the 
CuAAC reactions were performed. The aggregation of AuNPs due to the click reaction 
was considered as the basis for the detection of various analytes.  
 
Although, several groups have used the CuAAC reaction to attach thiolated ligands to 
various sugars and then subsequently attach these thiolated-sugar derivatives to 
AuNPs,
56-58
 there has only been one study that has reported the use of the CuAAC 
reaction to click sugars directly onto the AuNP surface . In 2008, Chikae et al. first 




Then azide-terminated sialic acid derivatives were attached to the AuNPs by the CuAAC 
as shown in Scheme 5.12.  
 









However, in contrast to these reports of the successful use of CuAAC for the 
modification of AuNPs, at least three groups have reported that attempts to modify azide-
functionalized AuNPs with alkyne derivatives by CuAAC either resulted in the reversible 
aggregation of the particles, or in negligible conversions.
43, 45, 47
 Fleming et al. attempted 
to increase the yield of the AAC reaction using several catalyst systems.
43
 As the 
particles (AuNPs functionalized with a mixture of decanethiol, Br-terminated 
undecanethiol, and azide-terminated undecanethiol) were insoluble in aqueous solutions, 
the most frequently used CuSO4-ascorbic acid system could not be used. Thus, catalysts 
soluble in organic solvents such as CuI, CuBr/2,6-lutidine, and 
bromotris(triphenylphosphinato) copper (I) were used, and, in all cases rapid and 
extensive particle aggregation or decomposition was observed. Limapichat et al. also 
reported similar results when Cu catalysts were used to try and enhance the cycloaddition 
reaction.
45
 Gobbo et al. reacted water soluble AuNPs (particles functionalized with a 
mixture of Me-EG3-SH and N3-EG4-SH) with 2-propyn-1-amine hydrochloride or 1-
ethynylpyrene, in the presence of CuSO4 and sodium ascorbate, and faced the same 
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problem of irreversible particle aggregation.
47
 It was suggested that the particles 
underwent aggregation/decomposition during the CuAAC reaction due to the reaction of 




The remaining sections of this chapter will detail the synthesis of a thiolated ligand which 
possesses a terminal alkyne group, the attachment of these ligands to AuNPs, and 
attempts to perform the one-pot synthesis of gAuNPs from these alkyne functionalized 
AuNPs using the CuAAC reaction.  
 
5.3. Results and Discussion 
5.3.1. Synthesis of alkyne-terminated thiol ligand (ATT). 
Reaction of triethylene glycol 5.7 (1 equivalent) by stirring with NaH (0.65 equivalent) in 
THF followed by the addition of propargyl bromide (0.5 equivalent) gave a mixture of 
the alkyne 5.8 (major product, Scheme 5.13) and a triethylene glycol derivative with 
propargyl group at both ends (minor product). Compound 5.8 was then reacted with 
mesylchloride (MsCl) and triethylamine in DCM, to form an intermediate mesylate, 
which was then reacted with potassium thioacetate in DMF at 65 
o
C to afford the 
thioacetate 5.9. Deacetylation of 5.9 with sodium methoxide in methanol, followed by 
neutralization with 1 M aqueous HCl, afforded a mixture of the disulfide 5.10 and the 
thiol 5.11. Initial attempts to reduce disulfide 5.10 to thiol 5.11 using Zn powder as the 
reducing agent and CH3COOH as an H
+
 donor in DCM gave a mixture of 5.11 and a 
compound bearing an alkene unit instead of the desired alkyne. Grimmer et al. have 
reported that alkynes can be reduced to alkenes by Zn/CH3COOH.
60
 An alternative 
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approach was attempted using NaBH4 as the reducing agent in MeOH, but this did not 
yield the desired thiol 5.11. Oae et al. have reported that although NaBH4 is capable of 
reducing diaryl disulfides to the corresponding thiols, it does not reduce dialkyl 
disulfides.
61
 Finally it was found that the use of dithiothreitol in the presence of N,N-
diisopropylethylamine effected reduction of the disulfide 5.10 to afford the alkyne-
terminated thiol (ATT) 5.11 (Scheme 5.13). 
 
Scheme 5.13. Synthesis of the alkyne-terminated thiol (ATT) ligand. 
 
5.3.2. Synthesis of AuNPs functionalized with alkyne-terminated thiol ligand (ATT-
AuNPs) 
Initially, an attempt was made to synthesize smaller sized (~2 nm) ATT-AuNPs both by a 
two-phase (water-toluene), and one-phase (MeOH) Brust-Schiffrin method (BSM). In 
two-phase BSM, HAuCl4 was transferred from water to toluene using 
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tetraoctylammonium bromide (TOAB) and then ATT 5.11 was added to the toluene 
phase followed by the addition of an aqueous solution of NaBH4. In one-phase BSM, 
ATT 5.11 dissolved in MeOH was added to a solution of HAuCl4 in MeOH followed by 
the addition of an aqueous solution of NaBH4. However, the AuNPs obtained from both 
the one-phase and two-phase BSM were found to be unstable and 
aggregated/decomposed a few hours into the reaction. Hashmi et al. have reported that 





 catalysed addition reactions.
62





  complexes resulting in the efficient activation of the bond for the attack of a 
nucleophile as shown in Scheme 5.14.
63
 For example, Thomas et al. have reported that 
HAuCl4 can be used as a catalyst for the conversion of a terminal alkyne in aqueous 
MeOH to a ketone (major product) by a Markovnikov addition as shown in Scheme 
5.15.
64
 Thus, we assume that a similar catalytic reaction of HAuCl4 with the terminal 
alkyne in ATT interfered with the Brust-Schiffrin reaction and resulted in the formation 
of unstable AuNPs.  
 
 
Scheme 5.14. Activation of a triple bond by Au complex followed by the attack of a 
nucleophile.  
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Scheme 5.15. HAuCl4 catalysed conversion of a terminal alkyne to a ketone. 
 
Next 12 nm sized ATT-AuNPs were synthesized by a ligand exchange reaction of Cit-
AuNPs (12 nm) with ATT 5.11 (Scheme 5.16). Compound 5.11 was dissolved in MeOH, 
and was then added to the Cit-AuNPs in water and stirred. After 24 h, the reaction 
yielded the ATT-AuNPs, which were not soluble in water or polar organic solvents, such 
as MeOH or MeCN, but which were soluble in non-polar organic solvents, such as DCM, 
CHCl3, and THF. The ATT-AuNPs were then purified by washing with water (to remove 
citrate), followed by repeated centrifugation (4 x 6000 rpm) in MeOH until no ATT 
ligands were found in the supernatant by 
1
H NMR analysis. The broad peaks 
corresponding to the ligand ATT protons in the 
1
H NMR spectra (Figure A5.1 in 
Appendix) confirmed the binding of the ATT ligands to the surface of AuNPs. The 
average molecular formula of the SG-gAuNPs was determined by TGA (Figure A5.2 in 
the Appendix) to be Au53568(C9H15O3S)43174. The average molecular formula calculations 
were carried out in the similar manner as described in Chapter 3, Section 3.2.2. The size 
distribution histograms of both the Cit-AuNPs and the ATT-AuNPs are shown in Figure 
A5.3 in Appendix.   
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Scheme 5.16. Synthesis of 12 nm sized ATT-AuNPs by a ligand exchange method. 
 
Previously, when water soluble ligands were used to perform the exchange reactions on 
Cit-AuNPs (Chapter 3 and 4), the wine-red colour of the AuNP solution, the dispersed 
state of the AuNPs (as determined by TEM images), and the SPR peak (obtained in UV-
Vis spectrophotometer measurements) was same both before and after the ligand 
exchange reaction. However, in this case, when this water-insoluble ligand was used, the 
solution turned purple (Figure 5.3), the SPR peak shifted to a higher wavelength (523 nm 
to 541 nm) and became broader (Figure 5.4), and the TEM images revealed partial 
aggregation of the particles (Figure 5.5). Despite the partial aggregation seen in TEM 
images, the ATT-AuNP solution remained stable without any precipitation at least for 
three months at 4 
o
C.       
 
 


































Figure 5.5. Representative TEM images of (a) Cit-AuNPs and (b) AAT-AuNPs 
 
Baranov et al. observed similar results when a ligand exchange reaction was performed 
with 11-azidoundecane-1-thiol on 15 nm sized Cit-AuNPs.
65
 In their work, 11-
azidoundecane-1-thiol dissolved in DMF was added to the Cit-AuNPs in water. The 
AuNP solution turned from red to violet and, occasionally, small dark flakes (aggregated 
thiol-functionalized AuNPs) were observed on top of the solution. The thiol-stabilized 
AuNPs were found to be soluble in all organic solvents. The SPR peak shifted from 518 
to 530 nm after the ligand exchange, and the particles were found to be self-assembled in 
the TEM images. 
 
The problems associated with the phase transfer of AuNPs from water to an organic 
solvent following a ligand exchange process still remain to be solved.
65
 The mode of 
binding of the ligands to the particles is entirely different in the two systems. In Cit-
AuNPs, the electrostatic forces between the negatively charged citrate anions and the 
electron-deficient AuNP surface bind them together, and this interaction is supported by 
water due to its high dielectric constant; whereas in thiolated AuNPs, the covalent 
interaction between the Au atoms on AuNP surface and the sulfur in the thiol ligands is 
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responsible for the binding of the ligands with the particles. Organic solvents have a 
much lower dielectric constant than water. During the transfer of Cit-AuNPs from water 
to an organic solvent, and before they are completely stabilized with organic thiols, the 
citrate ligands dissociate in the organic solvent resulting in the aggregation of the 
particles.
65
 The scattered and ambiguous experimental data present in the literature on the 
phase transfer of AuNPs from water to an organic solvent indicates that more detailed 




5.3.3. Synthesis of glycosyl azides  
The traditional method used to synthesize unprotected glycosyl azides involves at least 
three or four protecting group manipulations to obtain the desired product. A synthetic 
route generally involves converting the desired sugar, for example N-acetyl-D-
glucosamine (GlcNAc), into a protected glycosyl halide 5.13, followed by a nucleophilic 
displacement by azide to give the glycosyl azide 5.14 (Scheme 5.17). Finally, the acetyl 










Scheme 5.17. Synthesis of de-protected glycosyl azides. Conditions: i) AcCl; ii) NaN3, 
sat. aq. NaHCO3, 
t
BuNH4.HSO4, DCM; iii) Na, MeOH. 
 
5.3.4. Synthesis of glycosyl azides using 2-azido-1,3-dimethylimidazolinium 
hexafluorophosphate  
In 2014, the Fairbanks group demonstrated that 2-azido-1,3-dimethylimidazolinium 
hexafluorophosphate (ADMP) could be used to synthesize glycosyl azides efficiently.
1
 
Prior to that, 2-chloro-1,3-dimethylimidazolinium chloride (DMC) has been used as the 
activating agent and NaN3 as the nucleophile source.
68
 The Fairbanks group also showed 
that ADMP was capable of the dual roles of activating the reducing sugars, and providing 
an azide source without the use of sodium azide. ADMP 5.19 has also been used on 
several occasions in the literature as an efficient diazo-transfer reagent.
69-70
 Friction and 
impact sensitivity tests have demonstrated that ADMP is not explosive,
70
 making it in 
fact safer to handle than sodium azide. ADMP was synthesized following the procedure 
reported by Kitamura et al. (Scheme 5.18).
69
 Reaction of 1,3-dimethylimidazolidinone 
5.16 with oxalyl chloride in toluene afforded 2-chloro-1,3-dimethylimidazolinium 
chloride (DMC) 5.17. This was then converted to its hexafluorophosphate salt 5.18 by 
reaction with NaPF6 in MeCN, and then treated with sodium azide in MeCN to afford 
ADMP 5.19. 
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Scheme 5.18. Synthesis of ADMP 5.19. 
 
For the synthesis of the glycosyl azide, GlcNAc 5.12 was reacted with ADMP (3 
equivalents) in the presence of triethylamine (5 equivalents) in a D2O/MeCN mixture 
(Scheme 5.19).
1
  The reaction yielded a mixture of the desired β-azide 5.20 and the 
oxazoline 5.21 (from 
1
H NMR analysis in Figure 5.6). Five equivalents of triethylamine 
were used based on the need to deprotonate the anomeric hydroxyl group as well as 
accounting for any hydrolysis of ADMP. A solvent mixture of D2O/MeCN (4:1) was 
used to improve the solubility of ADMP. The crude reaction mixture (β-azide 5.20 and 
oxazoline 5.21) was then treated dropwise with 1 M aqueous HCl until the solution 
turned acidic, and then immediately neutralized using an aqueous solution of saturated 
NaHCO3. After the acid and base treatment, the anomeric oxazoline proton (5.9 ppm) 
completely disappeared from the 
1
H NMR spectrum, and the desired azide 5.20 was 
obtained as the sole product (Figure 5.6). When D-glucose 5.22 was treated with ADMP 
under the same conditions, the β-D-glucosyl azide 5.23 was obtained without the need for 
the acid and base treatment, along with 20% of 1,6-anhydro-β-D-glucose 5.24 as a side 
product (Scheme 5.20).  
 




Scheme 5.19. Reaction of GlcNAc 5.12 with ADMP 5.19. 
 
 





H NMR spectra of before (bottom) and after (top) acid workup of reaction of 
GlcNAc with ADMP. 
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5.3.5. Synthesis of glycosyl triazoles with alkyne-terminated thioacetate (5.9) in a 
one-pot reaction 
The Fairbanks group have developed a protecting-group-free one-pot synthesis of 
glycoconjugates directly from reducing sugars with the combined use of ADMP and the 
CuAAC reaction.
1
 It was shown that the reaction was entirely stereoselective and could 
be applied to attach a wide variety of alkyne derivatives to reducing sugars, including 
oligosaccharides. The coupling of GlcNAc 5.12 with propargyl alcohol performed by 
Fairbanks‟ group is shown in Scheme 5.21. After the formation of the glycosyl azide (the 
GlcNAc reaction with ADMP as explained in Section 5.2.4) was complete, propargyl 
alcohol, CuSO4∙5H2O, and L-ascorbic acid were added, and the mixture was heated to 50 









In this work, the same procedure was used to develop a one-pot reaction to functionalize 
the AAT-AuNPs with various reducing sugars. In order to establish the conditions, the 
reaction was performed with the alkyne-terminated thioacetate 5.9, before performing the 
reaction with the AAT-AuNPs. The thioacetate was used instead of the thiol 5.11 in order 
to avoid the possible interference of the thiol group in CuAAC reaction. GlcNAc 5.12 
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was used as the reducing sugar. After the formation of the glycosyl azide (the GlcNAc 
reaction with ADMP as explained in Section 5.2.4) was complete, thioacetate 5.9 
dissolved in THF (as 5.9 was insoluble in water), CuSO4∙5H2O, and L-ascorbic acid were 
added, and the mixture was heated to 50 °C. Even after 24 h, t.l.c did not show any 
progress of the reaction. Therefore, the reaction mixture was heated to 90 
o
C (Scheme 
5.22). After 14 h, t.lc. (CHCl3/MeOH, 4:1) indicated the complete consumption of 
starting material (Rf 0.3) and the formation of a major product (Rf 0.5). The product 
obtained was found to be a mixture of triazole thioacetate 5.26 and triazole thiol 5.27. 
Deacetylation was performed by treating with Na in MeOH, followed by neutralization 
with 1 M aqueous HCl, converted all the thioacetate to thiol. Although the click reaction 
was successful, the purification of the triazole thiol 5.27 was found to be very difficult. 
Compound 5.27 always co-eluted with ascorbic acid-related impurities (Figure A5.4 in 
Appendix) in flash chromatography purification. Since the click reaction went to 
completion and pure 5.27 was not the primary goal of the project, further purification 
attempts were not made.  
  
Scheme 5.22. One-pot synthesis of GlcNAc triazole from the alkyne-terminated 
thioacetate 5.9. 
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5.3.6. One-pot gAuNP synthesis by CuAAC 
It was then investigated if the one-pot reaction procedure developed by the Fairbanks 
group could be used to convert the AAT-AuNPs into gAuNPs. After the formation of 
GlcNAc azide 5.20 was complete (the GlcNAc reaction with ADMP as explained in 
Section 5.2.4), AAT-AuNPs dissolved in THF, L-ascorbic acid, and CuSO4∙5H2O 
(dissolved in water) were added and the mixture was stirred overnight at rt.  Initially, 1.5 
mol% CuSO4∙5H2O with respect to the ligands on the AAT-AuNPs was used for the 
reaction. After 24 h, the solvent was removed in vacuo, and the residue obtained was 
dissolved in and then dialyzed against water for 3 d. Dialysis tubing with 10 kDa 
molecular weight cut off (MWCO) was used for the dialysis process. The AuNP solution 
was freeze dried after the dialysis, and the 
1
H NMR analysis of the AuNPs revealed that 
the particles had not reacted with the glycosyl azide.  
 
Following the observation of Boisselier et al.,
50
 a stoichiometric amount of CuSO4∙5H2O 
with respect to the alkyne ligand on the AAT-AuNPs was used and the reaction was run 
under an inert atmosphere. Reagents were added to the glycosyl azide in the following 
order; firstly the AAT-AuNPs in THF, followed by ascorbic acid, and then finally the 
CuSO4∙5H2O dissolved in water. When the AuNP solution was added to the azide 
solution, the colour turned to that of the AuNP solution (purple), i.e. there was no change 
in the colour of the AuNP solution. The addition of the ascorbic acid did not cause any 
change in the physical properties of the solution. However, when the CuSO4∙5H2O was 
added, the particles immediately precipitated. Yet surprisingly after 15 to 20 minutes, a 
portion of the precipitate was found to have re-dispersed in the solution, and the solution 
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regained the original purple colour. After 24 h, the solvent was removed in vacuo, and the 
residue obtained was dissolved in and dialyzed against water for 3 d. Unfortunately, the 
particles precipitated completely during the dialysis treatment. However, in one particular 
experiment, some of the particles remained dispersed in water and a 
1
H NMR analysis 
was performed. The 
1
H-NMR of the freeze-dried sample (Figure 5.7) clearly showed the 
peaks corresponding to the triazole proton (8.15 ppm) and the H-1 proton of the glycosyl 
traizole (5.70 ppm) along with other sugar and ATT-AuNP protons. Additionally, these 
particles were found to be soluble in water and were insoluble in organic solvents. The 
change in particle solubility, from organic to aqueous soluble, and the
 1
H NMR spectrum, 
both suggest that polar sugar molecules had been clicked onto the particle surface. 
However, even this particular sample precipitated entirely within 24 h.  
 
In further experiments the CuAAC reaction was performed with the purified GlcNAc 
azide 5.20. However precipitation of the particles could not be prevented, although this 
did confirm that neither the triethylammonium salts or the ADMP urea (the by-products 
formed during the azide synthesis) were responsible for the particle aggregation. Similar 
results were obtained when the glucosyl azide was used as the sugar unit.   
 






H NMR spectra of the AuNPs obtained from the one-pot reaction of AAT-
AuNPs with GlcNAc.  
 
5.4. Conclusions and future work 
The results from this project suggest that the water-insoluble AAT-AuNPs used here 
were incompatible with the CuAAC reaction conditions and thus prevented the one-pot 
synthesis of gAuNPs. A number of different groups have obtained the similar results, i.e, 
have observed AuNP precipitation under CuAAC reaction conditions.
43, 45, 47
 The 
immediate precipitation of ATT-AuNPs upon the addition of CuSO4∙5H2O here indicates 
that the Cu catalyst reacted with the particles and caused precipitation. The precise reason 
as to how the Cu catalyst caused the aggregation of AuNPs is not yet clear, and further 
investigations are required in order to adequately explain this observation. Furthermore, 
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the very specific conditions that have enabled some groups to perform the CuAAC 
reaction without causing any AuNP precipitation also need to be explained.  
 
With respect to future work, the interfacial strain promoted azide-alkyne cycloaddition 
(I-SPAAC) is one of the potential methods that could be used to convert these AuNPs to 
gAuNPs without causing any particle precipitation. The procedure developed by Gobbo 
et al.
47
 can be used to synthesise DBCO-AuNPs (Scheme 5.7), and these particles could 
be reacted with glycosyl azides to obtain gAuNPs as shown in Scheme 5.23.  
 
 
Scheme 5.23. The conversion of AuNPs to gAuNPs by I-SPAAC reaction. 
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Chapter 6: Experimental Section 
 
6.1. General experimental procedures and instruments 
All chemical reagents were of analytical grade and used as supplied without further 
purification unless otherwise stated. Solvents were removed under reduced pressure using 
a Buchi
TM
 rotary evaporator. Water used for the synthesis of AuNPs was purified by a 
MilliQ system (Millipore). Thin Layer Chromatography (t.l.c.) was carried out on Merck 
Silica Gel 60F254 aluminium backed plates. Plate visualization was achieved using a UV 
lamp (λmax = 254 or 365 nm), and/or ammonium molybdate (5% in 2M H2SO4). Flash 
column chromatography was carried out using Sorbsil C60 40/60 silica.  
 




C) spectra were recorded on Bruker 
AV400 (400 MHz), or Bruker AV500 (500 MHz) spectrometers. All chemical shifts are 





spectra were assigned using COSY, DEPT, HSQC, HMBC, and TOCSY. High resolution 
mass spectra were recorded on a Bruker FT-ICR mass spectrometer using electrospray 
ionisation (ESI) or chemical ionisation (CI) techniques as stated. M/z values are reported 
in Daltons. Optical rotations were measured on a Perkin-Elmer 241 polarimeter with a 
water-jacketed 1 cm
3







Infrared spectra were recorded on a Perkin-Elmer Spectrum One FTIR instrument 
operating in diffuse reflectance mode with samples prepared as KBr pellets or on a 
Bruker FTIR spectrometer with Alpha‟s Platinum ATR single reflection diamond where 
the neat samples were recorded. 
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TGA was performed with an Alphatech SDT Q600 TGA/DSC apparatus, on 6 - 8 mg of 
purified, dry materials (alumina crucible was used as the sample holder), under N2 (with a 
flow rate of 100 mL/min), recording data from 25 to 1000 °C at a heating rate of 10 
°C/min. Elemental analyses were performed by the Campbell Microanalytical Laboratory 
at the University of Otago. TEM images of AuNPs were obtained using a Philips CM200 
TEM operating at 200 kV. Samples for TEM imaging were prepared by dropping 2 µL of 
a freshly prepared solution of nanostructured Au onto a holey carbon-coated copper grid 
(300 mesh, SPI Supplies, USA) and drying at room temperature. Analysis of the TEM 
images of the AuNPs (in each case at least 200 particles were measured) were performed 
using ImageJ software. UV-Vis absorption spectra were recorded with a Varian Cary 100 
UV-Vis spectrophotometer or a multimode reader (Varioskan Flash, Thermo Scientific). 
DLS measurements were performed using a Malvern Zetasizer Nano ZS DLS system 
(Malvern Instruments Ltd., UK). The DLS system is equipped with a λ=633 nm He-Ne 





6.2. Experimental for Chapter 2 
Synthesis of tetrachloroauric (III) acid trihydrate (HAuCl4∙3H2O)
1
 
Pure Au metal (99.99%, 15 g) was added to freshly prepared aqua regia (150 mL) at 60 
o
C. After 3 d Au was completely dissolved in aqua regia.  The solution was concentrated 
in vacuo to afford tetrachloroauric (III) acid trihydrate (HAuCl4∙3H2O) as a yellow 
solid (28 g). 
 




Synthesis of Au nanomaterials 
All experiments were performed under an air atmosphere. In a typical reaction, 150 mL 
of 0.25 mM aqueous solution of HAuCl4∙3H2O was refluxed (2.1a) or heated to the 
desired temperature (70 
o
C for 2.1b, 2.2a, 2.3a, and 2.4b, and 95 
o
C for 2.4a) in a 
temperature-controlled oil bath with continuous magnetic stirring (500 rpm). The 
required amount of trisodium citrate as an aqueous solution (38.8 mM) was added rapidly 
to the solution and the reaction was continued for 15 min, after which the reaction 
mixture was cooled to rt. In the case of 2.4a, the reaction was carried out for 60 min as 
well. 
 
6.3. Experimental for Chapter 3 
Reagents 
All chemicals and reagents other than those listed below were supplied by Sigma-Aldrich 
Chemical Co. The heat-labile enterotoxin B-subunit was purchased from Reagent 
Proteins (San Diego, USA). Recombinant influenza A virus H1N1 hemagglutinin 
(A/California/04/2009) was purchased from Sino Biological Inc. (Beijing, China). 
  
Colorimetric bioassay for LTB using Gal-gAuNPs 
Purified Gal-gAuNPs were freeze-dried, and then re-suspended in phosphate buffer (10 
mM, pH 7.2) to give a nanoparticle concentration of 10 nM. A series of solutions with a 
range of LTB concentrations (300, 600, 900 and 1200 nM) were prepared separately in 
Milli-Q water. Then, an aliquot of each of the LTB solutions (150 μl) was added (with 
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mixing) to an aliquot of the Gal-gAuNP solution (150 µl), and the progress of the 
reaction was monitored by UV-Vis spectroscopy, recording the absorption at 620 nm 
prior to recording of the whole UV-Vis absorbance spectrum. Aliquots of the Gal-gAuNP 
solution were also mixed with bovine serum albumin (BSA, aqueous solutions of 300-





















all at a concentration of 100 µM) to confirm that the Gal-gAuNPs did not 
undergo non-specific aggregation and also with Con A and Hemagglutinin (each 600 nM) 
to confirm that the particles were selective only towards LTB. Additionally, an 
electrolyte that mimicked the typical watery stool of diarrhoea patients, namely a solution 
containing Cl
ˉ
 at 100 mM, Na
+
 at 135 mM, K
+
 at 15 mM, and HCO3
ˉ
 at 45 mM,
2-4
 was 








Sodium acetate (41 g, 500 mmol) was added to acetic anhydride (315 mL), and the 
mixture was refluxed at 120 °C for 30 min. D-Galactose  (30.0 g, 165 mmol) was then 
added slowly over 30 min. After a further 120 min, t.l.c (petrol:EtOAc, 1:1) showed 
complete consumption of starting material (Rf 0) and the formation of single product (Rf 
0.7). The reaction mixture was then cooled to rt and a mixture of water and ice (400 mL) 
was added. The ensuing precipitate was filtered, and then recrystallized (EtOH) to give 
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 +27.1 (c, 1.03 in CHCl3)];  δH (500 
MHz, CDCl3)
7
 1.99, 2.04, 2.11, 2.16 (15H, 4 x s, 5 x CH3CO2), 4.07 (1H, m, H-5), 4.13-
4.16 (2H, m, H-6, H-6‟), 5.06 (1H, dd, J3,4 3.5 Hz, H-3), 5.32 (1H, dd, J2,3 10.5 Hz, H-2), 







BF3∙Et2O (1.9 mL, 15.4 mmol) was added to a solution of compound 3.1 (3.0 g, 7.7 
mmol) and triethylene glycol (2.2 mL, 17 mmol) in dry DCM (30 mL) and the resulting 
solution was stirred at rt for 5 h. The solution was then diluted with DCM (30 mL) and 
washed successively with an aqueous solution of saturated NaHCO3 (2 × 30 mL), H2O (2 
× 30 mL), and brine (30 mL). The organic extracts were dried (Na2SO4), filtered, and 
concentrated in vacuo. The residue was then purified by flash chromatography 
(petrol:EtOAc, 1:1 ) to afford alcohol 3.2 (1.5 g, 40 %) as a yellow syrup; [α]D
20
 + 0.3 (c, 
1.0 in MeOH); δH (400 MHz, CDCl3)
8
 2.15, 2.06, 2.04, 1.98 (12H, 4 x s, 4 x CH3), 3.77-
3.59 (10H, m, 5 x OCH2), 3.95 (2H, m, 1 x CH2O), 4.15 (3H, m, H-5, H-6, H-6`),  4.58 
(1H, d, J1,2 7.8 Hz, H-1), 5.02 (1H, dd, J3,4 2.1 Hz, H-3), 5.19 (1H, dd, J1,2 7.8 Hz, J2,3 8.7 
Hz, H-2), 5.38 (1H, m, H-4);  HRMS (ESI) Calcd. For C20H33O13 (MH
+
) 481.1916. 
Found 481.1914.  
 







Triethylene glycol galactoside 2.7 (2.5 g, 5.3 mmol) was dissolved in dry DCM (100 mL) 
under nitrogen at 0 
o
C and stirred. Mesyl chloride (0.7 mL, 10 mmol) was added 
dropwise, and then triethylamine (1.4 mL, 10 mmol) was added. The reaction mixture 
was then allowed to warm to rt. After 2h, t.l.c (EtOAc) indicated the formation of a 
single product (Rf 0.3) and the complete consumption of the starting material (Rf 0). The 
reaction was quenched by the addition of MeOH (10 mL) and concentrated in vacuo. The 
residue was dissolved in DMF (25 mL), and potassium thioacetate (2 g, 20 mmol) was 
added and the reaction was then stirred at 65 
o
C. After 16 h, t.l.c. (EtOAc) indicated the 
formation of a major product (Rf 0.4) and the complete consumption of the starting 
material (Rf 0.3). The reaction mixture was cooled, diluted with EtOAc (30 mL) and 
washed successively with an aqueous solution of saturated NaHCO3 (2 x 30 mL), H2O (2 
x 30 mL), and brine (30 mL). The organic layer was separated, dried (Na2SO4), filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography 
(petrol:EtOAc, 1:3) to afford 8-thioacetyl-3,6-dioxaoctyl 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranoside 3.3 (1.9 g, 64.5%) as a yellow syrup. [α]D
20
 -3.0 (c, 1.0 in CHCl3)]; δH 
(400 MHz, CDCl3)
8
 2.14, 2.06, 2.04, 1.98 (12H, 4 x s, 4 x CH3CO2), 2.34 (3H, s, 1 x 
CH3COS), 3.09 (2H, t, 2 x CH2S), 3.58-3.75 (8H, m, 4 x CH2O), 3.92 (2H, m, 1 x 
CH2O), 4.14 (3H, m, H-5, H-6, H-6`),  4.57 (1H, d, J1,2 7.8 Hz, H-1), 5.02 (1H, dd, J3,4 
2.1 Hz,  H-3), 5.21 (1H, dd, J2,1 7.8 Hz, J2,38.7 Hz, H-2), 5.39 (1H, m, H-4); HRMS (ESI) 
Calcd. For C22H34O13SNa(MNa
+
) 561.1612. Found 561.1617.  








NaOMe (0.17 M in MeOH, 1 mL) was added to a solution of compound 3.3 (500 mg, 
0.93 mmol) in MeOH (10 mL), and the solution was stirred at rt for 2 h. The solution was 
then neutralized by the addition of Amberlite IR-120 (H
+
 resin), filtered, and then air 
oxidized by bubbling air continuously through the solution for a total of 64 h. The solvent 
was then removed in vacuo to afford disulfide 3.4 (295 mg, 97 %) as a yellow syrup. 
[α]D
20
 –1.6 (c, 1.0 in D2O); δH (500 MHz, d6-DMSO)
8
 2.81 (2H, t, CH2S), 3.40 (1H, m, 
H-2 ), 3.48-3.65 (10H, m, 4 x CH2O, H-6, H-6`), 3.69 (3H, m,1 x CH2O, H-4), 3.77 (1H, 
m, H-3), 3.93 (1H, m, H-5), 4.28 (1H, d, J1,2 8.5 Hz, H-1); HRMS (ESI) Calcd. For 
C24H46O16S2 (MNa
+
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A solution of disulfide 3.4
8
 (50 mg, 0.076 mmol) in MeOH (12 mL) was added to a 
solution of HAuCl4∙3H2O (15 mg, 0.038 mmol) in water (3 mL) and stirred (500 rpm). A 
solution of NaBH4 (14.37 mg, 0.38 mmol) in water (1.7 mL) was added in small portions, 
and the reaction was then stirred for 2 h. The mixture was concentrated in vacuo, the 
residue was dissolved in Milli-Q water (10 mL), and then purified by centrifugal filtering 
(Amicon Ultra 10K, Millipore, MWCO=10,000, 1h, 5000 x g). The addition of 10 mL of 
Milli-Q water and centrifugal filtration was repeated until the NPs were free of salts and 
starting material (as seen by the absence of signals arising from disulfide 3.4 in the 
1
H 
NMR spectrum). The residue was then dissolved in water (2 mL) and lyophilized to 
obtain Gal-gAuNP-2. TEM: 2.3 ± 0.5 nm; IR (KBr): 3300 (br, OH), 2933, 2873, 1062 
cm
-1
; UV: 508 nm; TGA: ligand 41.6%, Au 58.4 %; Elemental analysis Found: C, 18.23; 
H, 3.31; S, 4.32. Calc. for Au377(C12H24O8S)162 : C, 18.3; H, 3.08; S, 4.08%; HRMS (ESI) 
Calcd. For C24H46O16S2 (MNa
+
) 677.2119. Found 677.2133. 
 
Gal-gAuNP-7   
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An aqueous solution of HAuCl4∙3H2O (0.25 mL, 0.254 mM, pH 1.6) was added to a 
boiling aqueous solution of trisodium citrate (34.25mL, 5.3 mM) with constant stirring 
(500 rpm). After 15 min, the reaction mixture was cooled to rt, and a solution of disulfide 
3.4
8
 (500 mg, 0.76 mmol) was added. The reaction was then stirred for 48 h at rt. The 
reaction mixture was concentrated in vacuo, the residue was dissolved in Milli-Q water 
(10 mL), and then purified by centrifugal filtering (Amicon Ultra 10K, Millipore, 
MWCO=10,000, 1h, 5000 x g). The residue was then dissolved in water (2 mL) and 
lyophilized to obtain Gal-gAuNP-7. TEM: 7.3 ± 0.9 nm; IR (KBr): 3300 (broad band), 
2933, 2873, 1062 cm
-1
; UV: 517 nm; TGA: ligand 23.1%, Au 76.9%; Elemental analysis 
Found: C, 10.21; H, 1.49; S, 2.37. Calc. for Au12060(C12H24O8S)2181: C, 10.16; H, 1.62; S, 
2.26%; HRMS (ESI) Calcd. For C24H46O16S2 (MNa
+
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An aqueous solution of trisodium citrate (5.6 mL, 38.8 mM) was added to a boiling 
aqueous solution of HAuCl4∙3H2O (25mL, 1 mM) with constant stirring (500 rpm). After 
15 min, the reaction mixture was cooled to room temperature, and a solution of disulfide 
3.4
8
 (650 mg, 1 mmol) was added. The reaction was then stirred for 48 h at rt. The 
reaction mixture was concentrated in vacuo, the residue was dissolved in Milli-Q water 
(10 mL), and then purified by centrifugal filtering (Amicon Ultra 10K, Millipore, 
MWCO=10,000, 1h, 5000 x g). The residue was then dissolved in water (2 mL) and 
lyophilized to obtain Gal-gAuNP-12. TEM: 12.0 ± 1.7 nm; IR (KBr): 3300 (broad band), 
2933, 2873, 1062 cm
-1
; UV: 523 nm; TGA: ligand 8.70%, Au 91.3%; Elemental analysis 
Found: C, 4.06; H, 0.64; S 0.97%. Calc. for Au53568(C12H24O8S)3074: C, 4.15; H, 0.64; S, 
0.92%; HRMS (ESI) Calcd. For C24H46O16S2 (MNa
+






An aqueous solution of trisodium citrate (1.24 mL, 16.9 mM) was added to a boiling 
aqueous solution of HAuCl4∙3H2O (25.4 mL, 0.3 mM) with constant stirring (500 rpm). 
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After 15 min, the reaction mixture was cooled to rt, and a solution of disulfide 3.4
8
 (81 
mg, 0.12 mmol) was added. The reaction was then stirred for 48 h at rt. The reaction 
mixture was concentrated in vacuo, the residue was dissolved in Milli-Q water (10 mL), 
and then purified by centrifugal filtering (Amicon Ultra 10K, Millipore, MWCO=10,000, 
1h, 5000 x g). The residue was then dissolved in water (2 mL) and lyophilized to obtain 
Gal-gAuNP-20. TEM: 20.3 ± 1.8 nm; IR (KBr): 3300 (broad band), 2933, 2873, 1062 
cm
-1
; UV: 527 nm; TGA: ligand 5.90 wt%, Au 94.10 wt%; Elemental analysis Found: C, 
2.58; H, 0.41; S, 0.58. Calc. for Au53568(C12H24O8S)3074: C, 2.58; H, 0.42; S, 0.57%; 
HRMS (ESI) Calcd. For C24H46O16S2 (MNa
+
) 677.2119. Found 677.2118. 
 
6.4. Experimental for chapter 4 
Reagents 
Recombinant influenza A virus H1N1 hemagglutinin (A/California/04/2009) was 
purchased from Sino Biological Inc. (Beijing, China). The influenza virus A/Puerto 
Rico/8/34 (H1N1) and A/New Caledonia/20/1999 (H1N1) strains were propagated in 10-
day old embryonated chicken eggs, and titrated on Madin-Darby Canine Kidney 
(MDCK) cells (this part was done by our collaborators, Dr. Matloob Husain`s virology 
group, in Otago University). 
 
Colorimetric detection of HA using SG-gAuNPs 
Purified SG-gAuNPs were freeze-dried, and then re-suspended in PBS (pH 7.4) to give a 
NP concentration of 3 nM. A solution of HA in (0.25 mg/mL) PBS (pH 7.4) was 
prepared. Then, aliquots of the HA solution (5, 10, 20, 30 and 40 µl) were added (with 
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mixing) to an aliquot of the SG-gAuNP solution (200 µl), and in each case solution was 
made up to a total volume of 300 µl by adding PBS, and the progress of the reaction was 
monitored by UV-Vis spectroscopy at different time intervals. Additionally, an aliquot of 
the SG-gAuNP solution (200 µl) were also mixed with bovine serum albumin (BSA) 
(600 nM) to confirm that the SG-gAuNPs did not undergo non-specific aggregation and 
also with Con A and B subunit of heat-labile enterotoxin (each at 600 nM) to confirm that 
the particles were selective only towards HA.  
 
Colorimetric detection of viral particles using SG-gAuNPs 
Egg allantoic fluid containing influenza A/New Caledonia/20/1999 (H1N1) (6 x 10
5 
PFU/mL) or influenza A/Puerto Rico/8/34 (H1N1) (2 x 10
7
 PFU/mL) strain was prepared 
in PBS. Aliquots of the A/New Caledonia/20/1999 (H1N1) solution (1.6, 8, 16.7, 33.4, 
and 50.1 µl) were added (with mixing) to an aliquot of the SG-gAuNP solution (30 µl of 
20 nM solution) and formalin (15 µL of 10% stock solution). In each case solution was 
made up to a total volume of 300 µl by adding PBS. The progress of the reaction was 
monitored by UV-Vis spectroscopy at different time intervals. In the case of the A/Puerto 
Rico/8/34 (H1N1) virus 1.5 µl of the stock solution was added to the SG-AuNP solution.  
 
DLS assay 
The sample was equilibrated at 25 
o
C for 120 seconds before analysis. Each measurement 
was for 12 scans, each of 30 seconds duration. The mean particle hydrodynamic 
diameters reported were calculated from intensity based particle size distributions. 
 
 Chapter 6                                                                                                                                                                          
213 
 
Extraction and synthesis 





Three hundred egg yolks (3.3 L) were stirred in water (1.5 L) and then freeze-dried to 
obtain 2.1 kg of yolk powder. This powder was washed successively with diethyl ether (6 
L x 2) and 70 % aqueous acetone (6 L) after thorough mixing. Aqueous acetone (40%, 3 
L x 2) was added, with vigorous mixing, and the solution was then filtered through 
Celite
®
. The filtrate was concentrated and freeze-dried to give 30 g of yolk extract 
powder. This powder (30 g) was dissolved in H2O, and purified by solid-phase extraction 
with an active carbon/Celite
®
(300 g:300 g) column (the column was sequentially washed 
with 5% and 10% aqueous MeCN, before elution of SGP with 30% aqueous MeCN) to 
afford 1.2 g of sialylglycopeptide (SGP) 4.1
9
 as a white powder; δH (400 MHz, D2O)
1
 
0.84 (6H, d, γ CH3 of Val), 1.04 (3H, d, γ CH3 of Thr), 1.25 (3H, d, β CH3 of Ala), 1.31 
(2H, m, γ CH2 of Lys), 1.52-1.64 (3H, m, δ CH2 of Lys, H-3axNeuAc7, H-3axNeuAc7`), 
1.75 (2H, m, β CH2 of Lys), 2.54 (1H, m, H-3eqNeuAc7, H-3eqNeuAc7`), 2.70 (2H, m, β 
CH2 of Asn), 2.87 (2H, t, ε CH2 of Lys), 4.33 (2H, d, H-1Gal-6, H-1Gal6`), 4.47 (3H, m, 
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H-1GlcNAc2, H-1GlcNAc5, H-1GlcNAc5`), 4.63 (1H, m, H-1Man3), 4.82 (1H, m, H-
1Man4`), 4.91 (1H, d, H-1GlcNAc1), 5.00 (1H, m, H-1Man-4); HRMS (ESI): calcd. For 
C112H189N15O70(MH
+









Pronase (3 mg, from Streptomyces griseus) was added to a solution of SGP 4.1
9
 (20 mg) 
and NaN3 in Tris-HCl buffer (50 mM, pH 7.5, 1 ml), and the mixture was incubated at 37 
o
C. The pH of the solution was checked regularly and adjusted to 7.5. After 7 d, the 
mixture was purified by gel filtration using a Sephadex G-25 column (8.7 x 1.7 cm) 
which was pre-equilibrated and eluted with 0.01% aqueous NH3. Fractions of 8 ml were 
collected at a flow rate of 0.5 mL/min, and examined for their sugar content using the 
phenol/sulfuric acid test. The fractions which showed positive results were pooled and 
lyophilized to obtain asparagine-linked N-glycan 4.2
10
 (10 mg, 57%) as a white powder; 
δH (400 MHz, D2O)
2
 1.80 (2H, dd, J 12.4 Hz, H-3axNeuAc7, H-3axNeuAc7`), 2.10-2.2 
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(18H, s, 6 x CH3CO2), 2.76 (2H, m, H-3eq NeuAc7, H-3eqNeuAc7`), 2.95 (1H, dd, J 8 Hz, 
J 16 Hz,  β-CH2 of Asn), 3.03 (1H, dd, J 4 Hz, J 16 Hz, β-CH2 of Asn), 4.17 (1H, bd, H-
2Man4`), 4.24 (1H, bd, H-2Man4), 4.30 (1H, bs,  H-2Man3), 4.49 (2H, d, J 7.6 Hz, H-
1Gal6, H-1Gal6`), 4.66 (3H, m, H-1GlcNAc2, H-1GlcNAc5, H-1GlcNAc5`), 4.86 (1H, s, 
H-1Man3), 5.15 (1H, d, J 9.5 Hz, H-1GlcNAc), 5.18 (1H, s, H-1Man4); HRMS (ESI) 
Calcd. For C88H144N8O64 (MH
+






Acetyl chloride (3.8 mL, 0.054 mmol) was added drop-wise to a stirred mixture of 
triethylamine (15 mL, 0.108 mol) and thioglycolic acid 4.3 (5.22 g, 0.054 mol) in 1,4-
dioxane (100 mL) at 0 
o
C under nitrogen, and the reaction was then warmed to rt. After 
12 h, t.l.c (EtOAc) showed the formation of a major product (Rf 0) and the complete 
consumption of starting material (Rf 0.5). The reaction mixture was filtered through 
Celite
®
 and concentrated in vacuo. 1 M Aqueous HCl (30 mL) was added, and the 
reaction was stirred for 1 h. The reaction mixture was extracted with DCM (3 x 30 mL), 
dried (MgSO4), filtered, and concentrated in vacuo to give S-acetylmercaptoacetic acid 
4.4
11
 (4.2 g, 54%) as a yellow oil; δH (400, d6-DMSO)
11 
2.35 (3H, s, CH3COS), 3.66 (2H, 
s, CH2CO2), 12.75 (1H, br s, COOH). 
 
 










 (2.6 g, 0.019 mol) and N-hydroxysuccinimide (2.2 g, 
0.019 mol) were dissolved in THF (50 mL), and the reaction mixture was stirred at rt for 
10 min before cooling to 0 
o
C. Dicylohexylcarbodiimide (DCC) (3.97 g, 0.019 mol) was 
dissolved in THF (5 mL), and then added to the reaction mixture. The reaction mixture 
was warmed to rt and stirred under nitrogen. After 12 h, t.l.c (EtOAc:MeOH, 4:1) showed 
the formation of a major product (Rf 0.6) and the complete consumption of the starting 
material (Rf 0.4). The residue was purified by flash column chromatography 
(petrol:EtOAc, 2:1) to afford N-hydroxysuccinimide ester 4.5
12
 (1.9 g, 61%) as a yellow 
oil. δH (400MHz, CD3Cl3)
12 
2.43 (3H, s, COCH3), 2.85 (4H, s, COCH2CH2CO), 3.99 
(2H, s, SCH2CO2). 
 
Sialylglycan thioacetate 4.6  
 




A solution of N-hydroxysuccinimide ester 4.5
12
 (12 mg, 0.049 mmol) in MeCN (0.3 mL) 
was added to a solution of asparagine-linked N-glycan 4.2
10
 (7.6 mg, 0.003 mmol) in 
sodium phosphate buffer (50 mM, 1 ml, pH 7.4) containing 20% MeCN. The mixture 
was stirred at rt for 12 h and then lyophilized. The residue was purified by gel filtration 
on a Sephadex G-25 column (8.7 x 1.7 cm), which was pre-equilibrated and eluted with 
0.01% aqueous ammonia, to obtain thioacetate 4.6 (5 mg, 68%) as a white powder; δH 
(400 MHz, D2O) 1.80 (dd, 2H, J 12.4 Hz, H-3axNeuAc7, H-3axNeuAc7`), 2.10-2.2 (18H, 
s, 6 x CH3CO2), 2.30 (3H, s, CH3COS), 2.53-2.67 (4H, m, β-CH2 of Asn, H-3eq NeuAc7, 
H-3eqNeuAc7`), 4.17 (1H, bd, H-2Man4`), 4.24 (1H, bd, H-2Man4), 4.30 (1H, bs,  H-
2Man3), 4.49 (2H, d, J 7.6 Hz, H-1Gal6, H-1Gal6`), 4.66 (3H, m, H-1GlcNAc2, H-
1GlcNAc5, H-1GlcNAc5`), 4.86 (1H, s, H-1Man3), 5.15 (1H, d, J 9.5 Hz, H-1GlcNAc), 
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Sialylglycan disulfide 4.7  
 
 
Hydroxylamine hydrochloride (51 mg, 0.73 mmol) was added to a solution of thioacetate 
4.6 (300 mg, 0.122 mmol) in sodium phosphate buffer (100 mM, 80 ml, pH 7.4). The 
mixture was stirred at rt for 2 h and then lyophilized. The residue was purified by gel 
filtration on a Sephadex G-25 column (8.7 x 1.7 cm), which was pre-equilibrated and 
eluted with 0.01% aqueous NH3, followed by air oxidation by bubbling air continuously 
through the solution for a total of 64 h to obtain sialylglycan disulfide 4.7 (210 mg, 71%) 
as a white powder; δH (400 MHz, D2O) 1.80 (dd, 2H, J 12.4 Hz, H-3axNeuAc7, H-
3axNeuAc7`), 2.10-2.2 (18H, s, 6 x CH3CO2), 2.53-2.67 (4H, m, β-CH2 of Asn, H-3eq 
NeuAc7, H-3eqNeuAc7`), 4.17 (1H, bd, H-2Man4`), 4.24 (1H, bd, H-2Man4), 4.30 (1H, 
bs,  H-2Man3), 4.49 (2H, d, J 7.6 Hz, H-1Gal6, H-1Gal6`), 4.66 (3H, m, H-1GlcNAc2, 
H-1GlcNAc5, H-1GlcNAc5`), 4.86 (1H, s, H-1Man3), 5.15 (1H, d, J 9.5 Hz, H-
1GlcNAc), 5.18 (1H, s, H-1Man4); HRMS (ESI) Calcd. For C90H146N8O65S (M+2H)
2+
 
1206.4116. Found 1206.4155. 








An aqueous solution of trisodium citrate (1.7 mL, 39.0 mM) was added to a boiling 
aqueous solution of HAuCl4∙3H2O (7.6 mL, 1 mM) with constant stirring (500 rpm). 
After 15 min, the reaction mixture was cooled to rt, and a solution of disulfide 4.7 (144 
mg, 1 mmol) was added. The reaction was stirred for 48 h at rt. The reaction mixture was 
concentrated in vacuo, the residue was dissolved in Milli-Q water (10 mL), and then 
purified by centrifugal filtering (Amicon Ultra 10K, Millipore, MWCO=10,000, 1h, 5000 
x g). The residue was then dissolved in water (2 mL) and lyophilized to obtain SG-
gAuNP. TEM: 12.1 ± 1.6 nm; IR (KBr): 3300 (broad band), 2933, 2873, 1062 cm
-1
; UV: 
523 nm; TGA: ligand 73.6%, Au 26.4%; Elemental analysis Found: C, 32.65; H, 4.50; N, 
3.44; S, 1.04. Calcd. for Au54464(C12H24O8S)12404: C,  32.96; H, 4.47; N, 3.42; S, 1.01%; 
HRMS (ESI) Calcd. For C90H146N8O66S (M+2H)
2+
 1206.4116. Found 1206.4155
 
 
 Chapter 6                                                                                                                                                                          
220 
 






Triethylene glycol 5.7 (15.02 g, 100 mmol) was dissolved in 40 mL of dry THF. NaH 
(2.60 g, 65 mmol, 60% dispersion in mineral oil) was slowly added under nitrogen at 0 
o
C, and stirred for 30 min. Propargyl bromide (7.9 mL, 50 mmol) was added dropwise, 
and the mixture was stirred at 0 
o
C for 2 h, and then at 25 
o
C for 20 h. After this time, 
t.l.c (petrol:EtOAc, 1:3) showed the complete consumption of the starting material (Rf 0) 
and the formation of a major product (Rf 0.3). The reaction was quenched by the addition 
of MeOH (20 mL), and the mixture was then filtered through Celite
® 
and concentrated in 
vacuo. The residue was purified by flash column chromatography (petrol:EtOAc, 2:1) to 
give 3,6,9-trioxadodec-11-yne-1-ol 5.8 (9 g, 48%) as a yellow oil. δH (400 MHz, 
CDCl3)
13
 2.26 (1H, br s, OH), 2.42 (1H, t, J 2.3 Hz, H2CCCH), 3.55 - 3.79 (12H, m, 6 x 
CH2O), 4.20 (2H, d, J 2.3 Hz, H2CCCH); HRMS (ESI) Calcd. For C9H17O4 (MH
+
) 
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Alkyne 5.8 (9 g, 47.8 mmol) was dissolved in dry DCM (150 mL) under nitrogen at 0 
o
C 
and stirred. Mesyl chloride (7.4 mL, 96 mmol) was added dropwise, followed by 
triethylamine (13.3 mL, 96 mmol). The reaction mixture was then warmed to rt. After 2h, 
t.l.c (petrol:EtOAc, 2:1) indicated the formation of a single product (Rf 0.4), and the 
complete consumption of the starting material (Rf 0.2). The reaction was quenched by the 
addition of MeOH (30 mL) and concentrated in vacuo. The residue was dissolved in 
DMF (150 mL), potassium thioacetate (22 g, 191 mmol) was added, and the reaction was 
then stirred at 65 
o
C. After 16 h, t.l.c. (petrol:EtOAc, 2:1) indicated the formation of a 
major product (Rf 0.6), and the complete consumption of the starting material (Rf 0.4). 
The reaction mixture was cooled to rt, diluted with EtOAc (100 mL) and washed 
successively with aqueous solution of saturated NaHCO3 (2 × 60 mL), H2O (2 × 60 mL), 
and brine (30 mL). The organic layer was separated, dried (Na2SO4), filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petrol:EtOAc, 
10:1) to afford 1-thioacetyl-3,6,9-trioxadodec-11-yne 5.9 (7.4 g, 63%) as a yellow syrup. 
νmax (KBr disc)  3271 (s, H2CCC-H) 2865 (s, H2CC-H) , 1685 (s, C=O) cm
-1
. δH  (400 
MHz, CDCl3) 2.31 (1H, s, CH3CO), 2.42 (1H, t, J 2.3 Hz, H2CCCH), 3.08 (2H, t, J 6.5 
Hz, CH2S), 3.53 - 3.73 (10H, m, 5 x CH2O), 4.20 (2H, d, J 2.3 Hz, H2CCCH); δC  (100 
MHz, CDCl3) 28.8 (t, CH2S), 30.5 (q, CH3CO), 58.4 (t, H2CCCH), 69.1 (t, CH2O) 69.7 
(t, CH2O), 70.3 (t, CH2O), 70.5 (t, CH2O), 70.7 (t, CH2O), 74.5 (d, H2CCCH), 79.6 (s, 
H2CCCH), 195.5 (s, CO);; HRMS (ESI) Calcd. For C11H19O4S (MH
+
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1,1`-Dithiobis (3,6,9-trioxadodec-11-yne) 5.10 
 
 
NaOMe (8.1 M solution in MeOH) was added to a solution of compound 5.9 (2 g, 8.1 
mmol) in MeOH (50 mL), and the solution was stirred at rt. After 2 h, the solution was 
neutralized (confirmed by pH paper) by the addition of 1M HCl, and then air-oxidized by 
bubbling air continuously through the solution for a total of 72 h. The solvent was then 
removed in vacuo to afford disulfide 5.10 (1.6 g, 95%) as a yellow syrup; νmax (KBr disc)  
3253 (w, H2CCC-H), 2865 (s, H2CC-H stretch), 1349 (w, H2CC-H bend), 1092 (s, C-O) 
cm
-1
; δH (400 MHz, CDCl3) 2.42 (1H, t, J 2.2 Hz, H2CCCH), 2.86 (2H, t, J 8 Hz, CH2S), 
3.55 - 3.77 (10H, m, 5 x CH2O), 4.18 (2H, d, J 2.4 Hz, H2CCCH); δC (100 MHz, CDCl3) 
38.4 (t, CH2S), 58.4 (t, H2CCCH), 69.1 (t, CH2O), 69.6 (t, CH2O), 70.3 (t, CH2O), 70.4 
(t, CH2O), 70.5 (t, CH2O), 74.5 (d, H2CCCH), 79.6 (s, H2CCCH); HRMS (ESI) Calcd. 
For C18H30O6S2Na (MNa
+





Dithiothreitol (DTT) (569 mg, 3.69 mmol) was added to a solution of the disulfide 5.10 
(300 mg, 0.739 mmol) and N, N-diisopropylethyl amine (DIPEA) (0.65 mL, 3.69 mmol) 
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in MeOH and stirred under nitrogen at room rt. After 3 h, t.l.c (petrol:EtOAc, 1:1) 
indicated the formation of a single product (Rf 0.4), and the complete consumption of the 
starting material (Rf 0.3). The reaction mixture was concentrated in vacuo, diluted with 
EtOAc (30 mL) and washed successively with 1 M aqueous HCl solution (2 x 30 mL), an 
aqueous solution of saturated NaHCO3 (2 × 30 mL), H2O (2 × 30 mL), and brine (30 
mL). The organic layer was separated, dried (Na2SO4), filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography (petrol:EtOAc, 10:1) to afford 
1-mercapta-3,6,9-trioxadodec-11-yne 5.11 (270 mg, 90.0%) as a yellow syrup. νmax (KBr 
disc)  3250 (w, H2CCC-H), 2865 (s, H2CC-H), 1348 (w, H2CC-H bend), 1090 (s, C-O) 
cm
-1
; δH (400 MHz, CDCl3) 1.56 (1H, t, J 8 Hz, SH), 2.42 (1H, t, J 2.2 Hz, H2CCCH), 
2.66 (2H, m, CH2S), 3.55 - 3.71 (10H, m, 5 x CH2O), 4.18 (2H, d, J 2.4 Hz, H2CCCH); 
δC (100 MHz, CDCl3) 23.5 (t, CH2S), 58.4 (t, H2CCCH), 69.1 (t, CH2O), 70.2 (t, CH2O), 
70.4 (t, CH2O), 70.5 (t, CH2O), 72.8 (t, CH2O), 74.5 (d, H2CCCH), 79.6 (s, H2CCCH); 
HRMS (ESI) Calcd. For C9H16O3SNa (MNa
+
) 227.0712. Found 227.0721. 
 





1,3-Dimethylimidazolidinone 5.16 (56.7 mL, 524 mmol) was dissolved in toluene (500 
mL) and stirred under a nitrogen atmosphere. Oxalyl chloride (59.4 mL, 693 mmol) was 
added dropwise, and the reaction was stirred at 50 °C. After 3 h, the flask was cooled to rt 
and then stirred overnight. After 18 h, the precipitate was filtered, washed with cold 
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toluene and then recrystallized (MeCN/Et2O). The white solid was filtered and dried 
under vacuum to yield 2-chloro-1,3-dimethylimidazolidinium chloride 5.17 (53 g, 60%) 
as a white powdery solid, m.p. 91-96 °C [lit. m.p. 95-100 °C];
14
 δH (400 MHz, CD3CN)
14
 
3.17 (6H, s, 2 x CH3), 4.02 (4H, s, 2 x CH2); HRMS (ESI) Calcd. For C5H10ClN2 (M+) 
133.0527. Found 133.0529. 
 





2-Chloro-1,3-dimethylimidazolidinium chloride 5.17 (37 g, 220 mmol) was dissolved in 
anhydrous MeCN (300 mL) and stirred under a nitrogen atmosphere. NaPF6 (40.5 g, 220 
mmol) was added and the reaction was stirred at rt. After 30 min, the solution was filtered 
through Celite
®
 which was washed with MeCN (100 mL). The combined washings were 
concentrated in vacuo, and the resultant solid was dissolved in a minimal amount of 
MeCN. Et2O was added until a precipitate formed, which was collected by suction 
filtration to afford 2-chloro-1,3-dimethylimidazolinium hexafluorophosphate 5.18 (49 g, 
80%) as a white solid, m.p. 226-232 °C [lit. 230-231 °C];
14
 δH (400 MHz, CD3CN)
14
 3.14 
(6H, s, 2 x CH3), 3.95 (4H, s, 2 x CH2); HRMS (ESI) Calcd. For C5H10ClN2(M+) 
133.0527. Found 133.052 
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2-Chloro-1,3-dimethylimidazolidinium hexafluorophosphate 5.18 (11.6 g, 41.7 mmol) 
was dissolved in anhydrous MeCN (120 mL) and stirred at 0 °C under a nitrogen 
atmosphere. Sodium azide (3.8 g, 58.5 mmol) was added to the reaction mixture. After 3 
h, the mixture was filtered through Celite
®
 which was washed with MeCN. The filtrate 
was concentrated in vacuo, and the resulting solid dissolved in a minimal amount of 
MeCN. Et2O was added until a precipitate formed, which was collected by suction 
filtration to afford 2-azido-1,3-dimethylimidazolinium hexafluorophosphate 5.19 (11.8 g, 
quant.) as a white solid, m.p. 201-205 
o
C [lit. 205-207 °C];
14
 δH (400 MHz, CD3CN)
14
 
3.08 (s, 6H, 2 x CH3), 3.81 (s, 4H, 2 x CH2); HRMS (ESI) Calcd. For C5H10N5 (M+) 






N-Acetyl-D-glucosamine 5.12 (250 mg, 1.13 mmol) and triethylamine (0.8 mL, 5.7 
mmol) were stirred in D2O/MeCN (4:1, 5 mL) and cooled to 0 °C. ADMP 5.19 (0.95 g, 
3.4 mmol) was added. After 1 h, t.l.c. (CHCl3/MeOH, 2:1) indicated complete 
consumption of starting material (Rf 0.2) and the formation of two major products (Rf 
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0.5, 0.6). The reaction mixture was acidified to pH 2 by dropwise addition of aqueous 1.2 
M HCl and then neutralized by addition of NaHCO3 (5 mL of a saturated aqueous 
solution). The solution pH was followed by using pH paper. The reaction mixture was 
concentrated, and the residue was dissolved in ethanol (10 mL), filtered through Celite
®
, 
and concentrated in vacuo. The residue was then redissolved in water (10 mL), washed 





treated with aqueous 1 M NaOH solution), and concentrated in vacuo. Purification by 
flash column chromatography (CHCl3:MeOH, 5:1) gave 2-acetamido-2-deoxy-β-D-





 -34 (c, 1.0 in MeOH) [lit. [α]D
20
 -34 (c, 1.0 in MeOH)];
15
 δH (400 
MHz, D2O)
29 
 1.88 (3H, s, CH3), 3.32 (1H, m, H-4), 3.35-3.42 (2H, m, H-3, H-5), 3.53 
(1H, at, J 9.5 Hz, H-2), 3.60 (1H, dd, J5,6 5.4 Hz, J6,6‟ 12.2 Hz, H-6), 3.75 (1H, m, H-6‟), 









N-Acetyl-D-glucosamine 5.12 (100 mg, 0.45 mmol) and triethylamine (313 µL, 2.26 
mmol) were dissolved in D2O/MeCN (4:1, 2 mL) and the mixture was cooled to 0 °C. 
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ADMP 5.19 (387 mg, 1.3 mmol) was then added, and the reaction was stirred at 0 °C.  
After 1 h, t.l.c. (CHCl3/MeOH, 2:1) indicated the complete consumption of the starting 
material (Rf 0.2), and the formation of two major products (Rf 0.5, 0.6). The reaction 
mixture was acidified to pH 2 by the dropwise addition of aqueous 1.2 M HCl and then 
neutralized by addition of saturated aqueous NaHCO3 solution. Alkyne 5.9 (223 mg, 0.9 
mmol) dissolved in 10 mL of MeCN, CuSO4∙5H2O (1.7 mg, 7 µmol), and L-ascorbic acid 
(15.9 mg, 0.09 mmol) were added, and the reaction mixture was stirred at 90 °C. After 14 
h, t.l.c. (CHCl3/MeOH, 4:1) indicated the complete consumption of starting material (Rf 
0.3) and the formation of a major product (Rf 0.5). The reaction mixture was 
concentrated, and the residue was dissolved in MeCN (20 mL), filtered through Celite
®
, 
and concentrated in vacuo. The residue was dissolved in MeOH (30 mL), and then 
NaOMe (3.2 M solution in MeOH) was added. The reaction was stirred at rt for 12 h. The 
solution was neutralized (confirmed by pH paper) by the addition of aqueous 1M HCl, 
and concentrated in vacuo. An unsuccessful attempt was made to purify the residue by 
flash chromatography (CHCl3:MeOH, 10:1). The product co-eluted along with ascorbic 
acid-related impurities. δH (400 MHz, CD3OD) 1.67 (3H, s, NHCOCH3), 2.90 (2H, m, 
CH2S), 3.52-3.83 (14H, m, H-3, H-4, H-5, H-6, 5 x CH2O), 3.90 (1H, m, H-6`), 4.20 (1H, 
m, H-2), 4.60 (2H, s, CH2O), 5.80 (1H, d, J1,2 10 Hz, H-1), 8.17 (1H, s, C=CH); HRMS 
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1-Mercapta-3,6,9-trioxadodec-11-yne-functionalized AuNPs (ATT-AuNPs) 
 
 
An aqueous solution of trisodium citrate (10 mL, 42.9 mM) was added to a boiling 
aqueous solution of HAuCl4∙3H2O (100 mL, 1 mM) with constant stirring (500 rpm). 
After 15 min, the reaction mixture was cooled to rt, and a solution of ATT 5.11 (150 mg, 
0.74 mmol) in MeOH (50 mL) was added. The reaction was stirred for 24 h at rt. The 
reaction mixture was concentrated in vacuo, and the residue was washed with water (3 x 
10 mL). It was then dissolved in MeOH and purified by centrifugation (4 x 6000 rpm) to 
afford ATT-AuNPs (20 mg). TEM: 12.0 ± 1.4 nm; IR (KBr): 2921 (s, H2CC-H stretch), 
1458 (w, H2CC-H bend), 1084 (s, C-O) cm
-1
; UV: 541 nm; TGA: ligand 45.4%, Au 
54.6%; δH (400 MHz, CDCl3) 2.44 (br. s, H2CCCH), 2.70-3.03 (br. m, CH2S), 3.50 - 3.80 
(br. m, CH2O), 4.20 (br. s, H2CCCH); HRMS (ESI) Calcd. For C9H16O3SNa (MNa
+
) 
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AuNPs functionalized with the GlcNAc triazole 5.27 
 
 
N-Acetyl-D-glucosamine 5.12 (10 mg, 0.045 mmol) and triethylamine (32 µL, 0.26 
mmol) were dissolved in D2O/MeCN (4:1, 0.2 mL) and the mixture was cooled to 0 °C. 
ADMP 5.19 (38 mg, 0.13 mmol) was then added, and the reaction was stirred at 0 °C. 
After 1 h, t.l.c. (CHCl3/MeOH, 2:1) indicated the complete consumption of the starting 
material (Rf 0.2), and the formation of two major products (Rf 0.5, 0.6). The reaction 
mixture was acidified to pH 2 by the dropwise addition of aqueous 1.2 M HCl and then 
neutralized by addition of saturated aqueous NaHCO3 solution. The solution pH was 
followed by using pH paper. ATT-AuNP (3 mg) dissolved in 2 mL of THF, L-ascorbic 
acid (25 mg, 0.14 mmol), CuSO4∙5H2O (2.5 mg, 0.01 mmol) dissolved in H2O were 
added to the reaction and stirred under nitrogen at rt. After 24 h, reaction mixture was 
dialyzed in H2O for 3 d and then lyophilized to obtain AuNPs functionalized with the 
GlcNAc triazole 5.27 (aggregated) (1 mg). δH (400 MHz, D2O) 1.67 (br. s, NHCOCH3), 
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2.80-2.90(m, CH2S), 3.30-3.80 (m, H-3, H-4, H-5, H-6, 5 x CH2O), 4.00 (br. s, H-6`), 4.2 
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Figure A3.2. FT-IR spectra of Gal-gAuNP-7. 
 








Figure A3.4. FT-IR spectra of Gal-gAuNP-20. 
 


























Figure A3.6. Size distribution histograms of a) Gal-gAuNP-2 (2.3 ± 0.5 nm), b) Gal-
gAuNP-7 (7.3 ± 0.9 nm), c) Gal-gAuNP-12 (12.0 ± 1.7 nm), and (d) Gal-gAuNP-20 
(20.3 ± 1.8 nm). At least 200 AuNPs were measured for the statistics of particle size 
















Figure A3.8. TGA plot of Gal-gAuNP-7. 
 








Figure A3.10. TGA plot of Gal-gAuNP-20. 
 
               
 
 




















































Figure A5.2. TGA plot of ATT-AuNPs. 
 
 
Figure A5.3. Size distribution histograms of Cit-AuNPs (12.1 ± 1.5 nm) and ATT-





























H-NMR spectrum of the compound 5.27 co-eluted with ascorbic acid-
related impurities. 
 
 
 
 
 
 
 
 
